Más de 11.000 Artículos Compilados por el Dr. Ricardo Kotliroff

Creo en la intuición y la inspiración. La imaginación es más importante que el conocimiento. Mientras que el conocimiento es limitado, la imaginación abraza al mundo entero, estimulando el progreso, dando luz a la evolución. Es, estrictamente hablando, un factor real en la investigación científica.

Albert Einstein

Cuando las leyes de la matemática se refieren a la realidad, no son ciertas; cuando son ciertas, no se refieren a la realidad.

Albert Einstein

Concerning matter, we have been all wrong. What we have called matter is energy, whose vibration has been so lowered as to be perceptible to the senses. There is no matter.

Albert Einstein

Spreading out the particle into a string is a step in the direction of making everything we're familiar with fuzzy. You enter a completely new world where things aren't at all what you're used to.

Edward Witten

String theory is an attempt at a deeper description of nature by thinking of an elementary particle not as a little point but as a little loop of vibrating string.

Edward Witten
  • Coronavirus 2019 (COVID-19)
  • Sección #1
  • Sección #2
  • Sección #3
  • Sección #4
  • Sección #5
  • Sección #6
  • Sección #7
  • Sección #8
  • Sección #9
  • Sección #10
  • 2018-2019
  1. Adams, M. J. et al. 50 years of the International Committee on Taxonomy of Viruses: progress and prospects. Arch. Virol. 162, 1441–1446 (2017).
  2. Administration for Community Living. 2017 profile of older Americans. Washington, DC: US Department of Health and Human Services, Administration for Community Living; 2018. https://acl.gov/sites/
  3. Ai T, Yang Z, Hou H, et al. Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases. Radiology 2020; :200642.
  4. Andersen, K.G., Rambaut, A., Lipkin, W.I. et al. The proximal origin of SARS-CoV-2. Nat Med (2020). https://doi.org/10.1038/s41591-020-0820-9
  5. Anderson J Ferreira, José A Hernández Prada, David A Ostrov and Mohan K Raizada, Cardiovascular protection by angiotensin-converting enzyme 2: a new paradigm, Future Cardiology, 10.2217/14796678.4.2.175, 4, 2, (175-182), (2008).
  6. Anderson J. Ferreira and Mohan K. Raizada, Are we poised to target ACE2 for the next generation of antihypertensives?, Journal of Molecular Medicine, 10.1007/s00109-008-0339-x, 86, 6, (685-690), (2008).
  7. Andre, P. et al. Anti-NKG2A mAb is a checkpoint inhibitor that promotes anti-tumor immunity by unleashing both T and NK cells. Cell 175, 1731–1743 (2018).
  8. Andrew B Goulter, Martin J Goddard, Jennifer C Allen and Kenneth L Clark, ACE2 gene expression is up-regulated in the human failing heart, BMC Medicine, 10.1186/1741-7015-2-19, 2, 1, (2004).
  9. Angeletti S, Benvenuto D, Bianchi M, Giovanetti M, Pascarella S, Ciccozzi M. COVID-2019: The role of the nsp2 and nsp3 in its pathogenesis. J. Med. Virol. 2020 Feb 21; [PubMed]
  10. Ankel H, Westra DF, Welling-Wester S, Lebon P. Induction of interferon-alpha by glycoprotein D of herpes simplex virus: a possible role of chemokine receptors. Virology. 1998;251:317–326. doi: 10.1006/viro.1998.9432.
  11. Anna de Lang, Albert D.M.E Osterhaus and Bart L. Haagmans, Interferon-γ and interleukin-4 downregulate expression of the SARS coronavirus receptor ACE2 in Vero E6 cells, Virology, 10.1016/j.virol.2006.06.011, 353, 2, (474-481), (2006).
  12. Anna Vašků, Julie Bienertová-Vašků, Jiří Pařenica, Monika Pávkova Goldbergová, Jolana Lipková, Filip Zlámal, Petr. Kala and Jindřich Špinar, ACE2 gene polymorphisms and invasively measured central pulse pressure in cardiac patients indicated for coronarography, Journal of the Renin-Angiotensin-Aldosterone System, (220-226), (2012).
  13. Anthony J. Turner and Nigel M. Hooper, Angiotensin-Converting Enzyme-2 (ACE2), xPharm: The Comprehensive Pharmacology Reference, 10.1016/B978-008055232-3.62913-7, (1-4), (2007).
  14. Anthony J. Turner, Adrenomedullin Receptor, xPharm: The Comprehensive Pharmacology Reference, 10.1016/B978-008055232-3.60179-5, (1-12), (2007).
  15. APA Roeska, K., & Seilheimer, B. (2010). Antiviral activity of Engystol® and Gripp-Heel®: an in-vitro assessment. Journal of immune based therapies and vaccines, 8, 6. https://doi.org/10.1186/1476-8518-8-6
  16. Au WC, Moore PA, LaFleur DW, Tombal B, Pitha PM. Characterization of the interferon regulatory factor-7 and its potential role in the transcription activation of interferon A genes. J Biol Chem.
  17. Baas, T., A. Roberts, T. H. Teal, L. Vogel, J. Chen, T. M. Tumpey, M. G. Katze, and K. Subbarao. 2008. Genomic analysis reveals age-dependent innate immune responses to severe acute respiratory syndrome coronavirus. J. Virol. 82:9465-9476.
  18. Bai HX, Hsieh B, Xiong Z, et al. Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT. Radiology 2020; :200823.
  19. Bai Y, Yao L, Wei T, et al. Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA 2020.
  20. Bajema KL, Oster AM, McGovern OL, et al. Persons Evaluated for 2019 Novel Coronavirus - United States, January 2020. MMWR Morb Mortal Wkly Rep 2020; 69:166.
  21. Barathan, M. et al. Viral persistence and chronicity in hepatitis C virus infection: role of T-cell apoptosis, senescence and exhaustion. Cells 7, 165 (2018).
  22. Barber, D. L. et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439, 682–687 (2006).
  23. Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., et al. (2006). Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439, 682–687. doi: 10.1038/nature04444
  24. Barry R. Palmer, Martin D. Jarvis, Anna P. Pilbrow, Katrina et al. Angiotensin-converting enzyme 2 A1075G polymorphism is associated with survival in an acute coronary syndromes cohort, American Heart Journal, 10.1016/j.ahj.2008.06.013, 156, 4, (752-758), (2008).
  25. Bastola A, Sah R, Rodriguez-Morales AJ, Lal BK, Jha R, et al. 2020. The first 2019 novel coronavirus case in Nepal. Lancet Infect Dis 20:279–280. doi:10.1016/S1473-3099(20)30067-0.
  26. Bauch CT, Lloyd-Smith JO, Coffee MP, Galvani AP. Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future. Epidemiology. 2005 Nov;16(6):791-801.
  27. Belouzard, S. et al. Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites(2009) Proc. Natl. Acad. Sci. U.S.A. 106:5871.
  28. Belperio, J. A., M. P. Keane, M. D. Burdick, J. P. Lynch III, Y. Y. Xue, A. Berlin, D. J. Ross, S. L. Kunkel, I. F. Charo, and R. M. Strieter. 2001. Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome. J. Clin. Invest. 108:547-556.
  29. Bender, B. S., T. Croghan, L. Zhang, and P. A. Small, Jr. 1992. Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge. J. Exp. Med. 175:1143-1145.
  30. Benjamin J. Weidemann, Susan Voong, Fabiola I. Morales-Santiago, Michael Z. Kahn, et al. Dietary Sodium Suppresses Digestive Efficiency via the Renin-Angiotensin System, Scientific Reports, 10.1038/srep11123, 5, 1, (2015).
  31. Biron CA. Role of early cytokines, including alpha and beta interferons (IFN-alpha/beta), in innate and adaptive immune responses to viral infections. Semin Immunol. 1998;10:383–390. doi: 10.1006/smim.1998.0138.
  32. Brigitte A Wevers and Lia van der Hoek, Renin–angiotensin system in human coronavirus pathogenesis, Future Virology, 10.2217/fvl.10.4, 5, 2, (145-161), (2010).
  33. Brown, D. M., E. Roman, and S. L. Swain. 2004. CD4 T cell responses to influenza infection. Semin. Immunol. 16:171-177.CrossRefPubMedWeb of ScienceGoogle Scholar
  34. Burke RM, Midgley CM, Dratch A, et al. Active Monitoring of Persons Exposed to Patients with Confirmed COVID-19 - United States, January-February 2020. MMWR Morb Mortal Wkly Rep 2020; 69:245.
  35. Carpéné, C. Dray, C. Attané, P. Valet, M. P. Portillo, I. Churruca, et al. Expanding role for the apelin/APJ system in physiopathology Implicación del sistema apelina/APJ en procesos fisiopatológicos (minirrevisión), Journal of Physiology and Biochemistry, 10.1007/BF03165767, 63, 4, (358-373), (2007).
  36. Tikellis, C. I. Johnston, J. M. Forbes, W. C. Burns, M. C. Thomas, et al, Identification of angiotensin converting enzyme 2 in the rodent retina, Current Eye Research, 10.1080/02713680490517944, 29, 6, (419-427), (2009).
  37. Walls, M. A. Tortorici, B. Frenz, J. Snijder, W. Li, F. A. Rey, Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy. Nat. Struct. Mol. Biol. 23, 899–905 (2016).
  38. Walls, M. A. Tortorici, J. Snijder, X. Xiong, B.-J. Bosch, F. A. Rey, D. Veesler, Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion. Proc. Natl. Acad. Sci. U.S.A. 114, 11157–11162 (2017).
  39. Walls, X. Xiong, Y.-J. Park, M. A. Tortorici, J. Snijder, et al Unexpected receptor functional mimicry elucidates activation of coronavirus fusion. Cell 176, 1026–1039.e15 (2019).
  40. -Y. Lu, H.-Y. Huang, T.-H. Yang, L.-Y. Chang, C.-Y. Lee and L.-M. Huang, siRNA silencing of angiotensin-converting enzyme 2 reduced severe acute respiratory syndrome-associated coronavirus replications in Vero E6 cells, European Journal of Clinical Microbiology & Infectious Diseases, 10.1007/s10096-008-0495-5, 27, 8, (709-715), (2008).
  41. Cai J, Xu J, Lin D, et al. A Case Series of children with 2019 novel coronavirus infection: clinical and epidemiological features. Clin Infect Dis 2020.
  42. Cameron, M. J., L. Ran, L. Xu, A. Danesh, J. F. Bermejo-Martin, Cao B, Wang Y, Wen D, et al. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med 2020.
  43. Cao B, Wang Y, Wen D, et al. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med 2020.
  44. Carlos M. Ferrario, Aaron J. Trask and Jewell A. Jessup, Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1–7) in regulation of cardiovascular function, American Journal of Physiology-Heart and Circulatory Physiology, (2005).
  45. Carmen Wolke, Alexander Teumer, Karlhans Endlich, Nicole Endlich, Rainer Rettig, et al. Serum protease activity in chronic kidney disease patients: The GANI_MED renal cohort, Experimental Biology and Medicine, 10.1177/1535370216684040, 242, 5, (554-563), (2016).
  46. Carragher, N. Kisseberth, D. Kriegman, R. A. Milligan, C. S. Potter, J. Pulokas, A. Reilein, Leginon: An automated system for acquisition of images from vitreous ice specimens. J. Struct. Biol. 132, 33–45 (2000).
  47. Carroll, D. et al. The global virome project. Science 359, 872–874 (2018).
  48. Cavanagh, D. A nomenclature for avian coronavirus isolates and the question of species status. Avian Pathol. 30, 109–115 (2001).
  49. CDC, Washington State report first COVID-19 death [Media statement]. Atlanta, GA: US Department of Health and Human Services, CDC; 2020. https://www.cdc.gov/media/releases/2020/s0229-COVID19-first-death.html
  50. Coronavirus disease 2019 (COVID-19): cases in U.S. Atlanta, GA: US Department of Health and Human Services, CDC; 2020. https://www.cdc.gov/coronavirus/2019-ncov/cases-in-us.html
  51. Coronavirus disease 2019 (COVID-19): if you are at higher risk. Get ready for COVID-19 now. Atlanta, GA:US Department of Health and Human Services; 2020. https://www.cdc.gov/coronavirus/2019- ncov/specific-groups/high-risk-complications.html
  52. Coronavirus disease 2019 (COVID-19): information for health departments on reporting a person under investigation (PUI), or presumptive positive and laboratory-confirmed cases of COVID-19. Atlanta, GA: US Department of Health and Human Services, CDC; 2020. https://www.cdc. gov/coronavirus/2019-ncov/php/reporting-pui.html
  53. Coronavirus disease 2019 (COVID-19): schools, workplaces, & community locations. Atlanta, GA: US Department of Health and Human Services, CDC; 2020. https://www.cdc.gov/coronavirus/2019-ncov/ community/index.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fpreparing-individualscommunities.html
  54. Centers for Disease Control and Prevention: Coronavirus Disease 2019 (COVID-19): COVID-19 Situation Summary. Atlanta,GA, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Updated February 26, 2020. Accessed February 27, 2020.
  55. Centers for Disease Control and Prevention. 2019 Novel coronavirus, Wuhan, China. Information for Healthcare Professionals. https://www.cdc.gov/coronavirus/2019-nCoV/hcp/index.html (Accessed on February 14, 2020).
  56. Centers for Disease Control and Prevention. 2019 Novel Coronavirus (2019-nCoV) in the US. https://www.cdc.gov/coronavirus/2019-ncov/cases-in-us.html (Accessed on February 10, 2020).
  57. Centers for Disease Control and Prevention. First travel-related case of 2019 novel coronavirus detected in United States, January 21, 2020.
  58. Centers for Disease Control and Prevention. Get your mass gatherings or large community events ready. https://www.cdc.gov/coronavirus/2019-ncov/community/large-events/mass-gatherings-ready-for-covid-19.html (Accessed on March 17, 2020).
  59. Centers for Disease Control and Prevention. Interim Clinical Guidance for Management of Patients with Confirmed 2019 Novel Coronavirus (2019-nCoV) Infection, Updated February 12, 2020. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html (Accessed on February 14, 2020).
  60. Centers for Disease Control and Prevention. Interim Considerations for Disposition of Hospitalized Patients with 2019-nCoV Infection. https://www.cdc.gov/coronavirus/2019-ncov/hcp/disposition-hospitalized-patients.html (Accessed on February 11, 2020).
  61. Centers for Disease Control and Prevention. Interim Guidance for Implementing Home Care of People Not Requiring Hospitalization for 2019 Novel Coronavirus (2019-nCoV). Updated Janury 31, 2020. https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-home-care.html (Accessed on February 04, 2020).
  62. Centers for Disease Control and Prevention. Interim guidance for persons who may have 2019 Novel Coronavirus (2019-nCoV) to prevent spread in homes and residential communities. https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-prevent-spread.html#First_heading (Accessed on February 06, 2020).
  63. Centers for Disease Control and Prevention. Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons Under Investigation (PUIs) for Coronavirus Disease 2019 (COVID-19). February 14, 2020. https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specimens.html (Accessed on March 15, 2020).
  64. Centers for Disease Control and Prevention. Interim Infection Prevention and Control Recommendations for Patients with Confirmed 2019 Novel Coronavirus (2019-nCoV) or Patients Under Investigation for 2019-nCoV in Healthcare Settings. February 3, 2020. https://www.cdc.gov/coronavirus/2019-nCoV/hcp/infection-control.html (Accessed on March 11, 2020).
  65. Centers for Disease Control and Prevention. Second travel-related case of 2019 novel coronavirus detected in United States, January 24, 2020. https://www.cdc.gov/media/releases/2020/p0124-second-travel-coronavirus.html (Accessed on January 24, 2020).
  66. Centers for Disease Control and Prevention. Severe outcomes among patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020. https://www.cdc.gov/mmwr/volumes/69/wr/mm6912e2. (Accessed on March 19, 2020).
  67. Centers for Disease Control and Prevention. Strategies to Prevent the Spread of COVID-19 in Long-Term Care Facilities (LTCF). https://www.cdc.gov/coronavirus/2019-ncov/healthcare-facilities/prevent-spread-in-long-term-care-facilities.html (Accessed on March 08, 2020).
  68. Centers for Disease Control and Prevention. Updated Guidance on Evaluating and Testing Persons for COVID-19. HAN429. https://emergency.cdc.gov/han/2020/han00429.asp?deliveryName=USCDC_511-DM22015 (Accessed on March 09, 2020).
  69. Cervantes-Barragan, L., R. Zust, F. Weber, M. Spiegel, K. S. Lang, S. Akira, V. Thiel, and B. Ludewig. 2007. Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon. Blood 109:1131-1137.
  70. Chan JF, Kok KH, Zhu Z, Chu H, To KK, Yuan S, Yuen KY. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020 Dec;9(1):221-236.
  71. Chan JF, To KK, Tse H, Jin DY, Yuen KY. Interspecies transmission and emergence of novel viruses: lessons from bats and birds. Trends Microbiol. 2013 Oct;21(10):544-55.
  72. Chan JF, Yao Y, Yeung ML, et al. Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset. J Infect Dis 2015; 212:1904.
  73. Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020; 395:514.
  74. Chan-Yeung, M., and R. H. Xu. 2003. SARS: epidemiology. Respirology 8(Suppl.):S9-S14.
  75. Chan, S. Yuan, K.-H. Kok, K. K.-W. To, H. Chu, J. Yang,et al A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster. Lancet 395, 514–523 (2020).
  76. Chang YC, Yu CJ, Chang SC, et al. Pulmonary sequelae in convalescent patients after severe acute respiratory syndrome: evaluation with thin-section CT. Radiology 2005; 236:1067–1075
  77. Chang, Lin M, Wei L, et al. Epidemiologic and Clinical Characteristics of Novel Coronavirus Infections Involving 13 Patients Outside Wuhan, China. JAMA 2020.
  78. Channappanavar, R. & Perlman, S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin. Immunopathol. 39, 529–539 (2017).
  79. Charo, I. F., and R. M. Ransohoff. 2006. The many roles of chemokines and chemokine receptors in inflammation. N. Engl. J. Med. 354:610-621.
  80. Chen H, Guo J, Wang C, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet 2020; 395:809.
  81. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395:507.
  82. Chen Y, Liu Q, Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J. Med. Virol. 2020 Apr;92(4):418-423.
  83. Chen, K. H. Lee, D. A. Steinhauer, D. J. Stevens, J. J. Skehel, D. C. Wiley, Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation. Cell 95, 409–417 (1998).
  84. Cheung, C. Y., L. L. Poon, I. H. Ng, W. Luk, S. F. Sia, M. H. Wu, K. H. Chan, K. Y. Yuen, S. Gordon, Y. Guan, and J. S. Peiris. 2005. Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis. J. Virol. 79:7819-7826.
  85. Chhinder P. Sodhi, Christine Wohlford-Lenane, Yukihiro Yamaguchi, et al.Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg 9 bradykinin/BKB1R axis and facilitates LPS-induced neutrophil infiltration , American Journal of Physiology-Lung Cellular and Molecular Physiology, 10.1152/ajplung.00498.2016, 314, 1, (L17-L31), (2018).
  86. Chien, J. Y., P. R. Hsueh, W. C. Cheng, C. J. Yu, and P. C. Yang. 2006. Temporal changes in cytokine/chemokine profiles and pulmonary involvement in severe acute respiratory syndrome. Respirology 11:715-722.
  87. Chih-Fong Chou, Chay Boon Loh, Yik Khoon Foo, Shuo Shen, Burtram C. Fielding, Timothy H.P. Tan, Sehaam Khan, Yue Wang, Seng Gee Lim, Wanjin Hong, Yee-Joo Tan and Jianlin Fu, ACE2 orthologues in non-mammalian vertebrates (Danio, Gallus, Fugu, Tetraodon and Xenopus), Gene, 10.1016/j.gene.2006.03.010, 377, (46-55), (2006).
  88. Chih-Fong Chou, Shuo Shen, Yee-Joo Tan, Burtram C. Fielding, Timothy H.P. Tan, Jianlin Fu, Qiurong Xu, Seng Gee Lim and Wanjin Hong, A novel cell-based binding assay system reconstituting interaction between SARS-CoV S protein and its cellular receptor, Journal of Virological Methods, 10.1016/j.jviromet.2004.09.008, 123, 1, (41-48), (2005).
  89. Chih-Sheng Lin, Chun-Hsu Pan, Cheng-Hao Wen, Tzu-Hui Yang and Tang-Ching Kuan, Regulation of angiotensin converting enzyme II by angiotensin peptides in human cardiofibroblasts, Peptides, 10.1016/j.peptides.2010.03.026, 31, 7, (1334-1340), (2010).
  90. Chris Tikellis and Colin I. Johnston, Angiotensin-Converting Enzymes: Properties and Function, Hypertension, 10.1016/B978-0-7216-0258-5.50099-5, (95-99), (2005).
  91. Christensen, J. P., C. Bartholdy, D. Wodarz, and A. R. Thomsen. 2001. Depletion of CD4+ T cells precipitates immunopathology in immunodeficient mice infected with a noncytocidal virus. J. Immunol. 166:3384-3391.
  92. Christy S Carter, Drake Morgan, Amrisha Verma, Gilberto Lobaton, Victor Aquino, Elaine Sumners, Mohan Raizada, Qiuhong Li and Thomas W Buford, Therapeutic Delivery of Ang(1–7) via Genetically Modified Probiotic: A Dosing Study, The Journals of Gerontology: Series A, 10.1093/gerona/glz222, (2019).
  93. Chu DKW, Pan Y, Cheng SMS, Hui KPY, Krishnan P, Liu Y, Ng DYM, Wan CKC, Yang P, Wang Q, Peiris M, Poon LLM. 2020. Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia. Clin Chem. doi:10.1093/clinchem/hvaa029.
  94. Chun-yan XIA, Hui-min LIU, Ling LI, Xiao-min SHI, Yi XU and Wen-ming CONG, Expression of angiotensin-converting enzyme 2 is increased during preservation injury of liver transplantation in rats, Academic Journal of Second Military Medical University, 10.3724/SP.J.1008.2009.00757, 29, 7, (757-761), (2010).
  95. Clare A. McKinney, Caroline Fattah, Christopher M. Loughrey, Graeme Milligan and Stuart A. Nicklin, Angiotensin-(1–7) and angiotensin-(1–9): function in cardiac and vascular remodelling, Clinical Science, 10.1042/CS20130436, 126, 12, (815-827), (2014).
  96. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China - JAMA, Wang et al., February 7, 2020
  97. Colleen T. Cole-Jeffrey, Meng Liu, Michael J. Katovich, Mohan K. Raizada and Vinayak Shenoy, ACE2 and Microbiota, Journal of Cardiovascular Pharmacology, 10.1097/FJC.0000000000000307, 66, 6, (540-550), (2015).
  98. Colson P, Rolain JM, Lagier JC, et al. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents 2020; :105932.
  99. Corman, V. M., Muth, D., Niemeyer, D. & Drosten, C. Hosts and sources of endemic human coronaviruses. Adv. Virus Res. 100, 163–188 (2018).
  100. Coronavirus disease (COVID-19) outbreak (World Health Organization, 2020); https://www.who.int/emergencies/diseases/novel-coronavirus-2019
  101. Cortegiani A, Ingoglia G, Ippolito M, et al. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. J Crit Care 2020.
  102. Cousens, L. P., J. S. Orange, and C. A. Biron. 1995. Endogenous IL-2 contributes to T cell expansion and IFN-gamma production during lymphocytic choriomeningitis virus infection. J. Immunol. 155:5690-5699.
  103. Coutard, C. Valle, X. de Lamballerie, B. Canard, N. G. Seidah, E. Decroly, The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Res. 176, 104742 (2020).
  104. Cui Y, Tian M, Huang D, et al. A 55-Day-Old Female Infant infected with COVID 19: presenting with pneumonia, liver injury, and heart damage. J Infect Dis 2020.
  105. Dai J, Megjugorac NJ, Amrute SB, Fitzgerald-Bocarsly P. Regulation of IFN regulatory factor-7 and IFN-alpha production by enveloped virus and lipopolysaccharide in human plasmacytoid dendritic cells. J Immunol. 2004;173:1535–1548.
  106. Dan Harmer Maureen Gilbert  Richard Borman  Kenneth L Clark Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme First published:07 November 2002
  107. Daniel W. Lambert, Nicola E. Clarke and Anthony J. Turner, Not just angiotensinases: new roles for the angiotensin-converting enzymes, Cellular and Molecular Life Sciences, 10.1007/s00018-009-0152-x, 67, 1, (89-98), (2009).
  108. Das KM, Lee EY, Enani MA, et al. CT correlation with outcomes in 15 patients with acute Middle East respiratory syndrome coronavirus. AJR 2015; 204:736–742
  109. David Baud, Xiaolong Qi, Karin Nielsen-Saines, Didier Musso, Léo Pomar, Guillaume Favre. Real estimates of mortality following COVID-19 infection. Published:March 12, 2020DOI:https://doi.org/10.1016/S1473-3099(20)30195-X
  110. David M. Morens, M.D., Peter Daszak, Ph.D., and Jeffery K. Taubenberger, M.D., Ph.D. Escaping Pandora’s Box — Another Novel Coronavirus N Engl J Med March 5, 2020
  111. Day M. Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists. BMJ 2020; 368:m1086.
  112. de Groot, R. J. et al. in Virus Taxonomy, Ninth Report of the International Committee o Taxonomy of Viruses (eds King, A. M. Q. et al.) 806–828 (Elsevier Academic Press, 2012).
  113. de Groot, R. J. et al. Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J. Virol. 87, 7790–7792 (2013).
  114. de Wit E, Feldmann F, Cronin J, Jordan R, Okumura A, Thomas T, et al. Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection. Proc. Natl. Acad. Sci. U.S.A. 2020 Feb 13.
  115. de Wit, E., van Doremalen, N., Falzarano, D. et al. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol 14, 523–534 (2016). https://doi.org/10.1038/nrmicro.2016.81
  116. DGS-urgent Actualisation recommandations Covid 19 Le 14/03/2020 18:38 Réf : 2020-REC-12 Objet : Actualisation recommandations Covid 19 https://dgs-urgent.sante.gouv.fr/dgsurgent/inter/detailsMessageBuilder.do?id=30500&cmd=visualiserMessage
  117. Ding, Y., L. He, Q. Zhang, Z. Huang, X. Che, J. Hou, H. Wang, et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J. Pathol. 203:622-630.
  118. Donnelly, C. A., M. C. Fisher, C. Fraser, A. C. Ghani, S. Riley, N. M. Ferguson, and R. M. Anderson. 2004. Epidemiological and genetic analysis of severe acute respiratory syndrome. Lancet Infect. Dis. 4:672-683.
  119. Doremalen N, Bushmaker T, Morris DH, et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med 2020.
  120. Drosten, C., S. Gunther, W. Preiser, S. van der Werf, H. R. Brodt, S. Becker, H. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 348:1967-1976.
  121. Duncan J. John Campbell, ACE Inhibition in Heart Failure and Ischaemic Heart Disease, Frontiers in Research of the Renin-Angiotensin System on Human Disease, 10.1007/978-1-4020-6372-5_2, (21-54), (2008).
  122. Early Release / Vol. 69 March 18, 2020 U.S. Department of Health and Human Services Centers for Disease Control and Prevention Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020
  123. Eichelberger, M., W. Allan, M. Zijlstra, R. Jaenisch, and P. C. Doherty. 1991. Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8+ T cells. J. Exp. Med. 174:875-880.
  124. Enbergs H. Effects of the homeopathic preparation Engystol on interferon-gamma production by human T-lymphocytes. Immunol Invest. 2006;35:19–27
  125. Engeland, C. E. et al. CTLA-4 and PD-L1 checkpoint blockade enhances oncolytic measles virus therapy. Mol. Ther. 22, 1949–1959 (2014).
  126. Epstein, S. L., C. Y. Lo, J. A. Misplon, C. M. Lawson, B. A. Hendrickson, E. E. Max, and K. Subbarao. 1997. Mechanisms of heterosubtypic immunity to lethal influenza A virus infection in fully immunocompetent, T cell-depleted, beta2-microglobulin-deficient, and J chain-deficient mice. J. Immunol. 158:1222-1230.
  127. European Centre for Disease Prevention and Control. Geographical distribution of 2019-nCov cases. https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases (Accessed on January 26, 2020).
  128. European Centre for Disease Prevention and Control. Novel coronavirus in China. https://www.ecdc.europa.eu/en/novel-coronavirus-china (Accessed on January 23, 2020).
  129. European Medicines Agency. EMA gives advice on the use of non-steroidal anti-inflammatories for COVID-19 https://www.ema.europa.eu/en/news/ema-gives-advice-use-non-steroidal-anti-inflammatories-covid-19 (Accessed on March 19, 2020).
  130. European Societyof Hypertension. ESH Statement on COVID-19. https://www.eshonline.org/spotlights/esh-statement-on-covid-19/ (Accessed on March 18, 2020).
  131. Pettersen, T. D. Goddard, C. C. Huang, G. S. Couch, et al. UCSF Chimera—A visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605–1612 (2004).
  132. Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med 2020.
  133. Fang Y, Zhang H, Xu Y, Xie J, Pang P, Ji W. CT manifestations of two cases of 2019 novel corona-virus (2019-nCoV) pneumonia. Radiology 2020 Feb 7
  134. Favre G, Pomar L, Qi X, et al. Guidelines for pregnant women with suspected SARS-CoV-2 infection. Lancet Infect Dis 2020.
  135. Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol. 2015;1282:1-23. doi: 10.1007/978-1-4939-2438-7_1. PMID: 25720466; PMCID: PMC
  136. Fehr, A.R. and S. Perlman (2015) Methods Mol. Biol. 1282:1. Centers for Disease Control and Prevention (n.d.) Common Human Coronaviruses. https://www.cdc.gov/coronavirus/general-information.html.
  137. Fimiani VC, Antonia, Ainis, Tommaso. Immunomodulatory Effect of the Homoeopathic Drug Engystol-N on Some Activities of Isolated Human Leucocytes and in Whole Blood. Immunopharmacology and Immunotoxicology. 2000;22:103–115. doi: 10.3109/08923970009016409. [PubMed] [CrossRef] [Google Scholar]
  138. Fiona J. Warner, Jodie L. Guy, Dan W. Lambert, et al. Angiotensin converting enzyme-2 (ACE2) and its possible roles in hypertension, diabetes and cardiac function, Letters in Peptide Science, 10.1007/BF02442567, 10, 5-6, (377-385), (2003).
  139. Fiona J. Warner, John S. Lubel, Geoffrey W. McCaughan and Peter W. Angus, Liver fibrosis: a balance of ACEs?, Clinical Science, 10.1042/CS20070026, 113, 3, (109-118), (2007).
  140. Fiona J. Warner, Rebecca A. Lew, A. Ian Smith, Daniel W. Lambert, Nigel M. Hooper and Anthony J. Turner, Angiotensin-converting Enzyme 2 (ACE2), But Not ACE, Is Preferentially Localized to the Apical Surface of Polarized Kidney Cells, Journal of Biological Chemistry, 10.1074/jbc.M508914200, 280, 47, (39353-39362), (2005).
  141. Florian Gembardt, Anja Sterner-Kock, Hans Imboden, Matthias Spalteholz, et al. Organ-specific distribution of ACE2 mRNA and correlating peptidase activity in rodents, Peptides, 10.1016/j.peptides.2005.01.009, 26, 7, (1270-1277), (2005).
  142. Florian Krammer, Gavin J. D. Smith, Ron A. M. Fouchier, Malik Peiris, Katherine Kedzierska, et al. Influenza. Nature Reviews Disease Primers volume 4, Article number: 3 (2018)
  143. Forni, D., Cagliani, R., Clerici, M. & Sironi, M. Molecular evolution of human coronavirus genomes. Trends Microbiol. 25, 35–48 (2017).
  144. Fujisawa, H. 2008. Neutrophils play an essential role in cooperation with antibody in both protection against and recovery from pulmonary infection with influenza virus in mice. J. Virol. 82:2772-2783.
  145. Fumihiro TAGUCHI and Shutoku MATSUYAMA, Cell entry mechanisms of coronaviruses, Uirusu, 10.2222/jsv.59.215, 59, 2, (215-222), (2009).
  146. Gao J, Tian Z, Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends 2020; 14:72.
  147. Gardiner, C. M., and Finlay, D. K. (2017). What fuels natural killers? metabolism and NK cell responses. Front. Immunol. 8:367. doi: 10.3389/fimmu.2017.00367
  148. Gautret et al. (2020) Hydroxychloroquine and azithromycin as a treatment of COVID‐19: results of an open‐label non‐randomized clinical trial. International Journal of Antimicrobial Agents – In Press 17 March 2020 DOI:10.1016/j.ijantimicag.2020.105949.
  149. Genentech Initiates Phase III Clinical Trial Of Actemra In Hospitalized Patients With Severe COVID-19 Pneumonia. Posted March 19, 2020. https://www.gene.com/media/press-releases/14841/2020-03-18/genentech-initiates-phase-iii-clinical-t. Accessed March 19, 2020.
  150. Gerhard, W., A. M. Haberman, P. A. Scherle, A. H. Taylor, G. Palladino, and A. J. Caton. 1991. Identification of eight determinants in the hemagglutinin molecule of influenza virus A/PR/8/34 (H1N1) which are recognized by class II-restricted T cells from BALB/c mice. J. Virol. 65:364-372.
  151. Gilead Sciences Statement on the Company’s Ongoing Response to the 2019 Novel Coronavirus (2019-nCoV). https://www.gilead.com/news-and-press/company-statements/gilead-sciences-statement-on-the-company-ongoing-response-to-the-2019-new-coronavirus (Accessed on February 02, 2020).
  152. Glass, W. G., K. Subbarao, B. Murphy, and P. M. Murphy. 2004. Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice. J. Immunol. 173:4030-4039.
  153. Glatthaar-Saalmuller B. In vitro evaluation of the antiviral effects of the homeopathic preparation Gripp-Heel on selected respiratory viruses. Can J Physiol Pharmacol. 2007;85:1084–1090. doi: 10.1139/Y07-100. [PubMed] [CrossRef] [Google Scholar]
  154. Glowacka, S. Bertram, M. A. Müller, P. Allen, E. Soilleux, S. Pfefferle, Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. J. Virol. 85, 4122–4134 (2011).
  155. González, J. M., Gomez-Puertas, P., Cavanagh, D., Gorbalenya, A. E. & Enjuanes, L. A comparative sequence analysis to revise the current taxonomy of the family Coronaviridae. Arch. Virol. 148, 2207–2235 (2003).
  156. Gorbalenya AE, Baker SC, Baric RS, et al. Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group. bioRxiv 2020. https://www.biorxiv.org/content/10.1101/2020.02.07.937862v1 (Accessed on February 12, 2020).
  157. Gorbalenya, A. E. et al. Practical application of bioinformatics by the multidisciplinary VIZIER consortium. Antiviral Res. 87, 95–110 (2010).
  158. Gorbalenya, A. E. et al. The new scope of virus taxonomy: partitioning the virosphere into 15 hierarchical ranks. Nat. Microbiol. (in the press).
  159. Gorbalenya, A. E., Lauber, C. & Siddell, S. Taxonomy of Viruses, in Reference Module in Biomedical Sciences (Elsevier, 2019) https://doi.org/10.1016/B978-0-12-801238-3.99237-7.
  160. Gorbalenya, A. E., Snijder, E. J. & Spaan, W. J. Severe acute respiratory syndrome coronavirus phylogeny: toward consensus. J. Virol. 78, 7863–7866 (2004).
  161. Gordon CJ, Tchesnokov EP, Feng JY, Porter DP, Gotte M. The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus. J. Biol. Chem. 2020 Feb 24; [PubMed]
  162. Grasselli G, Pesenti A, Cecconi M. Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response. JAMA 2020.
  163. Groneberg DA, Poutanen SM, Low DE, et al. Treatment and vaccines for severe acute respiratory syndrome. Lancet Infect Dis 2005; 5:147.
  164. Gu, C Korteweg Pathology and pathogenesis of severe acute respiratory syndrome - The American journal of pathology, 2007 – Elsevier
  165. Gu, J., E. Gong, B. Zhang, J. Zheng, Z. Gao, et al. 2005. Multiple organ infection and the pathogenesis of SARS. J. Exp. Med. 202:415-424.Abstract/
  166. Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020.
  167. Guillaume Rivière, Annie Michaud, Christophe Breton, Gilles VanCamp, et al. Angiotensin-Converting Enzyme 2 (ACE2) and ACE Activities Display Tissue-Specific Sensitivity to Undernutrition-Programmed Hypertension in the Adult Rat, Hypertension, 10.1161/01.HYP.0000185148.27901.fe, 46, 5, (1169-1174), (2005).
  168. Guillaume Rivière, L'enzyme de conversion de l'angiotensine : une protéase conservée au cours de l'évolution, Journal de la Société de Biologie, 10.1051/jbio/2009032, 203, 4, (281-293), (2010).
  169. Haanen, J. B. & Cerundolo, V. NKG2A, a new kid on the immune checkpoint block. Cell 175, 1720–1722 (2018
  170. Hammer, Q., Rückert, T., and Romagnani, C. (2018). Natural killer cell specificity for viral infections. Nat. Immunol. 19, 800–808. doi: 10.1038/s41590-018-0163-6
  171. Hao Xu, Liang Zhong, Jiaxin Deng, Jiakuan Peng, Hongxia Dan, Xin Zeng, Taiwen Li and Qianming Chen, High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa, International Journal of Oral Science, 10.1038/s41368-020-0074-x, 12, 1, (2020).
  172. He, Z., C. Zhao, Q. Dong, H. Zhuang, S. Song, G. Peng, and D. E. Dwyer. 2005. Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets. Int. J. Infect. Dis. 9:323-330.
  173. Heiko Meyer, Mareike Panz, Stefanie Albrecht, Maik Drechsler, et al. Drosophila metalloproteases in development and differentiation: The role of ADAM proteins and their relatives, European Journal of Cell Biology, 10.1016/j.ejcb.2011.04.015, 90, 9, (770-778), (2011).
  174. Heleia Roca-Ho, Marta Riera, Vanesa Palau, Julio Pascual and Maria Soler, Characterization of ACE and ACE2 Expression within Different Organs of the NOD Mouse, International Journal of Molecular Sciences, 10.3390/ijms18030563, 18, 3, (563), (2017).
  175. Hiscott J. Triggering the innate antiviral response through IRF-3 activation. J Biol Chem. 2007;282:15325–15329. doi: 10.1074/jbc.R700002200. [PubMed] [CrossRef] [Google Scholar]
  176. Hiscott, J., Grandvaux, N., Sharma, S., Tenoever, B. R., Servant, M. J., and Lin, R. (2003). Convergence of the NF-kappaB and interferon signaling pathways in the regulation of antiviral defense and apoptosis. Ann. N. Y. Acad. Sci. 1010, 237–248. doi: 10.1196/annals.1299.042
  177. HJ Fang and JK Yang, Tissue-Specific Pattern of Angiotensin-Converting Enzyme 2 Expression in Rat Pancreas, Journal of International Medical Research, 10.1177/147323001003800218, 38, 2, (558-569), (2010).
  178. Hoehl S, Berger A, Kortenbusch M, et al. Evidence of SARS-CoV-2 Infection in Returning Travelers from Wuhan, China. N Engl J Med 2020.
  179. Hoffmann Markus, HannahKleine-Weber, SimonSchroeder, AdineKrüger,AnjaHerrler SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. Available online 5 March 2020 In Press, Corrected Proof
  180. Hogan, R. J., G. Gao, T. Rowe, P. Bell, D. Flieder, J. Paragas, G. P. Kobinger, N. A. Wivel, R. G. Crystal, J. Boyer, H. Feldmann, T. G. Voss, and J. M. Wilson. 2004. Resolution of primary severe acute respiratory syndrome-associated coronavirus infection requires Stat1. J. Virol. 78:11416-11421.Abstract/
  181. Holshue ML, DeBolt C, Lindquist S, et al. First Case of 2019 Novel Coronavirus in the United States. N Engl J Med 2020; 382:929.
  182. Honda K, Yanai H, Takaoka A, Taniguchi T. Regulation of the type I IFN induction: a current view. Int Immunol. 2005;17:1367–1378. doi: 10.1093/intimm/dxh318.
  183. Hong Peng Jia, Dwight C. Look, Ping Tan, Lei Shi, Melissa Hickey, et al. Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia, American Journal of Physiology-Lung Cellular and Molecular Physiology, 10. (2009).
  184. Hosking, M. P., Flynn, C. T., Botten, J., and Whitton, J. L. (2013). CD8+ memory T cells appear exhausted within hours of acute virus infection. J. Immunol. 191, 4211–4222. doi: 10.4049/jimmunol.1300920
  185. https://hypertension.ca/wp-content/uploads/2020/03/2020-30-15-Hypertension-Canada-Statement-on-COVID-19-ACEi-ARB.pdf (Accessed on March 18, 2020).
  186. https://www.cdc.gov/media/releases/2020/p0121-novel-coronavirus-travel-case.html (Accessed on January 21, 2020).
  187. Hu Z, Song C, Xu C, et al. Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China. Sci China Life Sci 2020.
  188. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395:497.
  189. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. [PubMed]
  190. Huang, J., Y. Cao, J. Du, X. Bu, R. Ma, and C. Wu. 2007. Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses. Vaccine 25:6981-6991.
  191. Huang, K. J., I. J. Su, M. Theron, Y. C. Wu, S. K. Lai, C. C. Liu, and H. Y. Lei. 2005. An interferon-gamma-related cytokine storm in SARS patients. J. Med. Virol. 75:185-194.
  192. Hui DS, Chow BK, Lo T, Tsang OTY, Ko FW, Ng SS, Gin T, Chan MTV. Exhaled air dispersion during high-flow nasal cannula therapy versus CPAP via different masks. Eur. Respir. J. 2019 Apr;53(4) [PubMed]
  193. Huijing Xia and Eric Lazartigues, Angiotensin-Converting Enzyme 2: Central Regulator for Cardiovascular Function, Current Hypertension Reports, 10.1007/s11906-010-0105-7, 12, 3, (170-175), (2010).
  194. ICTV Code. The International Code of Virus Classification and Nomenclature https://talk.ictvonline.org/information/w/ictv-information/383/ictv-code (2018).
  195. International Society of Hypertension. A statement from the International Society of Hypertension on COVID-19. https://ish-world.com/news/a/A-statement-from-the-International-Society-of-Hypertension-on-COVID-19/ (Accessed on March 18, 2020).
  196. Bosch, R. van der Zee, C. A. de Haan, P. J. Rottier, The coronavirus spike protein is a class I virus fusion protein: Structural and functional characterization of the fusion core complex. J. Virol. 77, 8801–8811 (2003).
  197. Bosch, W. Bartelink, P. J. Rottier, Cathepsin L functionally cleaves the severe acute respiratory syndrome coronavirus class I fusion protein upstream of rather than adjacent to the fusion peptide. J. Virol. 82, 8887–8890 (2008).
  198. Guy, D.W. Lambert, F.J. Warner, N.M. Hooper and A.J. Turner, Membrane-associated zinc peptidase families: comparing ACE and ACE2, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 10.1016/j.bbapap.2004.10.010, 1751, 1, (2-8), (2005).
  199. Lubel, F.J. Warner and P.W. Angus, The Role of the Renin-Angiotensin System in Hepatic Fibrosis, Frontiers in Research of the Renin-Angiotensin System on Human Disease, 10.1007/978-1-4020-6372-5_6, (113-134), (2008).
  200. Jamieson DJ, Honein MA, Rasmussen SA, et al.; Novel Influenza A (H1N1) Pregnancy Working Group. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009; 374:451–458
  201. Japanese National Institute of Infectious Diseases. Field Briefing: Diamond Princess COVID-19 Cases, 20 Feb Update. https://www.niid.go.jp/niid/en/2019-ncov-e/9417-covid-dp-fe-02.html (Accessed on March 01, 2020).
  202. Jennifer A. Johnson, Anna R. Hemnes, Daniel S. Perrien, Manfred Schuster, Linda J. Robinson et al. , Cytoskeletal defects in Bmpr2-associated pulmonary arterial hypertension, American Journal of Physiology-Lung Cellular and Molecular Physiology, 10.1152/ajplung.00202.2011, 302, 5, (L474-L484), (2012).
  203. Jennifer A. Johnson, James West, Karen B. Maynard and Anna R. Hemnes, ACE2 Improves Right Ventricular Function in a Pressure Overload Model, PLoS ONE, 10.1371/journal.pone.0020828, 6, 6, (e20828), (2011).
  204. Jian Xu, Lihua Qi, Xiaochun Chi, Jingjing Yang, Xiaohong Wei, Encong Gong, Suatcheng Peh and Jiang Gu, Orchitis: A Complication of Severe Acute Respiratory Syndrome (SARS)1, Biology of Reproduction, 10.1095/biolreprod.105.044776, 74, 2, (410-416), (2006).
  205. Jianfeng Huang, Shufeng Chen, Xiangfeng Lu, Qi Zhao, Dabeeru C. Rao, Cashell E. Jaquish, James E. Hixson, Jichun Chen, Laiyuan Wang, Jie Cao, Jianxin Li, Hongfan Li, Jiang He, De-Pei Liu and Dongfeng Gu, Polymorphisms of ACE2 are Associated with Blood Pressure Response to Cold Pressor Test: The GenSalt Study, American Journal of Hypertension, 10.1038/ajh.2012.61, 25, 8, (937-942), (2012).
  206. Jiang F, Yang J, Zhang Y, Dong M, Wang S et al.Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets. Nat Rev Cardiol. 2014 Jul;11(7):413-26. doi: 10.1038/nrcardio.2014.59. Epub 2014 Apr 29.
  207. Jiang, Y., J. Xu, C. Zhou, Z. Wu, S. Zhong, J. Liu, W. Luo, T. Chen, Q. Qin, and P. Deng. 2005. Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome. Am. J. Respir. Crit. Care Med. 171:850-857.
  208. Jin-Kui Yang, Shan-Shan Lin, Xiu-Juan Ji and Li-Min Guo, Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes, Acta Diabetologica, 10.1007/s00592-009-0109-4, 47, 3, (193-199), (2009).
  209. Johkoh T, Itoh H, Müller NL, et al. Crazy-paving appearance at thin-section CT: spectrum of disease and pathologic findings. Radiology 1999; 211:155–160
  210. John J. Byrnes, Stefan Gross, Courtney Ellard, Kelly Connolly, Stephen Donahue and Dominic Picarella, Effects of the ACE2 inhibitor GL1001 on acute dextran sodium sulfate-induced colitis in mice, Inflammation Research, 10.1007/s00011-009-0053-3, 58, 11, (819-827), (2009).
  211. John Nicholls and Malik Peiris, Good ACE, bad ACE do battle in lung injury, SARS, Nature Medicine, 10.1038/nm0805-821, 11, 8, (821-822), (2005).
  212. Johnston, R. J. et al. The immunoreceptor TIGIT regulates antitumor and antiviral CD8(+) T cell effector function. Cancer Cell 26, 923–937 (2014).
  213. Joint GI society message: COVID-19 clinical insights for our community of gastroenterologists and gastroenterology care providers. https://www.gastro.org/press-release/joint-gi-society-message-covid-19-clinical-insights-for-our-community-of-gastroenterologists-and-gastroenterology-care-providers (Accessed on March 18, 2020).
  214. Julian M. Stewart, Anthony J. Ocon, Debbie Clarke, Indu Taneja and Marvin S. Medow, Defects in Cutaneous Angiotensin-Converting Enzyme 2 and Angiotensin-(1-7) Production in Postural Tachycardia Syndrome, Hypertension, 10.1161/HYPERTENSIONAHA.108.127357, 53, 5, (767-774), (2009).
  215. Jun Chen and Kanta Subbarao, The Immunobiology of SARS, Annual Review of Immunology, 10.1146/annurev.immunol.25.022106.141706, 25, 1, (443-472), (2007).
  216. Gauthier, D. X. Zhang, L. Cui, K. Nithipatikom and W. B. Campbell, Angiotensin II Relaxations of Bovine Adrenal Cortical Arteries: Role of Angiotensin II Metabolites and Endothelial Nitric Oxide, Hypertension, 10.1161/HYPERTENSIONAHA.107.104158, 52, 1, (150-155), (2008).
  217. Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect 2020; 104:246.
  218. Karen Hänel and Dieter Willbold, SARS-CoV accessory protein 7a directly interacts with human LFA-1, Biological Chemistry, 10.1515/BC.2007.157, 388, 12, (2007).
  219. Kato H, Sato S, Yoneyama M, Yamamoto M, Uematsu S, Matsui K, Tsujimura T, Takeda K, Fujita T, Takeuchi O, Akira S. Cell type-specific involvement of RIG-I in antiviral response. Immunity. 2005;23:19–28. doi: 10.1016/j.immuni.2005.04.010. [PubMed] [CrossRef] [Google Scholar]
  220. Katze MG, He Y, Gale M Jr. Viruses and interferon: a fight for supremacy. Nat Rev Immunol. 2002;2:675–687. doi: 10.1038/nri888. [PubMed] [CrossRef] [Google Scholar]
  221. Kausik Das, Sheila E. Norton, Jodi R. Alt, Gary D. Krzyzanowski, Thomas L. Williams and M. Rohan Fernando, Stabilization of Cellular RNA in Blood During Storage at Room Temperature: A Comparison of Cell-Free RNA BCT® with K3EDTA Tubes, Molecular Diagnosis & Therapy, 10.1007/s40291-014-0118-z, 18, 6, (647-653), (2014).
  222. Updates on COVID-19 in Korea. March 14, 2020. https://www.cdc.go.kr/board/board.es?mid=a30402000000&bid=0030 (Accessed on March 14, 2020).
  223. Keiji Kubaa, Yumiko Imaiab, TakayoOhto-Nakanishia, Josef M.Penningerc Trilogy of ACE2: A peptidase in the renin–angiotensin system, a SARS receptor, and a partner for amino acid transporters Pharmacology & Therapeutics Volume 128, Issue 1, October 2010, Pages 119-128
  224. Kenneth E. Bernstein, Frank S. Ong, Wendell-Lamar B. Blackwell, et al. , A Modern Understanding of the Traditional and Nontraditional Biological Functions of Angiotensin-Converting Enzyme, Pharmacological Reviews, 10.1124/pr.112.006809, 65, 1, (1-46), (2012).
  225. Kenneth E. Bernstein, Yosef Koronyo, Brenda C. Salumbides, Julia Sheyn, Lindsey Pelissier, et al. Angiotensin-converting enzyme overexpression in myelomonocytes prevents Alzheimer’s-like cognitive decline, Journal of Clinical Investigation, 10.1172/JCI66541, 124, 3, (1000-1012), (2014).
  226. Kerstin Roeska and Bernd Seilheimer Antiviral activity of Engystol® and Gripp-Heel®: an in-vitro assessment Journal of Immune Based Therapies and Vaccines BioMed Central
  227. Knipe DM, Samuel CE, Pales P. In: Fields virology 4th edition. 4. Knipe DM, Howley PM, Griffin DE, Martin M, Roizman B, Straus SE, editor. Philadelphia: Lippincott Raven; 2001. Virus-host cell interactions; pp. 133–170. [Google Scholar]
  228. Kogan A, Segel MJ, Ram E, Raanani E, Peled-Potashnik Y, Levin S, Sternik L. Acute Respiratory Distress Syndrome following Cardiac Surgery: Comparison of the American-European Consensus Conference Definition versus the Berlin Definition. Respiration. 2019;97(6):518-524. [PubMed]
  229. Koji Sakai and Curt D. Sigmund, Molecular evidence of tissue renin-angiotensin systems: A focus on the brain, Current Hypertension Reports, 10.1007/s11906-005-0088-y, 7, 2, (135-140), (2005).
  230. Ksiazek TG1, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003 May 15;348(20):1953-66. Epub 2003 Apr 10.
  231. Kuhn, J. H. et al. Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae. Arch. Virol. 158, 301–311 (2013).
  232. Kui, L. et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin. Med. J. https://doi.org/10.1097/CM9.0000000000000744 (2020).
  233. Kulwinder Singh, Tajinder Singh and P. L. Sharma, Beneficial effects of angiotensin (1–7) in diabetic rats with cardiomyopathy, Therapeutic Advances in Cardiovascular Disease, 10.1177/1753944711409281, 5, 3, (159-167), (2011).
  234. Kupferschmidt K. Study claiming new coronavirus can be transmitted by people without symptoms was flawed. Science. February 3, 2020. https://www.sciencemag.org/news/2020/02/paper-non-symptomatic-patient-transmitting-coronavirus-wrong (Accessed on February 04, 2020).
  235. Kurt-Jones EA, Chan M, Zhou S, Wang J, Reed G, Bronson R, Arnold MM, Knipe DM, Finberg RW. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci USA. 2004;101:1315–1320.
  236. L Huang, DJ Sexton, K Skogerson, M Devlin.. Novel peptide inhibitors of angiotensin-converting enzyme. The Journal of Biological Chemistry May 2, 2003
  237. Liu, Q. Wei, X. Alvarez, H. Wang, Y. Du, H. Zhu, H. Jiang, et al. Epithelial Cells Lining Salivary Gland Ducts Are Early Target Cells of Severe Acute Respiratory Syndrome Coronavirus Infection in the Upper Respiratory Tracts of Rhesus Macaques, Journal of Virology, 10.1128/JVI.02292-10, 85, 8, (4025-4030), (2011).
  238. Lai, C. C., Shih, T. P., Ko, W. C., Tang, H. J. & Hsueh, P. R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int. J. Antimicrob. Agents https://doi.org/10.1016/j.ijantimicag.2020.105924 (2020).
  239. Lan L, Xu D, Ye G, et al. Positive RT-PCR Test Results in Patients Recovered From COVID-19. JAMA 2020.
  240. Lauber, C. & Gorbalenya, A. E. Partitioning the genetic diversity of a virus family: approach and evaluation through a case study of picornaviruses. J. Virol. 86, 3890–3904 (2012).
  241. Lauber, C. & Gorbalenya, A. E. Toward genetics-based virus taxonomy: comparative analysis of a genetics-based classification and the taxonomy of picornaviruses. J. Virol. 86, 3905–3915 (2012).
  242. Lauber, C. et al. Mesoniviridae: a new family in the order Nidovirales formed by a single species of mosquito-borne viruses. Arch. Virol. 157, 1623–1628 (2012).
  243. Lauer SA, Grantz KH, Bi Q, et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann Intern Med 2020.
  244. Lawrence S. Zisman, ACE and ACE2: a tale of two enzymes, European Heart Journal, 10.1093/eurheartj/ehi043, 26, 4, (322-324), (2005).
  245. Le Sage, V., Cinti, A., Amorim, R., and Mouland, A. J. (2016). Adapting the stress response: viral subversion of the mTOR signaling pathway. Viruses 8:152. doi: 10.3390/v8060152
  246. Lebon P. Inhibition of herpes simplex virus type 1-induced interferon synthesis by monoclonal antibodies against viral glycoprotein D and by lysosomotropic drugs. J Gen Virol. 1985;66(Pt 12):2781–2786. doi: 10.1099/0022-1317-66-12-2781. [PubMed] [CrossRef] [Google Scholar]
  247. Lei J, Kusov Y, Hilgenfeld R. Nsp3 of coronaviruses: Structures and functions of a large multi-domain protein. Antiviral Res. 2018 Jan;149:58-74. [PubMed]
  248. Leonie Baginski, Gaëlle Tachon, Françoise Falson, John S. Patton, Udo Bakowsky and Carsten Ehrhardt, Reverse Transcription Polymerase Chain Reaction (RT-PCR) Analysis of Proteolytic Enzymes in Cultures of Human Respiratory Epithelial Cells, Journal of Aerosol Medicine and Pulmonary Drug Delivery, 10.1089/jamp.2010.0842, 24, 2, (89-101), (2011).
  249. Leung, W.K. et al. (2003) Gastroenterology 125:1011.
  250. Li Q, Guan X, Wu P, et al: Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 29 Jan. 2020. doi: 10.1056/NEJMoa2001316
  251. Li Q, Guan X, Wu P, Wang X, Zhou L, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N. Engl. J. Med. 2020 Jan 29; [PubMed]
  252. Li Y, Zhao R, Zheng S, et al. Lack of Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, China. Emerg Infect Dis 2020; 26.
  253. Li Z, Yi Y, Luo X, et al. Development and Clinical Application of A Rapid IgM-IgG Combined Antibody Test for SARS-CoV-2 Infection Diagnosis. J Med Virol 2020.
  254. Li Zhou, Hong Xue, Zhen Wang, Jun Ni, Tai Yao, Yu Huang, Chen Yu and Limin Lu, Angiotensin-(1–7) attenuates high glucose-induced proximal tubular epithelial-to-mesenchymal transition via inhibiting ERK1/2 and p38 phosphorylation, Life Sciences, 10.1016/j.lfs.2011.12.015, 90, 11-12, (454-462), (2012).
  255. Li, C. K. et al. T cell responses to whole SARS coronavirus in humans. J. Immunol. 181, 5490–5500 (2008).
  256. Li, C. K., H. Wu, H. Yan, S. Ma, L. Wang, M. Zhang, X. Tang, N. J. Temperton, R. A. Weiss, J. M. Brenchley, D. C. Douek, J. Mongkolsapaya, B. H. Tran, C. L. Lin, G. R. Screaton, J. L. Hou, A. J. McMichael, and X. N. Xu. 2008. T cell responses to whole SARS coronavirus in humans. J. Immunol. 181:5490-5500.
  257. Li, F. et al. Blocking the natural killer cell inhibitory receptor NKG2A increases activity of human natural killer cells and clears hepatitis B virus infection in mice. Gastroenterology 144, 392–401 (2013).
  258. Li, Q. et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N. Engl. J. Med. https://doi.org/10.1056/nejmoa2001316 (2020).
  259. Li, Structure, Function, and Evolution of Coronavirus Spike Proteins. Annu. Rev. Virol. 3, 237–261 (2016).
  260. Li, T., Z. Qiu, L. Zhang, Y. Han, W. He, Z. Liu, X. Ma, H. Fan, W. Lu, J. Xie, H. Wang, G. Deng, and A. Wang. 2004. Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome. J. Infect. Dis. 189:648-651.
  261. Lien, T. C., C. S. Sung, C. H. Lee, H. K. Kao, Y. C. Huang, C. Y. Liu, R. P. Perng, and J. H. Wang. 2008. Characteristic features and outcomes of severe acute respiratory syndrome found in severe acute respiratory syndrome intensive care unit patients. J. Crit. Care 23:557-564.
  262. Lim J, Jeon S, Shin HY, et al. Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Infected Pneumonia Monitored by Quantitative RT-PCR. J Korean Med Sci 2020; 35:e79.
  263. Lisi Deng, Chunna Li, Qi Zeng, Xi Liu, Xinghua Li, Haitang Zhang, Zhongsi Hong and Jinyu Xia, Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019:a retrospective cohort study, Journal of Infection, 10.1016/j.jinf.2020.03.002, (2020).
  264. Liu K, Fang YY, Deng Y, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J (Engl) 2020.
  265. Liu W, Zhang Q, Chen J, et al. Detection of Covid-19 in Children in Early January 2020 in Wuhan, China. N Engl J Med 2020.
  266. Liu YC, Liao CH, Chang CF, et al. A Locally Transmitted Case of SARS-CoV-2 Infection in Taiwan. N Engl J Med 2020; 382:1070.
  267. Liu, Y., Gayle, A. A., Wilder-Smith, A. & Rocklov, J. The reproductive number of COVID-19 is higher compared to SARS coronavirus. J. Travel Med. https://doi.org/10.1093/jtm/taaa021 (2020).
  268. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408.
  269. Louise M. Burrell, Colin I. Johnston, Christos Tikellis and Mark E. Cooper, ACE2, a new regulator of the renin–angiotensin system, Trends in Endocrinology & Metabolism, 10.1016/j.tem.2004.03.001, 15, 4, (166-169), (2004).
  270. Lu, R. et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395, 565–574 (2020).
  271. Lund J, Sato A, Akira S, Medzhitov R, Iwasaki A. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med. 2003;198:513–520. doi: 10.1084/jem.20030162. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  272. M Rudnicki and G Mayer, Pharmacogenomics of angiotensin converting enzyme inhibitors in renal disease – pathophysiological considerations, Pharmacogenomics, 10.1517/phgs.4.2.153.22630, 4, 2, (153-162), (2003).
  273. Gui, W. Song, H. Zhou, J. Xu, S. Chen, Y. Xiang, X. Wang, Cryo-electron microscopy structures of the SARS-CoV spike glycoprotein reveal a prerequisite conformational state for receptor binding. Cell Res. 27, 119–129 (2017).
  274. Hoffmann, H. Kleine-Weber, N. Krüger, M. Müller, C. Drosten, S. Pöhlmann, The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells.
  275. Jaume, M. S. Yip, C. Y. Cheung, H. L. Leung, P. H. Li, F. Kien, I. Dutry, B. Callendret, N. Escriou, R. Altmeyer, B. Nal, M. Daeron, R. Bruzzone and J. S. M. Peiris, Anti-Severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells via a pH- and Cysteine Protease-Independent Fc R Pathway, Journal of Virology, 10.1128/JVI.00671-11, 85, 20, (10582-10597), (2011).
  276. Kanaeva, I. V. Galtseva, E. N. Parovichnikova, Yu. O. Davydova, T. V. Gaponova, E. O. Gribanova, Ya. V. Balzhanova, L. A. Kuzmina, V. V. Troitskaya, S. K. Kravchenko, E. E. Zvonkov, L. P. Mendeleeva and V. G. Savchenko, Subpopulations of mobilized hematopoietic stem cells in patients with hematological malignances and donors: expression of CD38, HLA-DR and CD143, Oncohematology, 10.17650/1818-8346-2019-14-2-48-58, 14, 2, (48-58), (2019).
  277. Mahmoud S. Alghamri, Nathan M. Weir, Mark P. Anstadt, Khalid M. Elased, Susan B. Gurley and Mariana Morris, Enhanced Angiotensin II-Induced Cardiac and Aortic Remodeling in ACE2 Knockout Mice, Journal of Cardiovascular Pharmacology and Therapeutics, 10.1177/1074248412460124, 18, 2, (138-151), (2012).
  278. Maitham A. Khajah, Maryam M. Fateel, Kethireddy V. Ananthalakshmi and Yunus A. Luqmani, Anti-Inflammatory Action of Angiotensin 1-7 in Experimental Colitis, PLOS ONE, 10.1371/journal.pone.0150861, 11, 3, (e0150861), (2016).
  279. Malmgaard L. Induction and regulation of IFNs during viral infections. J Interferon Cytokine Res. 2004;24:439–454. doi: 10.1089/1079990041689665. [PubMed] [CrossRef] [Google Scholar]
  280. Mamadi Yilla, Brian H. Harcourt, Carole J. Hickman, Marcia McGrew, Azaibi Tamin, Cynthia S. Goldsmith, William J. Bellini and Larry J. Anderson, SARS-coronavirus replication in human peripheral monocytes/macrophages, Virus Research, 10.1016/j.virusres.2004.09.004, 107, 1, (93-101), (2005).
  281. Marc F. Doobay, Lauren S. Talman, Teresa D. Obr, Xin Tian, Robin L. Davisson and Eric Lazartigues, Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system, American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 10.1152/ajpregu.00292.2006, 292, 1, (R373-R381), (2007).
  282. Marcio Augusto Fressatto de Godoy, Larissa Pernomian, Ana Maria de Oliveira and Satish Rattan, Biosynthetic Pathways and the Role of the Mas Receptor in the Effects of Angiotensin-(1–7) in Smooth Muscles, International Journal of Hypertension, 10.1155/2012/121740, 2012, (1-6), (2012).
  283. Marco A. Marra, Steven J. M. Jones, Caroline R. Astell et al The Genome Sequence of the SARS-Associated Coronavirus Science 30 May 2003: Vol. 300, Issue 5624, pp. 1399-1404 DOI: 10.1126/science.1085953
  284. Marco Cascella; Michael Rajnik; Arturo Cuomo; Scott C. Dulebohn; Raffaela Di Napoli. Features, Evaluation and Treatment Coronavirus (COVID-19) March 8, 2020.
  285. Margarita Semis, Gabriel B. Gugiu, Ellen A. Bernstein, Kenneth E. Bernstein and Markus Kalkum, The Plethora of Angiotensin-Converting Enzyme-Processed Peptides in Mouse Plasma, Analytical Chemistry, 10.1021/acs.analchem.8b03828, (2019).
  286. Mark C. Chappell, Role of ACE, ACE2 and Neprilysin in the Kidney, Frontiers in Research of the Renin-Angiotensin System on Human Disease, 10.1007/978-1-4020-6372-5_1, (1-20), (2008).
  287. Mark J. Cameron, Longsi Ran, David J. Kelvin et al.Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome. J. Virol. 81:8692-8706.
  288. Martin Paul, Ali Poyan Mehr and Reinhold Kreutz, Physiology of Local Renin-Angiotensin Systems, Physiological Reviews, 10.1152/physrev.00036.2005, 86, 3, (747-803), (2006).
  289. Masters, P. S. The molecular biology of coronaviruses. Adv. Virus Res. 66, 193–292 (2006).
  290. Matics TJ, Sanchez-Pinto LN, Adaptation and Validation of a Pediatric Sequential Organ Failure Assessment Score and Evaluation of the Sepsis-3 Definitions in Critically Ill Children. JAMA Pediatr. 2017 Oct 2;171(10):e172352. doi: 10.1001/jamapediatrics.2017.2352. Epub 2017 Oct 2.
  291. Matsuyama, S. et al. Efficient Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by the Transmembrane Protease TMPRSS2 (2010) J. Virol. 84:12658.
  292.  
  293. Matusiewicz R. The effect of a homeopathic preparation on the clinical condition of patients with corticosteroid-dependent bronchial asthma. Biomed Ther. 1997;15:70–74. [Google Scholar]
  294. Matzer, S. P., T. Baumann, N. W. Lukacs, M. Rollinghoff, and H. U. Beuscher. 2001. Constitutive expression of macrophage-inflammatory protein 2 (MIP-2) mRNA in bone marrow gives rise to peripheral neutrophils with preformed MIP-2 protein. J. Immunol. 167:4635-4643.
  295. Mayur Garg, Louise M Burrell, Elena Velkoska, Karen Griggs, Peter W Angus, Peter R Gibson and John S Lubel, Upregulation of circulating components of the alternative renin-angiotensin system in inflammatory bowel disease: A pilot study, Journal of the Renin-Angiotensin-Aldosterone System, 10.1177/1470320314521086, 16, 3, (559-569), (2014).
  296. McCollough CH, Schueler BA, Atwell TD, et al. Radiation exposure and pregnancy: when should we be concerned? RadioGraphics 2007; 27:909–917; discussion, 917–918
  297. McMichael TM, Clark S, Pogosjans S, et al. COVID-19 in a long-term care facility—King County, Washington, February 27–March 9, 2020. MMWR. Morb Mortal Wkly Rep 2020. Epub March 18, 2020.
  298. Michiya IGASE, Katsuhiko KOHARA, Tokihisa NAGAI, Tetsuro MIKI and Carlos M. FERRARIO, Increased Expression of Angiotensin Converting Enzyme 2 in Conjunction with Reduction of Neointima by Angiotensin II Type 1 Receptor Blockade, Hypertension Research, 10.1291/hypres.31.553, 31, 3, (553-559), (2008).
  299. Ming Yip, Nancy Hiu Leung, Chung Cheung, Ping Li, Horace Hok Lee, Marc Daëron, Joseph Sriyal Peiris, Roberto Bruzzone and Martial Jaume, Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus, Virology Journal, 10.1186/1743-422X-11-82, 11, 1, (82), (2014).
  300. MLA Roeska, Kerstin, and Bernd Seilheimer. “Antiviral activity of Engystol® and Gripp-Heel®: an in-vitro assessment.” Journal of immune based therapies and vaccines vol. 8 6. 16 Nov. 2010, doi:10.1186/1476-8518-8-6
  301. Mohan K Raizada and Anderson J Ferreira, ACE2: A New Target for Cardiovascular Disease Therapeutics, Journal of Cardiovascular Pharmacology, 10.1097/FJC.0b013e3180986219, 50, 2, (112-119), (2007).
  302. Morin, B. Eisenbraun, J. Key, P. C. Sanschagrin, M. A. Timony, M. Ottaviano, P. Sliz, Collaboration gets the most out of software. eLife 2, e01456 (2013).
  303. Moro-Garcia, M. A., Mayo, J. C., Sainz, R. M. & Alonso-Arias, R. Influence of inflammation in the irocess of T lymphocyte differentiation: proliferative, metabolic, and oxidative changes. Front. Immunol. 9, 339 (2018).
  304. Moskophidis, D., and D. Kioussis. 1998. Contribution of virus-specific CD8+ cytotoxic T cells to virus clearance or pathologic manifestations of influenza virus infection in a T cell receptor transgenic mouse model. J. Exp. Med. 188:223-232.
  305. Myung-A. Kim, Dongheon Yang, Keisuke Kida, Natalia Molotkova, Seon Ju Yeo, Nissi Varki, Michikado Iwata, Nancy D. Dalton, Kirk L. Peterson, Wolf-Eberhard Siems, Thomas Walther, Randy T. Cowling, John Kjekshus and Barry Greenberg, Effects of ACE2 Inhibition in the Post-Myocardial Infarction Heart, Journal of Cardiac Failure, 10.1016/j.cardfail.2010.04.002, 16, 9, (777-785), (2010).
  306. N van Doremalen, et al. Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1. The New England Journal of Medicine. DOI: 10.1056/NEJMc2004973 (2020).
  307. Chen, M. Zhou, X. Dong, J. Qu, F. Gong, et al Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 395, 507–513 (2020).
  308. Shimizu, R. Ouchida, N. Yoshikawa, T. Hisada, H. Watanabe, K. Okamoto, M. Kusuhara, H. Handa, C. Morimoto and H. Tanaka, HEXIM1 forms a transcriptionally abortive complex with glucocorticoid receptor without involving 7SK RNA and positive transcription elongation factor b, Proceedings of the National Academy of Sciences, 10.1073/pnas.0409863102, 102, 24, (8555-8560), (2005).
  309. Naoko Iwata-Yoshikawa, Tadashi Okamura, et.al Pathogenesis and Immunity - TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection Journal of virology 2019-01-09J
  310. Nathalie Macours, Jeroen Poels, Korneel Hens, Carmen Francis and Roger Huybrechts, Structure, Evolutionary Conservation, and Functions of Angiotensin- and Endothelin-Converting Enzymes, , 10.1016/S0074-7696(04)39002-9, (47-97), (2004).
  311. National Health Commission of the People's Republic of China. New coronavirus cases rise to 571 in Chinese mainland. January 23, 2020. http://en.nhc.gov.cn/2020-01/23/c_76004.htm (Accessed on January 23, 2020).
  312. New coronavirus stable for hours on surfaces SARS-CoV-2 stability similar to original SARS virus. Tuesday, March 17, 2020 News Releases
  313. Nguyen, L. T., Schmidt, H. A., von Haeseler, A. & Minh, B. Q. IQ-TREE: a fast and effective stochastic algorithm for estimating maximum- likelihood phylogenies. Mol. Biol. Evol. 32, 268–274 (2015).
  314. Nicole K. Littlejohn and Justin L. Grobe, Opposing tissue-specific roles of angiotensin in the pathogenesis of obesity, and implications for obesity-related hypertension, American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 10.1152/ajpregu.00224.2015, 309, 12, (R1463-R1473), (2015).
  315. Nijhuis, R. H. T. et al. PCR assays for detection of human astroviruses: In silico evaluation and design, and in vitro application to samples collected from patients in the Netherlands. J. Clin. Virol. 108, 83–89 (2018).
  316. Ning Tang Dengju Li  Xiong Wang  Ziyong Sun Journal of Thrombosis and Haemostasis BRIEF REPORT  Free Access Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia First published:19 February 2020 https://doi.org/10.1111/jth.14768
  317. Ningjun Li, Joseph Zimpelmann, Keding Cheng, John A. Wilkins and Kevin D. Burns, The role of angiotensin converting enzyme 2 in the generation of angiotensin 1–7 by rat proximal tubules, American Journal of Physiology-Renal Physiology, 10.1152/ajprenal.00144.2004, 288, 2, (F353-F362), (2005).
  318. NLM Roeska K, Seilheimer B. Antiviral activity of Engystol® and Gripp-Heel®: an in-vitro assessment. J Immune Based Ther Vaccines. 2010 Nov 16;8:6. doi: 10.1186/1476-8518-8-6. PMID: 21080959; PMCID: PMC2998502.
  319. Novel Coronavirus (2019-nCoV) Situation Report – 22 (World Health Organization, 2020); https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200211-sitrep-22-ncov.pdf
  320. Novel Coronavirus Information Center. Elsevier’s free health and medical research on novel coronavirus (2019-nCoV) - January 27, 2020 - Updated March 10, 2020
  321. Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China [Chinese]. Chinese Center for Disease Control and Prevention Weekly 2020;41:145–51.
  322. Oberbaum M, Glatthaar-Saalmuller B, Stolt P, Weiser M. Antiviral activity of Engystol: an in vitro analysis. J Altern Complement Med. 2005;11:855–862. doi: 10.1089/acm.2005.11.855. [PubMed] [CrossRef] [Google Scholar]
  323. Ong SWX, Tan YK, Chia PY, et al. Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient. JAMA 2020.
  324. Adams, R. W. Grosse-Kunstleve, L.-W. Hung, T. R. Ioerger, et al: Building new software for automated crystallographic structure determination. Acta Crystallogr. D Biol. Crystallogr. 58, 1948–1954 (2002).
  325. Emsley, K. Cowtan, Coot: Model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126–2132 (2004).
  326. Prabakaran, J. Gan, Y. Feng, Z. Zhu, V. Choudhry, X. Xiao, X. Ji, D. S. Dimitrov, Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody. J. Biol. Chem. 281, 15829–15836 (2006).
  327. Zhou, X.-L. Yang, X.-G. Wang, B. Hu, L. Zhang, W. Zhang, H.-R. Si, Y. Zhu, B. Li, C.-L. Huang, H.-D. Chen, J. Chen, Y. Luo, H. Guo, R.-D. Jiang, M.-Q. Liu, Y. Chen, X.-R. Shen, X. Wang, X.-S. Zheng, K. Zhao, Q.-J. Chen, F. Deng, L.-L. Liu, B. Yan, F.-X. Zhan, Y.-Y. Wang, G.-F. Xiao, Z.-L. Shi, A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature (2020).
  328. Pallesen, N. Wang, K. S. Corbett, D. Wrapp, R. N. Kirchdoerfer, et al Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen. Proc. Natl. Acad. Sci. U.S.A. 114, E7348–E7357 (2017).
  329. Pan F, Ye T, Sun P, et al. Time Course of Lung Changes On Chest CT During Recovery From 2019 Novel Coronavirus (COVID-19) Pneumonia. Radiology 2020; :200370.
  330. Pan Y, Guan H, Zhou S, et al. Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China. Eur Radiol 2020 Feb 13
  331. Pasquale Pagliaro and Claudia Penna, Rethinking the Renin-Angiotensin System and Its Role in Cardiovascular Regulation, Cardiovascular Drugs and Therapy, 10.1007/s10557-005-6900-8, 19, 1, (77-87), (2005).
  332. Patel A, Jernigan DB, 2019-nCoV CDC Response Team. Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak - United States, December 31, 2019-February 4, 2020. MMWR Morb Mortal Wkly Rep 2020; 69:140.
  333. Patricia E. Gallagher, E. Ann Tallant and Carlos M. Ferrario, Angiotensin Converting Enzyme 2: A Critical Regulator of the Renin-Angiotensin System, The Local Cardiac Renin Angiotensin-Aldosterone System, 10.1007/0-387-27826-5_11, (129-142), (2006).
  334. Patricia E. Gallagher, Mark C. Chappell, Carlos M. Ferrario and E. Ann Tallant, Distinct roles for ANG II and ANG-(1–7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes, American Journal of Physiology-Cell Physiology, 10.1152/ajpcell.00409.2004, 290, 2, (C420-C426), (2006).
  335. Paula Armesto, Xavier Cousin, Emilio Salas-Leiton, Esther Asensio, et al. Molecular characterization and transcriptional regulation of the renin–angiotensin system genes in Senegalese sole (Solea senegalensis Kaup, 1858): Differential gene regulation by salinity, Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology, 10.1016/j.cbpa.2015.01.021, 184, (6-19), (2015).
  336. Paulo Castro-Chaves, Rui Cerqueira, Mariana Pintalhao and Adelino F Leite-Moreira, New pathways of the renin–angiotensin system: the role of ACE2 in cardiovascular pathophysiology and therapy, Expert Opinion on Therapeutic Targets, 14, 5, (485-496), (2010).
  337. Peiris, J. S. M. et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361, 1319–1325 (2003).
  338. Peiris, J. S., W. C. Yu, C. W. Leung, C. Y. Cheung, W. F. Ng, J. M. Nicholls, T. K. Ng, K. H. Chan, S. T. Lai, W. L. Lim, K. Y. Yuen, and Y. Guan. 2004. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 363:617-619.
  339. Peiris, J. S., Y. Guan, and K. Y. Yuen. 2004. Severe acute respiratory syndrome. Nat. Med. 10:S88-97.
  340. Perlman S, Netland J. Coronaviruses post-SARS: update on replication and pathogenesis. Nat. Rev. Microbiol. 2009 Jun;7(6):439-50. [PMC free article] [PubMed]
  341. Perlman S. Another Decade, Another Coronavirus. N Engl J Med 2020; 382:760.
  342. Perlman, S., and A. A. Dandekar. 2005. Immunopathogenesis of coronavirus infections: implications for SARS. Nat. Rev. Immunol. 5:917-927.
  343. Position Statement of the ESC Council on Hypertension on ACE-Inhibitors and Angiotensin Receptor Blockers https://www.escardio.org/Councils/Council-on-Hypertension-(CHT)/News/position statement of the esc council on hypertension on ace inhibitors and ang (Accessed on March 18, 2020).https://hypertension.ca/wp-content/uploads/2020/03/2020-30-15-Hypertension-Canada-Statement-on-COVID-19-ACEi-ARB.pdf (Accessed on March 18, 2020).
  344. Practice Advisory: Novel Coronavirus 2019 (COVID-19) https://www.acog.org/Clinical-Guidance-and-Publications/Practice-Advisories/Practice-Advisory-Novel-Coronavirus2019 (Accessed on March 17, 2020).
  345. Punjani, J. L. Rubinstein, D. J. Fleet, M. A. Brubaker, cryoSPARC: Algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290–296 (2017).
  346. Li, X. Guan, P. Wu, X. Wang, L. Zhou, Y. Tong, R. Ren, al Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N. Engl. J. Med. NEJMoa2001316 (2020).
  347. Qi Zhang, Mingyu Cong, Ningning Wang, Xueyan Li, et al. Association of angiotensin-converting enzyme 2 gene polymorphism and enzymatic activity with essential hypertension in different gender, Medicine, 42, (e12917), (2018).
  348. Qiao J. What are the risks of COVID-19 infection in pregnant women? Lancet 2020; 395:760.
  349. Qiao Y, Shin JI, Chen TK, et al. Association Between Renin-Angiotensin System Blockade Discontinuation and All-Cause Mortality Among Persons With Low Estimated Glomerular Filtration Rate. JAMA Intern Med 2020.
  350. Lu, X. Zhao, J. Li, P. Niu, B. Yang, H. Wu, W. Wang, et al Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet S0140-6736(20)30251-8 (2020).
  351. Kirchdoerfer, C. A. Cottrell, N. Wang, t al. Pre-fusion structure of a human coronavirus spike protein. Nature 531, 118–121 (2016).
  352. Kirchdoerfer, N. Wang, J. Pallesen, D. Wrapp, H. L. et al Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis. Sci. Rep. 8, 15701 (2018).
  353. Rabe A, Weiser M, Klein P. Effectiveness and tolerability of a homoeopathic remedy compared with conventional therapy for mild viral infections. Int J Clin Pract. 2004;58:827–832. doi: 10.1111/j.1742-1241.2004.00150.x. [PubMed] [CrossRef] [Google Scholar]
  354. Rabe A. Symptomatic treatment of acute upper respiratory infections: a comparison of homeopathic and conventinoal therapies. Der Allgemeinarzt. 2003;25:1522–1530. [Google Scholar]
  355. Rabenau HF, Cinatl J, Morgenstern B, et al. Stability and inactivation of SARS coronavirus. Med Microbiol Immunol 2005; 194:1.
  356. Ramírez-Aportela, J. L. Vilas, A. Glukhova, R. Melero, P. Conesa, et al. Automatic local resolution-based sharpening of cryo-EM maps. Bioinformatics, Volume 36, Issue 3, 1 February 2020, Pages 765–772
  357. Ran-hui Cha, Joon-Sung Joh, Ina Jeong, et al. Renal Complications and Their Prognosis in Korean Patients with Middle East Respiratory Syndrome-Coronavirus from the Central MERS-CoV Designated Hospital, Journal of Korean Medical Science, 10.3346/jkms.2015.30.12.1807, 30, 12, (1807), (2015).
  358. Report of the WHO-China Joint Mission on Coronavirus DIsease 2019 (COVID-2019). February 16-24, 2020. http://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf (Accessed on March 04, 2020).
  359. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) [Pdf] - World Health Organization, Feb. 28, 2020
  360. China approves use of Roche drug in battle against coronavirus complications. https://www.reuters.com/article/us-health-coronavirus-china-roche-hldg/china-approves-use-of-roche-arthritis-drug-for-coronavirus-patients-idUSKBN20R0LF (Accessed on March 11, 2020).
  361. Riordan, J.F. (2003) Angiotensin-I-converting enzyme and its relatives Genome Bio. 4:225.
  362. Rivers, T. M. Filterable viruses: a critical review. J. Bacteriol. 14, 217–258 (1927).
  363. Robert A. Coleman and Kenneth L. Clark, Target validation using human tissue: from gene expression to function, TARGETS, 10.1016/S1477-3627(03)02298-0, 2, 2, (58-64), (2003).
  364. Robert W. Regenhardt, Douglas M. Bennion and Colin Sumners, Cerebroprotective action of angiotensin peptides in stroke, Clinical Science, 10.1042/CS20130324, 126, 3, (195-205), (2014).
  365. Roberts, A., C. Paddock, L. Vogel, E. Butler, S. Zaki, and K. Subbarao. 2005. Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans. J. Virol. 79:5833-5838.
  366. Roberts, A., D. Deming, C. D. Paddock, A. Cheng, B. Yount, L. Vogel, B. D. Herman, t al. 2007. A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice. PLoS Pathog. 3:e5.
  367. Roberts, A., L. Vogel, J. Guarner, N. Hayes, B. Murphy, S. Zaki, and K. Subbarao. 2005. Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters. J. Virol. 79:503-511.
  368. Robson A S Santos, Anderson J Ferreira, Thiago Verano-Braga and Michael Bader, Angiotensin-converting enzyme 2, angiotensin-(1–7) and Mas: new players of the renin–angiotensin system, Journal of Endocrinology, 10.1530/JOE-12-0341, 216, 2, (R1-R17), (2013).
  369. Roche, J. K., T. R. Keepers, L. K. Gross, R. M. Seaner, and T. G. Obrig. 2007. CXCL1/KC and CXCL2/MIP-2 are critical effectors and potential targets for therapy of Escherichia coli O157:H7-associated renal inflammation. Am. J. Pathol. 170:526-537.
  370. Rodriguez-Morales AJ, Bonilla-Aldana DK, Balbin-Ramon GJ, Paniz-Mondolfi A, Rabaan A, Sah R, Pagliano P, Esposito S. 2020. History is repeating itself, a probable zoonotic spillover as a cause of an epidemic: the case of 2019 novel coronavirus. Infez Med 28:3–5.
  371. Rodriguez-Morales AJ, MacGregor K, Kanagarajah S, Patel D, Schlagenhauf P. 2020. Going global: travel and the 2019 novel coronavirus. Travel Med Infect Dis 33:101578. doi:10.1016/j.tmaid.2020.101578.
  372. Roeska K, Seilheimer B. Antiviral activity of Engystol® and Gripp-Heel®: an in-vitro assessment. J Immune Based Ther Vaccines. 2010;8:6. Published 2010 Nov 16. doi:10.1186/1476-8518-8-6
  373. Rothe C, Schunk M, Sothmann P, et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. N Engl J Med 2020; 382:970.
  374. Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet 2020; 395:473.https://dgs-urgent.sante.gouv.fr/dgsurgent/inter/detailsMessageBuilder.do?id=30500&cmd=visualiserMessage (Accessed on March 19, 2020).
  375. Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet 2020; 395:473.
  376. Jeffers, S. M. Tusell, L. Gillim-Ross, E. M. Hemmila, J. E. Achenbach, G. J. Babcock, W. D. Thomas, L. B. Thackray, M. D. Young, R. J. Mason, D. M. Ambrosino, D. E. Wentworth, J. C. DeMartini and K. V. Holmes, CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus, Proceedings of the National Academy of Sciences, 10.1073/pnas.0403812101, 101, 44, (15748-15753), (2004).
  377. Belouzard, V. C. Chu, G. R. Whittaker, Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites. Proc. Natl. Acad. Sci. U.S.A. 106, 5871–5876 (2009).
  378. Sabine Senkel, Belén Lucas, Ludger Klein-Hitpass and Gerhart U. Ryffel, Identification of target genes of the transcription factor HNF1β and HNF1α in a human embryonic kidney cell line, Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 10.1016/j.bbaexp.2005.10.003, 1731, 3, (179-190), (2005).
  379. Saeidi, A. et al. T-cell exhaustion in chronic infections: reversing the state of exhaustion and reinvigorating optimal protective immune responses. Front. Immunol. 9, 2569 (2018).
  380. Šali, T. L. Blundell, Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234, 779–815 (1993).
  381. Samuel CE. Antiviral actions of interferons. Clin Microbiol Rev. 2001;14:778–809, table of contents. doi: 10.1128/CMR.14.4.778-809.2001. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  382. Sarah Cargnin, Marco Quaglia, Pier Luigi Canonico, Piero Stratta and Salvatore Terrazzino, Impact of recipient ACE I/D genotype on kidney function in renal transplant patients: a meta-analysis of cross-sectional and longitudinal studies, Pharmacogenomics, 10.2217/pgs.15.119, 16, 16, (1887-1902), (2015).
  383. Satoshi Hagiwara, Hideo Iwasaka, Seigo Hidaka, Akira Hasegawa, Hironori Koga and Takayuki Noguchi, Antagonist of the Type-1 ANG II receptor prevents against LPS-induced septic shock in rats, Intensive Care Medicine, 10.1007/s00134-009-1545-x, 35, 8, (1471-1478), (2009).
  384. Saunders Comprehensive Veterinary Dictionary (3rd ed.). Elsevier, Inc. 2007. as cited in "peplomer". The Free Dictionary. Farlex. 2011. Retrieved 30 Mar 2011.
  385. Schmiedel V, Klein P. A complex homeopathic preparation for the symptomatic treatment of upper respiratory infections associated with the common cold: An observational study. Explore (NY) 2006;2:109–114. [PubMed] [Google Scholar]
  386. Schoeman, D. and B.C. Fielding (2019) Virol. J. 16:69.
  387. Science News from research organizations. COVID-19 coronavirus epidemic has a natural origin Date: March 17, 2020 Source: Scripps Research Institute
  388. Scott A. Jeffers, Erin M. Hemmila and Kathryn V. Holmes, Human Coronavirus 229E can Use CD209L (L-Sign) to Enter Cells, The Nidoviruses, 10.1007/978-0-387-33012-9_44, (265-269), (2006).
  389. Serbina, N. V., T. Jia, T. M. Hohl, and E. G. Pamer. 2008. Monocyte-mediated defense against microbial pathogens. Annu. Rev. Immunol. 26:421-452.
  390. Seymour CW, Kennedy JN, Wang S, Chang CH, Elliott CF, Xu Z, Berry S, Clermont G, Cooper G, Gomez H, Huang DT, Kellum JA, Mi Q, Opal SM, Talisa V, van der Poll T, Visweswaran S, Vodovotz Y, Weiss JC, Yealy DM, Yende S, Angus DC. Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis. JAMA. 2019 May 28;321(20):2003-2017. [PubMed]
  391. Seymour CW, Kennedy JN, Wang S, Chang CH, Elliott CF, Xu Z, Berry S, Clermont G, Cooper G, Gomez H, Huang DT, Kellum JA, Mi Q, Opal SM, Talisa V, van der Poll T, Visweswaran S, Vodovotz Y, Weiss JC, Yealy DM, Yende S, Angus DC. Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis. JAMA. 2019 May 28;321(20):2003-2017. [PubMed]
  392. Shant Der Sarkissian, Matthew J. Huentelman, Jillian Stewart, Michael J. Katovich and Mohan K. Raizada, ACE2: A novel therapeutic target for cardiovascular diseases, Progress in Biophysics and Molecular Biology, 10.1016/j.pbiomolbio.2005.05.011, 91, 1-2, (163-198), (2006).
  393. Sheahan TP, Sims AC, Graham RL, et al. Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses. Sci Transl Med 2017; 9.
  394. Sheahan, T., T. E. Morrison, W. Funkhouser, S. Uematsu, S. Akira, R. S. Baric, and M. T. Heise. 2008. MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV. PLoS Pathog. 4:e1000240.
  395. Shi H, Han X, Jiang N, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis 2020.
  396. Shlomo Keidar, Aviva Gamliel-Lazarovich, Marielle Kaplan, Elsa Pavlotzky, et al. Mineralocorticoid Receptor Blocker Increases Angiotensin-Converting Enzyme 2 Activity in Congestive Heart Failure Patients, Circulation Research, 10.1161/01.RES.0000187500.24964.7A, 97, 9, (946-953), (2005).
  397. Shuchang Zhou, Yujin Wang, Tingting Zhu and Liming Xia, CT Features of Coronavirus Disease 2019 (COVID-19) Pneumonia in 62 Patients in Wuhan, China, American Journal of Roentgenology, 10.2214/AJR.20.22975, (1-8), (2020).
  398. Siddell, S. G. et al. Additional changes to taxonomy ratified in a special vote by the International Committee on Taxonomy of Viruses (October 2018). Arch. Virol. 164, 943–946 (2019).
  399. Siddell, S. G. et al. Binomial nomenclature for virus species: a consultation. Arch. Virol. 165, 519–525 (2020).
  400. Siewierrska K, Denys A. Efficacy of preoperative immunoprophylaxis in patients with neoplastic deseases. II. Estimation of antihaemagglutinin and antineuraminidase antibody titre or influenza viruses A and B. Int Rev Allergol Clin Immunol. 1999;5:46–50. [Google Scholar]
  401. Siewierrska K, Denys A. Efficacy of preoperative immunoprophylaxis in patients with neoplastic deseases. I. Phagocyte activity and bactericidal properties of peripheral blood granulocytes. Int Rev Allergol Clin Immunol. 1999;5:39–45. [Google Scholar]
  402. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, et al.Angus DC. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016 Feb 23;315(8):801-10. [PMC free article] [PubMed]
  403. Snijder, E. J. et al. Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J. Mol. Biol. 331, 991–1004 (2003).
  404. Song W, Gui M, Wang X, Xiang Y. Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2. PLoS Pathog. 2018 Aug;14(8):e1007236. [PubMed]
  405. Statement from the American Heart Association, the Heart Failure Society of America and the American College of Cardiology. Patients taking ACE-i and ARBs who contract COVID-19 should continue treatment, unless otherwise advised by their physician. https://newsroom.heart.org/news/patients-taking-ace-i-and-arbs-who-contract-covid-19-should-continue-treatment-unless-otherwise-advised-by-their-physician (Accessed on March 18, 2020).
  406. Subbarao, K., J. McAuliffe, L. Vogel, G. Fahle, S. Fischer, K. Tatti, M. Packard, W. J. Shieh, S. Zaki, and B. Murphy. 2004. Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice. J. Virol. 78:3572-3577.
  407. Sylvie Rodrigues-Ferreira and Clara Nahmias, G-protein coupled receptors of the renin-angiotensin system: new targets against breast cancer?, Frontiers in Pharmacology, 10.3389/fphar.2015.00024, 6, (2015).
  408. Grant, A. Rohou, N. Grigorieff, cisTEM, user-friendly software for single-particle image processing. eLife 7, e35383 (2018).
  409. Croll, ISOLDE: A physically realistic environment for model building into low-resolution electron-density maps. Acta Crystallogr. D Struct. Biol. 74, 519–530 (2018).
  410. Tang A, Tong ZD, Wang HL, et al. Detection of Novel Coronavirus by RT-PCR in Stool Specimen from Asymptomatic Child, China. Emerg Infect Dis 2020; 26.
  411. Tang X, Wu C, Li X, et al. On the origin and continuing evolution of SARS-CoV-2. National Science Review 2020.
  412. Tang, B. et al. Estimation of the transmission risk of the 2019-nCoV and its implication for public health interventions. J. Clin. Med. 9, 462 (2020).
  413. Tang, N. L., P. K. Chan, C. K. Wong, K. F. To, A. K. Wu, Y. M. Sung, D. S. Hui, J. J. Sung, and C. W. Lam. 2005. Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndrome. Clin. Chem. 51:2333-2340.
  414. Tate, M. D., A. G. Brooks, and P. C. Reading. 2008. The role of neutrophils in the upper and lower respiratory tract during influenza virus infection of mice. Respir. Res. 9:57.CrossRefPubMedGoogle Scholar
  415. Taylor, P. M., and B. A. Askonas. 1986. Influenza nucleoprotein-specific cytotoxic T-cell clones are protective in vivo. Immunology 58:417-420.
  416. Tegunov, P. Cramer, Real-time cryo-electron microscopy data preprocessing with Warp. Nat. Methods 16, 1146–1152 (2019).
  417. The American Academy of Dermatology. https://assets.ctfassets.net/1ny4yoiyrqia/PicgNuD0IpYd9MSOwab47/023ce3cf6eb82cb304b4ad4a8ef50d56/Biologics_and_COVID-19.pdf (Accessed on March 18, 2020).
  418. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China CCDC, February 17 2020
  419. The European League Against Rheumatism. EULAR Guidance for patients COVID-19 outbreak. https://www.eular.org/eular_guidance_for_patients_covid19_outbreak.cfm (Accessed on March 18, 2020).
  420. The results provide key information about the stability of SARS-CoV-2, which causes COVID-19 disease, and suggests that people may acquire the virus through the air and after touching contaminated objects.
  421. Thompson JD, Higgins DG, Gibson TJ. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673–4680. doi:10.1093/nar/22.22.4673.
  422. Tian S, Hu W, Niu L, Liu H, Xu H, Xiao SY. Pulmonary pathology of early phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol. 2020 Feb 27; [PubMed]
  423. Tian Xue, Nie Wei, Zhou Xin and Xiu Qingyu, Angiotensin-converting enzyme-2 overexpression attenuates inflammation in rat model of chronic obstructive pulmonary disease, Inhalation Toxicology, 10.3109/08958378.2013.850563, 26, 1, (14-22), (2014).
  424. Tikellis, C. and M.C. Thomas (2012) Int. J. Pept. 2012:256294.
  425. Tommy R. Tong, Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV), Emerging Viruses in Human Populations, 10.1016/S0168-7069(06)16004-8, (43-95), (2006).
  426. Topham, D. J., and P. C. Doherty. 1998. Clearance of an influenza A virus by CD4+ T cells is inefficient in the absence of B cells. J. Virol. 72:882-885.
  427. Traggiai, E., S. Becker, K. Subbarao, L. Kolesnikova, Y. Uematsu, M. R. Gismondo, B. R. Murphy, R. Rappuoli, and A. Lanzavecchia. 2004. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat. Med. 10:871-875.
  428. Tuantuan Zhao, Kenneth E Bernstein, Jianmin Fang and Xiao Z Shen, Angiotensin-converting enzyme affects the presentation of MHC class II antigens, Laboratory Investigation, 10.1038/labinvest.2017.32, 97, 7, (764-771), (2017).
  429. Food and Drug Administration (FDA) Accepts for Priority Review Bristol-Myers Squibb’s Biologics License Application (BLA) for Lisocabtagene Maraleucel (liso-cel) for Adult Patients with Relapsed or Refractory Large B-Cell Lymphoma. Published February 13, 2020. https://bit.ly/39uYC0l. Accessed February 13, 2020.
  430. United States Centers for Disease Control and Prevention. Discontinuation of home isolation for persons with COVID-19 (Interim Guidance). https://www.cdc.gov/coronavirus/2019-ncov/hcp/disposition-in-home-patients.html (Accessed on March 17, 2020).
  431. United States Centers for Disease Control and Prevention. Discontinuation of In-Home isolation for immunocompromised persons with COVID-19 (Interim Guidance). https://www.cdc.gov/coronavirus/2019-ncov/hcp/ending-isolation.html (Accessed on March 18, 2020).
  432. United States Centers for Disease Control and Prevention. Novel Coronavirus Information for Travel. https://www.cdc.gov/coronavirus/2019-ncov/travelers/index.html (Accessed on February 18, 2020).
  433. Updated: WHO Now Doesn't Recommend Avoiding Ibuprofen For COVID-19 Symptoms. Science Alert 2020. https://www.sciencealert.com/who-recommends-to-avoid-taking-ibuprofen-for-covid-19-symptoms (Accessed on March 19, 2020).
  434. Ursula Danilczyk and Josef M. Penninger, Angiotensin-Converting Enzyme II in the Heart and the Kidney, Circulation Research, 10.1161/01.RES.0000205761.22353.5f, 98, 4, (463-471), (2006).
  435. van Boheemen, S. et al. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. mBio 3, e00473-12 (2012).
  436. Van Braeckel, E. et al. Polyfunctional CD4(+) T cell responses in HIV-1-infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccine. Vaccine 31, 3739–3746 (2013).
  437. van Doremalen N, Bushmaker T, Morris DH, et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med 2020.
  438. Van Regenmortel, M. H. V. The species problem in virology. Adv. Virus Res. 100, 1–18 (2018).
  439. Van Regenmortel, M. H., Maniloff, J. & Calisher, C. The concept of virus species. Arch. Virol. 120, 313–314 (1991).
  440. Vijaya Lakshmi Bodiga and Sreedhar Bodiga, Renin Angiotensin System in Cognitive Function and Dementia, Asian Journal of Neuroscience, 10.1155/2013/102602, 2013, (1-18), (2013).
  441. Vivian Delcourt, Julien Franck, Jusal Quanico, Jean-Pascal Gimeno, Maxence Wisztorski, Antonella Raffo-Romero, Firas Kobeissy, Xavier Roucou, Michel Salzet and Isabelle Fournier, Spatially-Resolved Top-down Proteomics Bridged to MALDI MS Imaging Reveals the Molecular Physiome of Brain Regions, Molecular & Cellular Proteomics, 10.1074/mcp.M116.065755, 17, 2, (357-372), (2017).
  442. Vogel, L. N., A. Roberts, C. D. Paddock, G. L. Genrich, E. W. Lamirande, S. U. Kapadia, J. K. Rose, S. R. Zaki, and K. Subbarao. 2007. Utility of the aged BALB/c mouse model to demonstrate prevention and control strategies for severe acute respiratory syndrome coronavirus (SARS-CoV). Vaccine 25:2173-2179.
  443. Hwang, Y. Lin, E. Santelli, J. Sui, L. Jaroszewski, B. Stec, M. Farzan, W. A. Marasco, R. C. Liddington, Structural basis of neutralization by a human anti-severe acute respiratory syndrome spike protein antibody, 80R. J. Biol. Chem. 281, 34610–34616 (2006).
  444. Li, M. J. Moore, N. Vasilieva, J. Sui, S. K. Wong, M. A. Berne, M. Somasundaran, Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426, 450–454 (2003).
  445. Song, M. Gui, X. Wang, Y. Xiang, Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2. PLOS Pathog. 14, e1007236 (2018).
  446. Wagner H, Jurcic K. Immunological studies of plant-extract combinations - invitro and invivo studies on the stimulation of phagocytosis. Arzneimittel-Forschung/Drug Research. 1991;41(2):1072–1076. [PubMed] [Google Scholar]
  447. Walmor C. De Mello, Angiotensin (1–7) reduces the cell volume of swollen cardiac cells and decreases the swelling-dependent chloride current. Implications for cardiac arrhythmias and myocardial ischemia, Peptides, 10.1016/j.peptides.2010.08.024, 31, 12, (2322-2324), (2010).
  448. Wan Y, Shang J, Graham R, et al. Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS. J Virol 2020.
  449. Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 2020.
  450. Wang M, Cao R, Zhang L, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 2020; 30:269.
  451. Wang ML, Munoz J, Goy A, et al. KTE-X19, an anti-CD19 chimeric antigen receptor (CAR) T cell therapy, in patients (pts) with relapsed/refractory (r/r) mantle cell lymphoma (MCL): results of the phase 2 zuma-2 study. Presented at: 2019 ASH Annual Meeting, Orlando, FL, December 7-10, 2019. Abstract 754.
  452. Wang S, Guo L, Chen L, et al. A case report of neonatal COVID-19 infection in China. Clin Infect Dis 2020.
  453. Wang X, Zhou Z, Zhang J, et al. A case of 2019 Novel Coronavirus in a pregnant woman with preterm delivery. Clin Infect Dis 2020.
  454. Wang Y, Liu Y, Liu L, et al. Clinical outcome of 55 asymptomatic cases at the time of hospital admission infected with SARS-Coronavirus-2 in Shenzhen, China. J Infect Dis 2020.
  455. Wang Z, Chen X, Lu Y, et al. Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. Biosci Trends 2020; 14:64.
  456. Wei M, Yuan J, Liu Y, et al. Novel Coronavirus Infection in Hospitalized Infants Under 1 Year of Age in China. JAMA 2020.
  457. Wenhui Li, Hyeryun Choe and Michael Farzan, Insights from the Association of SARS-CoV S-Protein with its Receptor, ACE2, The Nidoviruses, 10.1007/978-0-387-33012-9_36, (209-218), (2006).
  458. Wenhui Li, Michael J. Moore, Natalya Vasilieva, Jianhua Sui, Swee Kee Wong, Michael A. Berne, Mohan Somasundaran, John L. Sullivan, Katherine Luzuriaga, Thomas C. Greenough, Hyeryun Choe and Michael Farzan, Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus, Nature, 10.1038/nature02145, 426, 6965, (450-454), (2003).
  459. Wentworth, D. E., L. Gillim-Ross, N. Espina, and K. A. Bernard. 2004. Mice susceptible to SARS coronavirus. Emerg. Infect. Dis. 10:1293-1296.
  460. WHO (2003) Summary of Probable SARS Cases with Onset of Illness from 1 November 2002 to 31 July 2003.
  461. WHO (2020) Coronavirus Disease 2019 (COVID-10) Situation Report – 50.
  462. Wiley, J. A., A. Cerwenka, J. R. Harkema, R. W. Dutton, and A. G. Harmsen. 2001. Production of interferon-gamma by influenza hemagglutinin-specific CD8 effector T cells influences the development of pulmonary immunopathology. Am. J. Pathol. 158:119-130.
  463. Wisecaver JH, Hackett JD. 2014. The impact of automated filtering of BLAST-determined homologs in the phylogenetic detection of horizontal gene transfer from a transcriptome assembly. Mol Phylogenet Evol 71:184–192. doi:10.1016/j.ympev.2013.11.016.
  464. Wong SF, Chow KM, Leung TN, et al. Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am J Obstet Gynecol 2004; 191:292–297
  465. Wong, C. K., C. W. Lam, A. K. Wu, W. K. Ip, N. L. Lee, I. H. Chan, L. C. Lit, D. S. Hui, M. H. Chan, S. S. Chung, and J. J. Sung. 2004. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin. Exp. Immunol. 136:95-103.
  466. Wong, R. S., A. Wu, K. F. To, N. Lee, C. W. Lam, C. K. Wong, P. K. Chan, M. H. Ng, L. M. Yu, D. S. Hui, J. S. Tam, G. Cheng, and J. J. Sung. 2003. Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. BMJ 326:1358-1362.
  467. World Health Organization best practices for the naming of new human infectious diseases (World Health Organization, 2015); https://apps.who.int/iris/handle/10665/163636
  468. World Health Organization Director-General's opening remarks at the media briefing on COVID-19 - 24 February 2020 https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---24-february-2020 (Accessed on February 26, 2020).
  469. World Health Organization. 2003. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. World Health Organization, Geneva, Switzerland. http://www.who.int/csr/sars/country/table2003_09_23/en/.
  470. World Health Organization. 2003. Update 49: SARS case fatality ratio, incubation period. World Health Organization, Geneva, Switzerland. http://www.who.int/csr/sars/archive/2003_05_07a/en/.
  471. World Health Organization. Advice on the use of masks the community, during home care and in health care settings in the context of the novel coronavirus (2019-nCoV) outbreak. January 29, 2020. http://www.who.int/publications-detail/advice-on-the-use-of-masks-the-community-during-home-care-and-in-health-care-settings-in-the-context-of-the-novel-coronavirus-(2019-ncov)-outbreak (Accessed on January 31, 2020).
  472. World Health Organization. Coronavirus disease (COVID-19) technical guidance: Surveillance and case definitions. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/surveillance-and-case-definitions (Accessed on February 28, 2020).
  473. World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report - 36. February 25, 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200225-sitrep-36-covid-19.pdf?sfvrsn=2791b4e0_2 (Accessed on February 26, 2020).
  474. World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report – 28. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200217-sitrep-28-covid-19.pdf?sfvrsn=a19cf2ad_2 (Accessed on February 18, 2020).
  475. World Health Organization. Coronavirus disease 2019 (COVID-19) situation report–57. Geneva, Switzerland: World Health Organization; 2020. https://www.who.int/docs/default-source/coronaviruse/situationreports/20200317-sitrep-57-covid-19.pdf?sfvrsn=a26922f2_2
  476. World Health Organization. Coronavirus disease 2019 (COVID-19) situation report–51. Geneva, Switzerland: World Health Organization; 2020. https://www.who.int/docs/default-source/coronaviruse/situationreports/20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_10
  477. World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report - 36. February 25, 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200225-sitrep-36-covid-19.pdf?sfvrsn=2791b4e0_2 (Accessed on February 26, 2020).
  478. World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report – 28. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200217-sitrep-28-covid-19.pdf?sfvrsn=a19cf2ad_2 (Accessed on February 18, 2020).
  479. World Health Organization. Director-General's remarks at the media briefing on 2019-nCoV on 11 February 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020 (Accessed on February 12, 2020).
  480. World Health Organization. Home care for patients with suspected novel coronavirus (nCoV) infection presenting with mild symptoms and management of contacts. Updated February 4, 2020. https://www.who.int/publications-detail/home-care-for-patients-with-suspected-novel-coronavirus-(ncov)-infection-presenting-with-mild-symptoms-and-management-of-contacts (Accessed on February 14, 2020).
  481. World Health Organization. Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected. January 25, 2020. https://www.who.int/publications-detail/infection-prevention-and-control-during-health-care-when-novel-coronavirus-(ncov)-infection-is-suspected-20200125 (Accessed on February 04, 2020).
  482. World Health Organization. Key considerations for repatriation and quarantine of travellers in relation to the outbreak of novel coronavirus 2019-nCoV. February 11, 2020. https://www.who.int/ith/Repatriation_Quarantine_nCoV-key-considerations_HQ-final11Feb.pdf?ua=1 (Accessed on February 18, 2020).
  483. World Health Organization. Novel Coronavirus (2019-nCoV) technical guidance. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance (Accessed on February 14, 2020).
  484. World Health Organization. Novel Coronavirus (2019-nCoV) technical guidance: Patient management. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/patient-management (Accessed on February 02, 2020).
  485. World Health Organization. Novel coronavirus situation report -2. January 22, 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200122-sitrep-2-2019-ncov.pdf (Accessed on January 23, 2020).
  486. World Health Organization. Updated WHO advice for international traffic in relation to the outbreak of the novel coronavirus 2019-nCoV, 24 January 2020, https://www.who.int/ith/2020-24-01-outbreak-of-Pneumonia-caused-by-new-coronavirus/en/ (Accessed on January 26, 2020).
  487. World Health Organization. WHO Disease outbreak news: Novel Coronavirus – Republic of Korea (ex-China). January 21, 2020. https://www.who.int/csr/don/21-january-2020-novel-coronavirus-republic-of-korea-ex-china/en/ (Accessed on January 21, 2020).
  488. Wrapp D, Wang N, Corbett KS, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 2020 Feb 18
  489. Wrapp, J. S. McLellan, The 3.1-angstrom cryo-electron microscopy structure of the porcine epidemic diarrhea virus spike protein in the prefusion conformation. J. Virol. 93, e00923-19 (2019).
  490. Wu C, Chen X, Cai Y, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med 2020.
  491. Wu C, Chen X, Cai Y, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med 2020.
  492. Wu J, Liu J, Zhao X, et al. Clinical Characteristics of Imported Cases of COVID-19 in Jiangsu Province: A Multicenter Descriptive Study. Clin Infect Dis 2020.
  493. Wu J, Liu J, Zhao X, et al. Clinical Characteristics of Imported Cases of COVID-19 in Jiangsu Province: A Multicenter Descriptive Study. Clin Infect Dis 2020.
  494. Wu Z, McGoogan JM: Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72,314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020 Feb 24. doi: 10.1001/jama.2020.2648. [Epub ahead of print]
  495. Wu, A. et al. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe https://doi.org/10.1016/j.chom.2020.02.001 (2020).
  496. Wu, S. Zhao, B. Yu, Y.-M. Chen, W. Wang, et al A new coronavirus associated with human respiratory disease in China. Nature (2020).
  497. Tian, C. Li, A. Huang, S. Xia, S. Lu, Z. Shi, L. Lu, S. Jiang, Z. Yang, Y. Wu, T. Ying, Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. bioRxiv 9, 382–385 (2020).
  498. Xiao Z Shen, Sandrine Billet, Chentao Lin, Derick Okwan-Duodu, Xu Chen, Aron E Lukacher and Kenneth E Bernstein, The carboxypeptidase ACE shapes the MHC class I peptide repertoire, Nature Immunology, 10.1038/ni.2107, 12, 11, (1078-1085), (2011).
  499. Xiao Z. Shen and Kenneth E. Bernstein, The peptide network regulated by angiotensin converting enzyme (ACE) in hematopoiesis, Cell Cycle, 10.4161/cc.10.9.15444, 10, 9, (1363-1369), (2014).
  500. Xiao Z. Shen, Aron E. Lukacher, Sandrine Billet, Ifor R. Williams and Kenneth E. Bernstein, Expression of Angiotensin-converting Enzyme Changes Major Histocompatibility Complex Class I Peptide Presentation by Modifying C Termini of Peptide Precursors, Journal of Biological Chemistry, 10.1074/jbc.M709574200, 283, 15, (9957-9965), (2008).
  501. Xiao Z. Shen, Hong D. Xiao, Ping Li, Chentao X. Lin, Sandrine Billet, Derick Okwan-Duodu, Jon W. Adams, Ellen A. Bernstein, Yi Xu, Sebastien Fuchs and Kenneth E. Bernstein, New insights into the role of angiotensin-converting enzyme obtained from the analysis of genetically modified mice, Journal of Molecular Medicine, 10.1007/s00109-008-0325-3, 86, 6, (679-684), (2008).
  502. Xie X, Zhong Z, Zhao W, et al. Chest CT for Typical 2019-nCoV Pneumonia: Relationship to Negative RT-PCR Testing. Radiology 2020; :200343.
  503. Xie Xudong, Chen Junzhu, Wang Xingxiang, Zhang Furong and Liu Yanrong, Age- and gender-related difference of ACE2 expression in rat lung, Life Sciences, 10.1016/j.lfs.2005.09.038, 78, 19, (2166-2171), (2006).
  504. Xin Zou, Ke Chen, Jiawei Zou, Peiyi Han, Jie Hao and Zeguang Han, Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection, Frontiers of Medicine, 10.1007/s11684-020-0754-0, (2020).
  505. Xu XW, Wu XX, Jiang XG, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ 2020; 368:m606.
  506. Wan, J. Shang, R. Graham, R. S. Baric, F. Li, Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS. J. Virol. JVI.00127-20 (2020).
  507. Yuan, D. Cao, Y. Zhang, J. Ma, J. Qi, Q. Wang, et al Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains. Nat. Commun. 8, 15092 (2017).
  508. Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H, Takeuchi O, Sugiyama M, Okabe M, Takeda K, Akira S. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science. 2003;301:640–643. doi: 10.1126/science.1087262. [PubMed] [CrossRef] [Google Scholar]
  509. Yan‐Chao Li, Wan‐Zhu Bai and Tsutomu Hashikawa, The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients, Journal of Medical Virology, , (2020).
  510. Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020.
  511. Yang, L., H. Peng, Z. Zhu, G. Li, Z. Huang, Z. Zhao, R. A. Koup, R. T. Bailer, and C. Wu. 2007. Persistent memory CD4+ and CD8+ T-cell responses in recovered severe acute respiratory syndrome (SARS) patients to SARS coronavirus M antigen. J. Gen. Virol. 88:2740-2748.
  512. Yang, Y. et al. (2020) J. Autoimmun. [Epub ahead of print].
  513. Yao X, Ye F, Zhang M, et al. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis 2020.
  514. Yen, Y. T., F. Liao, C. H. Hsiao, C. L. Kao, Y. C. Chen, and B. A. Wu-Hsieh. 2006. Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro. J. Virol. 80:2684-2693.
  515. Yiu-Wing Kam, Yuushi Okumura, Hiroshi Kido, Lisa F. P. Ng, Roberto Bruzzone and Ralf Altmeyer, Cleavage of the SARS Coronavirus Spike Glycoprotein by Airway Proteases Enhances Virus Entry into Human Bronchial Epithelial Cells In Vitro, PLoS ONE, 10.1371/journal.pone.0007870, 4, 11, (e7870), (2009).
  516. Yong Wang, Maria da Consolação V Moreira, Silvia Heringer-Walther, Heinz-Peter Schultheiss, Wolf-Eberhard Siems, Niels Wessel and Thomas Walther, Beta Blockers Prevent Correlation of Plasma ACE2 Activity With Echocardiographic Parameters in Patients With Idiopathic Dilated Cardiomyopathy, Journal of Cardiovascular Pharmacology, 10.1097/FJC.0000000000000156, 65, 1, (8-12), (2015).
  517. Yong Wang, Maria da Consolação V. Moreira, Silvia Heringer-Walther, Linda Ebermann, Heinz-Peter Schultheiss, Niels Wessel, Wolf-Eberhard Siems and Thomas Walther, Plasma ACE2 Activity is an Independent Prognostic Marker in Chagas' Disease and Equally Potent as BNP, Journal of Cardiac Failure, 10.1016/j.cardfail.2009.09.005, 16, 2, (157-163), (2010).
  518. Young BE, Ong SWX, Kalimuddin S, et al. Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore. JAMA 2020.
  519. Yu P, Zhu J, Zhang Z, et al. A familial cluster of infection associated with the 2019 novel coronavirus indicating potential person-to-person transmission during the incubation period. J Infect Dis 2020.
  520. Yu Yang, Zeyu Xiong, Sheng Zhang, Yan Yan, Justin Nguyen, al Bcl-xL inhibits T-cell apoptosis induced by expression of SARS coronavirus E protein in the absence of growth factors, Biochemical Journal, 10.1042/BJ20050698, 392, 1, (135-143), (2005).
  521. Yuchun Nie, Peigang Wang, Xuanling Shi, Guangwen Wang, et al. Highly infectious SARS-CoV pseudotyped virus reveals the cell tropism and its correlation with receptor expression, Biochemical and Biophysical Research Communications, 10.1016/j.bbrc.2004.07.060, 321, 4, (994-1000), (2004).
  522. Yun Shi, Bo Zhang, Xiang-Jun Chen, Dun-Quan Xu, et al. Osthole protects lipopolysaccharide-induced acute lung injury in mice by preventing down-regulation of angiotensin-converting enzyme 2, European Journal of Pharmaceutical Sciences, 10.1016/j.ejps.2012.12.031, 48, 4-5, (819-824), (2013).
  523. Su, J. Zimpelmann and K.D. Burns, Angiotensin-(1–7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells, Kidney International, 10.1038/sj.ki.5001509, 69, 12, (2212-2218), (2006).
  524. Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E. & Fouchier, R. A. M. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med. 367, 1814–1820 (2012).
  525. Zhang, B., Y. K. Chan, B. Lu, M. S. Diamond, and R. S. Klein. 2008. CXCR3 mediates region-specific antiviral T cell trafficking within the central nervous system during West Nile virus encephalitis. J. Immunol. 180:2641-2649.
  526. Zhang, C. et al. NKG2A is a NK cell exhaustion checkpoint for HCV persistence. Nat. Commun. 10, 1507 (2019).
  527. Zhang, Q. et al. Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity. Nat. Immunol. 19, 723–732 (2018).
  528. Zhang, Y.-Z., Chen, Y.-M., Wang, W., Qin, X.-C. & Holmes, E. C. Expanding the RNA virosphere by unbiased metagenomics. Annu. Rev. Virol. 6, 119–139 (2019).
  529. Zhao W, Zhong Z, Xie X, et al. Relation Between Chest CT Findings and Clinical Conditions of Coronavirus Disease (COVID-19) Pneumonia: A Multicenter Study. AJR Am J Roentgenol 2020; :1.
  530. Zhen Yang, Xin Yu, Li Cheng, Li-yan Miao, Hong-xia Li, Lian-hua Han and Wen-ping Jiang, Effects of enalapril on the expression of cardiac angiotensin-converting enzyme and angiotensin-converting enzyme 2 in spontaneously hypertensive rats, Archives of Cardiovascular Diseases, 10.1016/j.acvd.2013.01.004, 106, 4, (196-201), (2013).
  531. Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol 2020.
  532. Zheng, D. P. et al. Norovirus classification and proposed strain nomenclature. Virology 346, 312–323 (2006).
  533. Zhili Shao, Kevin Shrestha, Allen G. Borowski, David J. et al.Increasing Serum Soluble Angiotensin-Converting Enzyme 2 Activity After Intensive Medical Therapy Is Associated With Better Prognosis in Acute Decompensated Heart Failure, Journal of Cardiac Failure, 10.1016/j.cardfail.2013.06.296, 19, 9, (605-610), (2013).
  534. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020.
  535. Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579:270.
  536. Zhou, W., M. Sharma, J. Martinez, T. Srivastava, D. J. Diamond, W. Knowles, and S. F. Lacey. 2007. Functional characterization of BK virus-specific CD4+ T cells with cytotoxic potential in seropositive adults. Viral Immunol. 20:379-388.
  537. Zhou, Y. et al. (2015) Protease inhibitors targeting coronavirus and filovirus entry. Antiviral Res. 116:76.
  538. Zhu H, Wang L, Fang C, et al. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr 2020; 9:51.
  539. Zhu N, Zhang D, Wang W, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 2020; 382:727.
  540. Ziebuhr, J. et al. Proposal 2017.013S. A.v1. Reorganization of the family Coronaviridae into two families, Coronaviridae (including the current subfamily Coronavirinae and the new subfamily Letovirinae) and the new family Tobaniviridae (accommodating the current subfamily Torovirinae and three other subfamilies), revision of the genus rank structure and introduction of a new subgenus rank. (ICTV, 2017); https://ictv.global/proposal/2017.Nidovirales/.
  541. Ziebuhr, J. et al. Proposal 2019.021S.Ac.v1. Create ten new species and a new genus in the subfamily Orthocoronavirinae of the family Coronaviridae and five new species and a new genus in the subfamily Serpentovirinae of the family Tobaniviridae. (ICTV, 2019); https://ictv.global/proposal/2019.Nidovirales/.
  542. Ziegler, T., S. Matikainen, E. Ronkko, P. Osterlund, M. Sillanpaa, J. Siren, R. Fagerlund, M. Immonen, K. Melen, and I. Julkunen. 2005. Severe acute respiratory syndrome coronavirus fails to activate cytokine-mediated innate immune responses in cultured human monocyte-derived dendritic cells. J. Virol. 79:13800-13805.
  543. Zou L, Ruan F, Huang M, et al. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. N Engl J Med 2020.
  544. Zumla, A., Hui, D. S. & Perlman, S. Middle East respiratory syndrome. Lancet 386, 995–1007 (2015).
  545. Bengsch, B., Johnson, A. L., Kurachi, M., Odorizzi, P. M., Pauken, K. E., Atanasio, J., et al. (2016). Bioenergetic insufficiencies due to metabolic alterations regulated by PD-1 are an early driver of CD8+ T Cell Exhaustion. Immunity 45,358–373.
  546. Buck, M. D., Sowell, R. T., Kaech, S. M., and Pearce, E. L. (2017). Metabolic instruction of immunity. Cell 169, 570–586. doi: 10.1016/j.cell.2017.04.004
  547. Carr, S. M., Carnero, E., Garcia-Sastre, A., Brownlee, G. G., and Fodor, E. (2006). Characterization of a mitocondrial-targeting signal in the PB2 protein of influenza viruses. Virology 344, 492–508. doi: 10.1016/j.virol.2005.08.041
  548. Cereghetti, G. M., Stangherlin, A., Martins de Brito, O., Chang, C. R., Blackstone, C., Bernardi, P., et al. (2008). Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondria. Proc. Natl. Acad. Sci. U.S.A. 105, 15803–15808. doi: 10.1073/pnas.0808249105
  549. Christensen, M. H., Jensen, S. B., Miettinen, J. J, Luecke, S., Prabakaran, T., Reinert, L. S., et al. (2016). HSV-1 ICP27 targets the TBK1-activated STING signalsome to inhibit virus-induced type I IFN expression. EMBO J. 35, 1385–1399. doi: 10.15252/embj.201593458
  550. Conenello, G. M., Zamarin, D., Perrone, L. A., Tumpey, T., and Palese, P. (2007). A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog. 4, 1414–1421. doi: 10.1371/journal.ppat.0030141
  551. Brumfiel, G. Physicists propose 'Schrödinger's virus' experiment. Nature (2009).
  552. Oriol Romero-Isart et al. Toward quantum superposition of living organisms. New Journal of Physics, 12 (2010) 033015) DOI: 10.1088/1367-2630/12/3/033015
  553. Towards quantum superpositions of living organisms" (Oriol Romero-Isart et al. New Journal of Physics 12 (2010)
  554. Institute of Physics. "Can we detect quantum behavior in viruses?." ScienceDaily. ScienceDaily, 11 March 2010.
  555. Rodrigo D. Requião, Rodolfo L. Carneiro, et al. Viruses with different genome types adopt a similar strategy to pack nucleic acids based on positively charged protein domains. Scientific Reports volume 10,
  556. Gita Mahmoudabadi, Ron Milo, and Rob Phillips Energetic cost of building a virus PNAS May 30, 2017
  557. Alexander E. Gorbalenya, Susan C. Baker et al. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 Nature Microbiology 5 , 536–544
  558. Beauchemin Catherine, Mathematical and computer models of viral infection dynamics within a host or a cell culture. Natural Sciences and Engineering Research Council of Canada. 2013
  559. Abbot D, Davies P C, and Pati A K (2008). Quantum Aspects of Life. Imperial College Press.
  560. Adam Zlotnick Viruses and the physics of soft condensed matter PNAS November 2, 2004 101 (44) 15549-15550;
  561. Amico L, Fazio R, Osterloh A, and Vedral V (2008). “Entanglement in many-body systems.” Rev. Mod. Phys. 80, 517–576.10.1103/RevModPhys.80.517
  562. Arndt M, Nairz O, Voss-Andreae J, Keller C, der Zouw G V, and Zeilinger A (1999). “Wave-particle duality of C60 molecules.” Nature (London) 401, 680–682.10.1038/44348
  563. Bouwmeester D, Ekert A, and Zeilinger A (eds) (2000). The physics of quantum information, Springer, Berlin.
  564. Barber, G. N. (2015). STING: infection, inflammation and cancer. Nat. Rev. Immunol. 15, 760–770.
  565. Brougham D F, Caciuffo R, and Horsewill A J (1999). “Coordinated proton tunnelling in a cyclic network of four hydrogen bonds in the solid state.” Nature (London) 397, 241–243.10.1038/16672
  566. Brukner C, Vedral V, and Zeilinger A (2006). “Crucial role of quantum entanglement in bulk properties of solids.” Phys. Rev. A 73, 012110.10.1103/PhysRevA.73.012110
  567. Cai J, Guerreschi G G, and Briegel H J (2009). “Quantum control and entanglement in a chemical compass.” arXiv:0906.2383.
  568. Cai J, Popescu S, and Briegel H J (2008). “Dynamic entanglement in oscillating molecules.” arXiv:0809.4906.
  569. Cha Y, Murray C, and Klinman J (1989). “Hydrogen tunneling in enzyme reactions.” Science 243, 1325–1330.10.1126/science.2646716
  570. Clauser J (1997). “De Broglie-wave interference of small rocks and live viruses.” In Experimental Metaphysics, Cohen R, Horne M, and Stachel J (eds), pp 1–11, Kluwer Academic, Dordrecht, Germany.
  571. Akira, S., and Takeda, K. (2004). Toll-like receptor signalling. Nat. Rev. Immunol. 4,499–511. doi: 10.1038/nri1391
  572. María Maximina B. Moreno-Altamirano Virus Control of Cell Metabolism for Replication and Evasion of Host Immune Responses Front. Cell. Infect. Microbiol, 18 April 2019
  573. Ernest C. Pollard The Physics of Viruses Imprint: Academic Press Published Date: 1st January 1953
  574. Oriol Romero-Isart, Mathieu L. Juan, Romain Quidant, J. Ignacio Cirac. Toward Quantum Superposition of Living Organisms Quantum Physics 2009
  575. Closs G L (1969). “Mechanism explaining nuclear spin polarizations in radical combination reactions.” J. Am. Chem. Soc. 91, 4552–4554.10.1021/ja01044a043
  576. Cory D G, Price M D, Maas W, Knill E, Laflamme R, Zurek W H, Havel T F, and Somaroo S S (1998). “Experimental quantum error correction.” Phys. Rev. Lett. 81, 2152–2155.10.1103/PhysRevLett.81.2152
  577. Roya Zandi, David Reguera, Robijn F. Bruinsma, et al. Origin of icosahedral symmetry in viruses PNAS November 2, 2004 101 (44) 15556-1556
  578. Dahan M, Levi S, Luccardini C, Rostaing P, Riveau B, and Triller A (2003). “Diffusion dynamics of glycine receptors revealed by single-quantum dot tracking.” Science 302, 442–445.10.1126/science.1088525
  579. Dahlbom M, Pullerits T, Mukamel S, and Sundstrom V (2001). “Exciton delocalization in the B850 light-harvesting complex: comparison of different measures.” J. Phys. Chem. B 105, 5515–5524.10.1021/jp004496i
  580. Diosi L (1989). “Models for universal reduction of macroscopic quantum fluctuations.” Phys. Rev. A 40, 1165–1174.10.1103/PhysRevA.40.1165
  581. Eisert J, Wilkens M, and Lewenstein M (1999). “Quantum games and quantum strategies.” Phys. Rev. Lett. 83, 3077–3080.10.1103/PhysRevLett.83.3077
  582. Eisert J, and Wiseman H, (2007). “Quantum aspects of life,” In Nontrivial Quantum Effects in Biology: A Skeptical Physicists’ View, World Scientific, Singapore.
  583. Engel G S, Calhoun T R, Read E L, Ahn T Y, Mančal T, Cheng Y C, Blankenship R E, and Fleming G R (2007). “Evidence for wavelike energy transfer through quantum coherence in photosynthetic systems.” Nature (London) 446, 782–786.10.1038/nature05678
  584. Ghirardi G C, Rimini A, and Weber T (1986). “Unified dynamics for microscopic and macroscopic systems.” Phys. Rev. D 34, 470–491.10.1103/PhysRevD.34.470
  585. Glauber R J (2006). “Nobel lecture: one hundred years of light quanta.” Rev. Mod. Phys. 78, 1267–1278.10.1103/RevModPhys.78.1267
  586. Goldanskii V (1979). “Facts and hypotheses of molecular chemical tunnelling.” Nature (London) 279, 109–115.10.1038/279109a0
  587. Gray H, and Winkler J (2003). “Electron tunneling through proteins.” Q. Rev. Biophys. 36, 341–372.10.1017/S0033583503003913
  588. Hackermüller L, Hornberger K, Brezger B, Zeilinger A, and Arndt M (2004). “Decoherence of matter waves by thermal emission of radiation.” Nature (London) 427, 711–714.10.1038/nature02276
  589. Hackermüller L, Uttenthaler S, Hornberger K, Reiger E, Brezger B, Zeilinger A, and Arndt M (2003). “Wave nature of biomolecules and fluorofullerenes.” Phys. Rev. Lett. 91, 090408.10.1103/PhysRevLett.91.090408
  590. Hecht S, Shlaer S, and Pirenne M (1942). “Energy, quanta and vision.” J. Gen. Physiol. 25, 819–840.10.1085/jgp.25.6.819
  591. Hornberger K, Uttenthaler S, Brezger B, Hackermüller L, Arndt M, and Zeilinger A. “Collisional decoherence observed in matter wave Interferometry.” Phys. Rev. Lett. 90, 160401.10.1103/PhysRevLett.90.160401
  592. Johnsen S, and Lohmann K J. “Magnetoreception in animals.” Phys. Today 61, 2008.
  593. Joos E, and Zeh H D. “The emergence of classical properties through interaction with the environment.” Z. Phys. 1985
  594. Joos E, Zeh H D, Kiefer C, Giulini D, Kupsch J, and Stamatescu I O (2003). Decoherence and the Appearance of a Classical World in Quantum Theory, 2nd ed., Springer, Berlin.
  595. Kaptein R, and Oosterhoff J L (1969). “Chemically induced dynamic nuclear polarization II: (relation with anomalous ESR spectra).” Chem. Phys.
  596. Kasprzak J, et al. (2006). “Bose-Einstein condensation of exciton polaritons.” Nature (London) 443(7110), 409–414.10.1038/nature05131
  597. Longuet-Higgins H C (1962). “Quantum mechanics and biology.” Biophys. J. 2, 207–215.10.1016/S0006-3495(62)86957-4
  598. Löwdin P O (1963). “Proton tunneling in DNA and its biological implocations.” Rev. Mod. Phys. 35,
  599. Marcus R A (1956). “Theory of oxidation-reduction reactions involving electron transfer.” J. Chem. Phys. 24(5)
  600. Markham D, Anders J, Vedral V, Murao M, and Miyake A. “Survival of entanglement in thermal states.” Eur. Phys. Lett. 81 2008
  601. Masgrau L, Roujeinikova A, Johannissen L, Hothi P, Basran J, Ranaghan K, Mulholland A, Sutcliffe M, Scrutton N, and Leys D . “Atomic description of an enzyme reaction dominated by proton tunneling.” Science 312. 2006
  602. Matsuno K. “Cell motility as an entangled quantum coherence.” BioSystems 51, (1999)
  603. McFadden J. Quantum Evolution: How Physics’ Weirdest Theory Explains Life’s Biggest Mystery, Harper Collins, New York. 2000
  604. Mohseni M, Rebentrost P, Lloyd S, and Aspuru-Guzik A. “Environment-assisted quantum walks in energy transfer of photosynthetic complexes.” J. Chem. Phys. 2008
  605. Penrose R. The Emperor’s New Mind: Concerning Computers, Minds and the Laws of Physics, Oxford University Press, New York. 1989
  606. Penrose R. “On gravity’s role in quantum state reduction.” Gen. Relativ. Gravit. 28, 581– 1996
  607. Polson R C, and Vardeny Z V. “Random lasing in human tissues.” Appl. Phys. Lett. 85 2004.
  608. Rebentrost P, Mohseni M, Kassal I, Lloyd S, and Aspuru-Guzik A. “Environment-assisted quantum transport.” New J. Phys. 11, 2009
  609. Reiger E, Hackermüller L, Berninger M, and Arndt M. “Exploration of gold nanoparticle beams for matter wave interferometry.” Opt. Commun. 264, 326–332 2006.
  610. Romero-Isart O, Juan M L, Quidant R, and Cirac J I. “Towards quantum superposition of living organisms.” arXiv:0909.1469. 2009
  611. Sanchez-Mosteiro G, Koopman M, van Dijk EMHP, Hernando J, van Hulst N F, and García-Parajó M F. “Photon antibunching proves emission from a single subunit in the autofluorescent protein DsRed.” ChemPhysChem 5, 1782–1785 2004
  612. Schrödinger E . What Is Life? The Physical Aspect of the Living Cell, Cambridge University Press, Cambridge, U.K. 1944
  613. Schulten K, Swenberg C, and Weller A. “Biomagnetic sensory mechanism based on magnetic-field modulated coherent electron-spin motion.” Z. Phys. Chem. 111(1), 1–5. 1978
  614. Sherson J, Krauter H, Olsson R, Julsgaard B, Hammerer K, Cirac I, and Polzik E (2006). “Quantum teleportation between light and matter.” Nature (London)
  615. Solov’yov I A, and Schulten K (2009). “Magnetoreception through cryptochrome may involve superoxide.” Biophys. J. 96, 4804–4813.10.1016/j.bpj.2009.03.048 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  616. Tegmark M (2000). “The importance of quantum decoherence in brain processes.” Phys. Rev. E 61, 4194–4206.10.1103/PhysRevE.61.4194 [PubMed] [CrossRef] [Google Scholar]
  617. Tronrud D, Wen J, Gay L, Fenna R, and Blankenship RE (2009). “Unique bidentate ligation of a bacteriochlorophyll found in an FMO antenna protein.” to be published.
  618. Winkler J, Gray H, Prytkova T, Kurnikov I, and Beratan D (2005). “Electron transfer through proteins.” Bioelectronics, pp 15–33, Wiley-VCH, Weinheim, Germany.
  619. Aldabe, R., Irurzun, A., and Carrasco, L. (1997). Poliovirus protein 2BC increase cytosolic free calcium concentrations. J. Virol. 71, 6214–6217.
  620. Daniels, B. P., Kofman, S. B., Smith, J. R., Norris, G. T., Snyder, A. G., Kolb, J. P., et al. (2019). The nucleotide sensor ZBP1 and kinase RIPK3 induce the enzyme IRG1 to promote an antiviral metabolic state in neurons. Immunity 50, 64–76.e4. doi: 10.1016/j.immuni.2018.11.017
  621. Darnell, J. E. Jr., Kerr, I. M., and Stark, G. R. (1994). Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415–1421. doi: 10.1126/science.8197455
  622. Delgado-Rizo, V., Martínez-Guzmán, M. A., I-iguez-Gutierrez, L., García-Orozco, A., Alvarado-Navarro, A., and Fafutis-Morris, M. (2017). Neutrophil extracellular traps and its implications in inflammation: an overview. Front. Immunol 8:81. doi: 10.3389/fimmu.2017.00081
  623. Dörner, T., and Radbruch, A. (2007). Antibodies and B cell memory in viral immunity. Immunity 27, 384–392. doi: 10.1016/j.immuni.2007.09.002
  624. Duchen, M. R. (2000). Mitochondria and calcium: from cell signalling to cell death. J. Physiol. 529, 57–68. doi: 10.1111/j.1469-7793.2000.00057.x
  625. Fitzgerald, K. A., McWhirter, S. M., Faia, K. L., Rowe, D. C., Latz, E., Golenbock, D. T., et al. (2003). IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4, 491–496. doi: 10.1038/ni921
  626. Foti, M., Cartier, L., Piguet, V., Lew, D. P., Carpentier, J. L., Trono, D., et al. (1999). The HIV Nef protein alters Ca2+ signaling in myelomonocytic cells through SH3- mediated protein-protein interactions. J. Biol. Chem. 274, 34765–34772. doi: 10.1074/jbc.274.49.34765
  627. Freeman, G. J., Long, A. J., Iwai, Y., Bourque, K., Chernova, T., Nishimura, H., et al. (2000). Engagement of the Pd-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192, 1027–1034. doi: 10.1084/jem.192.7.1027
  628. Galani, I. E., and Andreakos, E. (2015). Neutrophils in viral infections: current concepts and caveats. J. Leukoc. Biol. 98, 557–564. doi: 10.1189/jlb.4VMR1114-555R
  629. Ganeshan, K., and Chawla, A. (2014). Metabolic regulation of immune responses. Annu Rev Immunol. 32, 609–634. doi: 10.1146/annurev-immunol-032713-120236
  630. Hoffmann, H. H., Schneider, W. M., Blomen, V. A., Scull, M. A., Hovnanian, A., Brummelkamp, T. R., et al. (2017). Diverse viruses require the calcium transporter SPCA1 for maturation and spread. Cell Host Microbe 22, 460–470. doi: 10.1016/j.chom.2017.09.002
  631. Honda, K., Yanai, H., Negishi, H., Asagiri, M., Sato, M., Mizutani, T., et al. (2005). IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434, 772–777. doi: 10.1038/nature03464
  632. Hsu, P. P., Kang, S. A., Rameseder, J., Zhang, Y., Ottina, K. A., Lim, D., et al. (2011). The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1 mediated inhibition of growth factor signaling. Science 332, 1317–1322. doi: 10.1126/science.1199498
  633. Jellusova, J., and Rickert, R. C. (2016). The PI3K pathway in B cell metabolism. Crit. Rev. Biochem. Mol. Biol. 51, 359–378. doi: 10.1080/10409238.2016.1215288
  634. Koshiba, T. (2013). Mitochondrial-mediated antiviral immunity. Biochim. Biophys. Acta 1833, 225–232. doi: 10.1016/j.bbamcr.2012.03.005
  635. Lam, W. Y., Becker, A. M., Kennerly, K. M., et al. (2016). Mitochondrial pyruvate import promotes long-term survival of antibody-secreting plasma cells. Immunity 45, 60–73. doi: 10.1016/j.immuni.2016.06.011
  636. Ford LH: Estimate of the vibrational frequencies of spherical virus particles. Phys Rev 2003. E67, 051924-1-051924-3
  637. Tsen KT, Dykeman EC, Sankey OF, Lin N-T, Tsen S-WD, Kiang JG: Raman scattering studies of the low-frequency vibrational modes of bacteriophage M13 in water -observation of an axial torsion mode. Nanotechnology 2006, 17: 5474-5479.
  638. Tsen KT, Dykeman EC, Sankey OF, Lin N-T, Tsen S-WD, Kiang JG: Probing the low-frequency vibrational modes of viruses with Raman scattering – bacteriophage M13 in water. J Biomed Opt 2007,12(2):024009. 10.1117/1.2718935
  639. Tsen, K., Tsen, S.D., Chang, C. et al. Inactivation of viruses by coherent excitations with a low power visible femtosecond laser. Virol J 4, 50 (2007). https://doi.org/10.1186/1743-422X-4-50
  640. Adamo SA. Comparative psychoneuroimmunology: Evidence from the insects. Behavioral and Cognitive Neuroscience Reviews. 2006;5:128–140.
  641. Adey W. Potential therapeutic applications of non-thermal electromagnetic fields: ensemble organization of cells in tissue as a factor in biological field sensing. In: Rosch PJ, Markov M, eds. Bioelectromagnetic Medicine. Boca Raton, FL: CRC Press; 2004: 21–35.
  642. Aiewsakun, Pakorn; Katzourakis, Aris. "Marine origin of retroviruses in the early Palaeozoic Era". Nature Communications. 8: 13954. 2017
  643. Are viruses alive? The replicator paradigm sheds decisive light on an old but misguided question. Studies in History and Philosophy of Biological and Biomedical Sciences. 7 March 2016;59:125–134.
  644. Ashour HM, Elkhatib WF, Rahman MM, Elshabrawy HA. "Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks". Pathogens (Basel, Switzerland). 9 (3): 186. March 2020
  645. Assinger A. Platelets and infection—an emerging role of platelets in viral infection. Front Immunol 2014; 5:649.
  646. Bao L, J M. Research progress of Da Yuan Yin on the treatment of infectious diseases. Emerg Tradit Chin Med. 2010;2:263-87
  647. Barnard CJ, Behnke JM. From psychoneuroimmunology to ecological immunology: Life history strategies and immunity trade-offs. In: Ader R, Felton DL, Cohen N, editors. Psychoneuroimmunology. 3. Vol. 2. San Diego, CA: Academic Press; 2001. pp. 35–47.
  648. Barnard CJ, Behnke JM. Reviews the principles of ecological immunology and related empirical tests, mainly in mice 2001
  649. Barr JN, Fearns R. "How RNA viruses maintain their genome integrity". The Journal of General Virology. 91 (Pt 6): 1373–87. June 2010
  650. Barré-Sinoussi, F. et al.. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science. 1983;220(4599):868–71.
  651. Barrett, Ron; Armelagos George J. An unnatural history of emerging infections. Oxford: Oxford University Press. 2013
  652. Barrett, Thomas C; Pastoret, Paul-Pierre; Taylor, William J. Rinderpest and peste des petits ruminants: virus plagues of large and small ruminants. 2006
  653. Barril PA, Fumian TM, Prez VE, Gil PI, Martínez LC, Giordano MO, et al. "Rotavirus seasonality in urban sewage from Argentina: effect of meteorological variables on the viral load and the genetic diversity". Environmental Research. 138: 409–15. April 2015
  654. Barry, John M. The great influenza: the epic story of the deadliest plague in history. New York: Penguin Books 2005
  655. Bassett C. Fundamental and practical aspects of therapeutic uses of pulsed electromagnetic fields (PEMFs). Crit Rev Biomed Eng 1989; 17:451–529.
  656. Berngruber TW, Froissart R, Choisy M, Gandon S. "Evolution of Virulence in Emerging Epidemics". PLOS Pathogens. 9(3) 2013
  657. Bernstein H, Bernstein C, Michod RE. "Sex in microbial pathogens". Infection, Genetics and Evolution. 57: 8–25. January 2018
  658. Boutwell CL, Rolland MM, Herbeck JT, Mullins JI, Allen TM. "Viral evolution and escape during acute HIV-1 infection". The Journal of Infectious Diseases. 202 (Suppl 2) 2010
  659. Breitbart M. Here a virus, there a virus, everywhere the same virus?. Trends in Microbiology. 2005;13(6):278–84.
  660. Brownstein M. Biophotonic tools in cell and tissue diagnostics. J Res Natl Inst Stand Technol 2007; 112:139–152.
  661. Buttgereit F, Burmester GR, Brand MD. Bioenergetics of immune functions: Fundamental and therapeutic aspects. Immunology Today. 2000;21:192–199.
  662. Canchaya C, Fournous G, Chibani-Chennoufi S, Dillmann ML, Brüssow H. Phage as agents of lateral gene transfer. Current Opinion in Microbiology. 2003;6(4):417–24
  663. Carbente MD, Peralta R, Hernández-Mendoza A, Dobson AD, Gonzalez RA, Pastor N, Batista-García RA. "A Review on Viral Metagenomics in Extreme Environments". Frontiers in Microbiology. 10: 2403. 2019
  664. Centers for Disease Control and Prevention. "Compendium of Measures To Prevent Disease Associated with Animals in Public Settings, 2005: National Association of State Public Health Veterinarians, Inc. (NASPHV)" (PDF). MMWR. 54 (RR–4 2005
  665. Chan MC, Chan RW, Mok CK, Mak NK, Wong RN. Indirubin-3'-oxime as an antiviral and immunomodulatory agent in treatment of severe human influenza virus infection. Hong Kong Med J. 2018;24(Suppl 6):45-7
  666. Chang FR, Yen CT, Ei-Shazly M, Lin WH, Yen MH, Lin KH. et al. Anti-Human Coronavirus (anti-HCoV) Triterpenoids from the Leaves of Euphorbia Neriifolia. Nat Prod Commun. 2012;7:1934578X1200701103
  667. Chang S. The meridian system and mechanism of acupuncture: a comparative review. Part 2: mechanism of acupuncture analgesia. Taiwan J Obstet Gynecol 2013; 52:14–24.
  668. Chang XJ, Xiao W, Zhang S, Chang YP, Chen CM, Chen J. et al. Mechanism of Re Du Ning injection on anti-acute lung injury in rats based on cytokines storm. Chin Herb Med. 2014;46:236-9
  669. Chen CJ, Michaelis M, Hsu HK, Tsai CC, Yang KD, Wu YC. et al. Toona sinensis Roem tender leaf extract inhibits SARS coronavirus replication. J Ethnopharmacol. 2008;120:108-11
  670. Chen F, Chan KH, Jiang Y, Kao RY, Lu HT, Fan KW. et al. In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds. J Clin Virol. 2004;31:69-75
  671. Chen H, Du Q. Potential Natural Compounds for Preventing 2019-nCoV Infection. Preprints. 2020
  672. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; doi: https://doi.org/10.1016/S0140-6736(20)30211-7.
  673. Chen X, Beutler JA, McCloud TG, Loehfelm A, Yang L, Dong HF. et al. Tannic acid is an inhibitor of CXCL12 (SDF-1alpha)/CXCR4 with antiangiogenic activity. Clin Cancer Res. 2003;9:3115-23
  674. Chen X, Howard OM, Yang X, Wang L, Oppenheim JJ, Krakauer T. Effects of Shuanghuanglian and Qingkailing, two multi-components of traditional Chinese medicinal preparations, on human leukocyte function. Life Sci. 2002;70:2897-913
  675. Chen X, Mellon RD, Yang L, Dong H, Oppenheim JJ, Howard OM. Regulatory effects of deoxycholic acid, a component of the anti-inflammatory traditional Chinese medicine Niuhuang, on human leukocyte response to chemoattractants. Biochem Pharmacol. 2002;63:533-41
  676. Chen X, Murakami T, Oppenheim JJ, Howard OM. Triptolide, a constituent of immunosuppressive Chinese herbal medicine, is a potent suppressor of dendritic-cell maturation and trafficking. Blood. 2005;106:2409-16
  677. Chen X, Oppenheim JJ, Howard OM. Chemokines and chemokine receptors as novel therapeutic targets in rheumatoid arthritis (RA): inhibitory effects of traditional Chinese medicinal components. Cell Mol Immunol. 2004;1:336-42
  678. Chen X, Yang D, Shen W, Dong HF, Wang JM, Oppenheim JJ. et al. Characterization of chenodeoxycholic acid as an endogenous antagonist of the G-coupled formyl peptide receptors. Inflamm Res. 2000;49:744-55
  679. Chen X, Yang L, Zhang N, Turpin JA, Buckheit RW, Osterling C. et al. Shikonin, a component of chinese herbal medicine, inhibits chemokine receptor function and suppresses human immunodeficiency virus type 1. Antimicrob Agents Chemother. 2003;47:2810-6
  680. Chen Z, Nakamura T. Statistical evidence for the usefulness of Chinese medicine in the treatment of SARS. Phytotherapy research: PTR. 2004;18:592-4
  681. Cheng PW, Ng LT, Chiang LC, Lin CC. Antiviral effects of saikosaponins on human coronavirus 229E in vitro. Clin Exp Pharmacol Physiol. 2006;33:612-6
  682. Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr HW. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. The Lancet. 2003;361:2045-6
  683. Coffin, John M. "Structure and Classification of Retroviruses". In Levy, Jay A. (ed.). The Retroviridae. 1 (1st ed.). New York: Plenum. (1992)
  684. Coffin, John M.; Hughes, Stephen H.; Varmus, Harold E. (1997). "Genetic Organization". Retroviruses. Cold Spring Harbor Laboratory Press.
  685. Cragg GM, Newman DJ. Natural products: a continuing source of novel drug leads. Biochimica et biophysica acta. 2013;1830:3670-95
  686. Crawford, Dorothy H. The invisible enemy: a natural history of viruses. 2000
  687. Daszak P, Cunningham AA, Hyatt AD (2001). "Anthropogenic environmental change and the emergence of infectious diseases in wildlife". Acta Tropica. 78 (2): 103–116.
  688. Deng SQ, Peng HJ. "Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China". Journal of Clinical Medicine. 9 (2): 575 February 2020
  689. Deng YF, Aluko RE, Jin Q, Zhang Y, Yuan LJ. Inhibitory activities of baicalin against renin and angiotensin-converting enzyme. Pharm Biol. 2012;50:401-6
  690. Desport, M, ed. Lentiviruses and Macrophages: Molecular and Cellular Interactions. Caister Academic. 2010
  691. Ding Y, Zeng L, Li R, Chen Q, Zhou B, Chen Q. et al. The Chinese prescription lianhuaqingwen capsule exerts anti-influenza activity through the inhibition of viral propagation and impacts immune function. BMC Complement Altern Med. 2017;17:130
  692. Domingo E, Escarmís C, Sevilla N, Moya A, Elena SF, Quer J, Novella IS, Holland JJ. "Basic concepts in RNA virus evolution". The FASEB Journal. 10 (8): 859–64. 1996
  693. Dong L, Xia JW, Gong Y, Chen Z, Yang H-H, Zhang J. et al. Effect of Lianhuaqingwen Capsules on Airway Inflammation in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Evid Based Complement Alternat Med. 2014;2014:1-11
  694. Drake JW, Holland JJ (November 1999). "Mutation rates among RNA viruses". Proceedings of the National Academy of Sciences of the United States of America. 96 (24): 13910–3.
  695. Du CY, Zheng KY, Bi CW, Dong TT, Lin H, Tsim KW. Yu Ping Feng San, an Ancient Chinese Herbal Decoction, Induces Gene Expression of Anti-viral Proteins and Inhibits Neuraminidase Activity. Phytother Res. 2015;29:656-61
  696. Edwards RA, Rohwer F. Viral metagenomics. Nature Reviews Microbiology. 2005;3(6):504–10.
  697. Emerman M, Malik HS. Virgin SW (ed.). "Paleovirology—modern consequences of ancient viruses". PLoS Biology. 8 (2): 2010
  698. Ershler WB, Keller ET. Age-associated increased interleukin-6, gene expression, late-life diseases, and frailty. Annual Review of Medicine. 2000;51:245–270.
  699. Fairclough SH, Houston K. A metabolic measure of mental effort. Biological Psychology. 2004;66:177–190.
  700. Fields BN. How do viruses cause different diseases? J Am Med Assoc. 1983;250:1754.
  701. Francki RI, Fauquet CM, Knudson DL, Brown F. Classification and nomenclature of viruses. Fifth report of the International Committee on Taxonomy of Viruses, Archives of Virology (Suppl. 2). 1991
  702. Frederick, A. Murphy. "The Threat Posed by the Global Emergence of Livestock, Food-borne, and Zoonotic Pathogens". Annals of the New York Academy of Sciences. 894 (1): 20–7 1999
  703. Fröhlich H. Evidence for Bose condensation-like excitation of coherent modes in biological systems. Phys Lett 1975; 51A:21.
  704. Fu YJ, Yan YQ, Qin HQ, Wu S, Shi SS, Zheng X. et al. Effects of different principles of Traditional Chinese Medicine treatment on TLR7/NF-κB signaling pathway in influenza virus infected mice. Chin Med. 2018;13:42
  705. Fung KP, Leung PC, Tsui KW, Wan CC, Wong KB, Waye MY. et al. Immunomodulatory activities of the herbal formula Kwan Du Bu Fei Dang in healthy subjects: a randomised, double-blind, placebo-controlled study. Hong Kong Med J. 2011;17(Suppl 2):41-3
  706. Funk H, Monsees T, Ozkucur N. Electromagnetic effects—from cell biology to medicine. Prog Histochem Cytochem 2009; 43:177–264.
  707. Funk R, Monsees T. Effects of electromagnetic fields on cells: physiological and therapeutical approaches and molecular mechanisms of interaction. Cells Tissues Organs 2006; 182:59–78.
  708. Gao J, Li J, Shao X, Jin Y, Lu XW, Ge JF. et al. Antiinflammatory and immunoregulatory effects of total glucosides of Yupingfeng powder. Chin Med J (Engl). 2009;122:1636-41
  709. Gao Y, Fang L, Cai R, Zong C, Chen X, Lu J. et al. Shuang-Huang-Lian exerts anti-inflammatory and anti-oxidative activities in lipopolysaccharide-stimulated murine alveolar macrophages. Phytomedicine. 2014;21:461-9
  710. Gibrat JF, Mariadassou M, Boudinot P, Delmas B. "Analyses of the radiation of birnaviruses from diverse host phyla and of their evolutionary affinities with other double-stranded RNA and positive strand RNA viruses using robust structure-based multiple sequence alignments and advanced phylogenetic methods". BMC Evolutionary Biology. 13: 154. July 2013
  711. Gingerich, Daniel A. (2008). "Lymphocyte T-cell immunomodulator (LTCI): Review of the immunopharmacology of a new biologic" (PDF). International Journal of Applied Research in Veterinary Medicine. 6 (2): 61–68.
  712. Gong SJ, Su XJ, Yu HP, Li J, Qin YJ, Xu Q. et al. A study on anti-SARS-CoV 3CL protein of flavonoids from litchi chinensis sonn core. Chinese Pharmacological Bulletin. 2008;24:699-700
  713. Hamrick N, Cohen S, Rodriguez MS. Being popular can be healthy or unhealthy: Stress, social network diversity, and incidence of upper respiratory infection. Health Psychology. 2002;21:294–298.
  714. Han Q, Lin Q, Jin S, You L. "Coronavirus 2019-nCoV: A brief perspective from the front line". The Journal of Infection. 80 (4): 373–377. February 2020
  715. Han YY, Zhao MR, Shi B, Song ZH, Zhou SP, He Y. Application of integrative medicine protocols on treatment of coronavirus disease 2019. Chi Tradit Herbal Drugs. 1-5.
  716. He J, He ZD, Chen X. Effects of Chinese medicinal components on chemokine receptors: theory, results and methodology. Evidence-based Research Methods for Chinese Medicine. 2016:187-97
  717. Helmreic S. Potential energy and the body electric cardiac waves, brain waves, and the making of quantities into qualities. Curr Anthropol 2013; 54:S139.
  718. Hille B. Ionic Channels of Excitable Membranes. 2nd ed Sunderland, MA: Sinauer Associates, Inc; 1992. [Google Scholar]
  719. Ho T, Wu S, Chen J, Li C, Hsiang C. Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction. Antiviral Res. 2007;74:92-101
  720. Hobfoll SE. The ecology of stress. New York: Hemisphere; 1988.
  721. Horvath P, Barrangou R. "CRISPR/Cas, the immune system of bacteria and archaea" (PDF). Science (New York, N.Y.). 327 (5962): 167–70. January 2010
  722. Houghton F. "Geography, global pandemics & air travel: Faster, fuller, further & more frequent". Journal of Infection and Public Health. 12 (3): 448–49. 2019
  723. House JS, Landis KR, Umberson D. Social relationships and health. Science. 1988;241:540–545.
  724. Hsu CH, Hwang KC, Chao CL, Chang SG, Ho MS, Chou P. Can herbal medicine assist against avian flu? Learning from the experience of using supplementary treatment with Chinese medicine on SARS or SARS-like infectious disease in 2003. J Altern Complement Med. 2006;12:505-6
  725. Hu WS, Temin HM. "Retroviral recombination and reverse transcription". Science. 250 (4985): 1227–33. November 1990
  726. International Committee on Taxonomy of Viruses (ICTV) Virus Taxonomy: 2018b Release". March 2019. Retrieved 16 March 2019.
  727. Iyer LM, Balaji S, Koonin EV, Aravind L. Evolutionary genomics of nucleo-cytoplasmic large DNA viruses. Virus Research. 2006;117(1):156–84.
  728. Jandová A, Pokorný J, Pokorný J, et al. Diseases caused by defects of energy level and loss of coherence in living cells. Electromagn Biol Med 2015; 34:151–155.
  729. Jo S, Kim H, Kim S, Shin DH, Kim MS. Characteristics of flavonoids as potent MERS-CoV 3C-like protease inhibitors. Chem Biol Drug Des. 2019
  730. Jo S, Kim S, Shin DH, Kim M-S. Inhibition of SARS-CoV 3CL protease by flavonoids. J Enzyme Inhib Med Chem. 2020;35:145-51
  731. Jolly C. "Cell-to-cell transmission of retroviruses: Innate immunity and interferon-induced restriction factors". Virology. 411 (2): 251–9 March 2011
  732. Jordan PC, Stevens SK, Deval J. Nucleosides for the treatment of respiratory RNA virus infections. Antivir Chem Chemother. 2018;26:2040206618764483
  733. Kim DE, Min JS, Jang MS, Lee JY, Shin YS, Song JH. et al. Natural Bis-Benzylisoquinoline Alkaloids-Tetrandrine, Fangchinoline, and Cepharanthine, Inhibit Human Coronavirus OC43 Infection of MRC-5 Human Lung Cells. Biomolecules. 2019;9:696
  734. Kim FJ, Battini JL, Manel N, Sitbon M. "Emergence of vertebrate retroviruses and envelope capture". Virology. 318 (1): 183–91. January 2004
  735. Koonin EV, Dolja VV (1993). "Evolution and taxonomy of positive-strand RNA viruses: implications of comparative analysis of amino acid sequences". Critical Reviews in Biochemistry and Molecular Biology. 28 (5): 375–430.
  736. Koonin EV, Senkevich TG, Dolja VV (September 2006). "The ancient Virus World and evolution of cells". Biology Direct. 1 (1): 29.
  737. Koonin EV, Wolf YI, Nagasaki K, Dolja VV. "The Big Bang of picorna-like virus evolution antedates the radiation of eukaryotic supergroups". Nature Reviews. Microbiology. 6 (12): 925–39. December 2008
  738. Koonin EV. "The phylogeny of RNA-dependent RNA polymerases of positive-strand RNA viruses". The Journal of General Virology. 72 ( Pt 9) (Pt 9): 2197–206 September 1991
  739. Krupovic M, Kuhn JH, Fischer MG. "A classification system for virophages and satellite viruses". Archives of Virology. 161 (1): 233–47. January 2016
  740. Krupovic, M; Blomberg, J; Coffin, JM; Dasgupta, I; Fan, H; et al. (4 April 2018). "Ortervirales: A new viral order unifying five families of reverse-transcribing viruses". Journal of Virology. 92 (12).
  741. Kuhn JH, Radoshitzky SR, Li W, Wong SK, Choe H, Farzan M. The SARS Coronavirus receptor ACE 2 A potential target for antiviral therapy. In: (ed.) Holzenburg A, Bogner E. New Concepts of Antiviral Therapy. Boston, MA: Springer US. 2006 p. 397-418
  742. Kurstak, E. Applied virology. Boston: Academic Press. 1984
  743. Lai CC, Liu YH, Wang CY, Wang YH, Hsueh SC, Yen MY, Ko WC, Hsueh PR. "Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths". Journal of Microbiology, Immunology, and Infection March 2020
  744. Lam TT, Hon CC, Tang JW. "Use of phylogenetics in the molecular epidemiology and evolutionary studies of viral infections". Critical Reviews in Clinical Laboratory Sciences. 47 (1): 5–49. 2010
  745. Larson SJ, Dunn AJ. Behavioral effects of cytokines. Brain Behavior and Immunity. 2001;15:371–387.
  746. Lau JT, Leung PC, Wong EL, Fong C, Cheng KF, Zhang SC. et al. The use of an herbal formula by hospital care workers during the severe acute respiratory syndrome epidemic in Hong Kong to prevent severe acute respiratory syndrome transmission, relieve influenza-related symptoms, and improve quality of life: a prospective cohort study. J Altern Complement Med. 2005;11:49-55
  747. Lau KM, Lee KM, Koon CM, Cheung CS, Lau CP, Ho HM. et al. Immunomodulatory and anti-SARS activities of Houttuynia cordata. J Ethnopharmacol. 2008;118:79-85
  748. Lau, Leung PC, Wong ELY, Fong C, Cheng KF, Zhang SC, et al. Using Herbal Medicine as a Means of Prevention Experience During the SARS Crisis. Am J Chin Med. 2005;33:345-56
  749. Lauber C, Seitz S, Mattei S, Suh A, Beck J, Herstein J, Börold J, Salzburger W, Kaderali L, Briggs JA, Bartenschlager R (September 2017). "Deciphering the Origin and Evolution of Hepatitis B Viruses by Means of a Family of Non-enveloped Fish Viruses". Cell Host & Microbe. 22 (3): 387–399.e6.
  750. Lawrence CM, Menon S, Eilers BJ, et al.. Structural and functional studies of archaeal viruses. The Journal of Biological Chemistry. 2009;284(19):12599–603
  751. Leppard, Keith; Nigel Dimmock; Easton, Andrew. Introduction to modern virology. Oxford: Blackwell Publishing Limited. 2007
  752. Letko M, Munster V. Functional assessment of cell entry and receptor usage for lineage B β-coronaviruses, including 2019-nCoV. bioRxiv. 2020. 2020:01 22.915660
  753. Levin M. Molecular bioelectricity: how endogenous voltage potentials control cell behavior and instruct pattern regulation in vivo. Mol Biol Cell 2014; 25:3835–3850.
  754. Levins, Richard; Wilson, Mary E. Disease in evolution: global changes and emergence of infectious diseases. New York, N.Y: New York Academy of Sciences. 1994
  755. Li CX, Shi M, Tian JH, Lin XD, Kang YJ, Chen LJ, et al. "Unprecedented genomic diversity of RNA viruses in arthropods reveals the ancestry of negative-sense RNA viruses". eLife. 4. January 2015
  756. Li S, Chen C, Zhang H, Guo H, Wang H, Wang L. et al. Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antiviral Res. 2005;67:18-23
  757. Lin CW, Tsai FJ, Tsai CH, Lai CC, Wan L, Ho TY. et al. Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds. Antiviral Res. 2005;68:36-42
  758. Lin HX, Feng Y, Wong G, Wang L, Li B, Zhao X. et al. Identification of residues in the receptor-binding domain (RBD) of the spike protein of human coronavirus NL63 that are critical for the RBD-ACE2 receptor interaction. J Gen Virol. 2008;89:1015-24
  759. Liu LS, Lei N, Lin Q, Wang WL, Yan HW, Duan XH. The Effects and Mechanism of Yinqiao Powder on Upper Respiratory Tract Infection. Int J Biotechnol Wellness Ind. 2015;4:57-60
  760. Liu X, Zhang M, He L, Li Y. Chinese herbs combined with Western medicine for severe acute respiratory syndrome (SARS). Cochrane Database Syst Rev. 2012;10:Cd004882
  761. Lu H. Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci Trends. 2020
  762. Luo W, Su X, Gong S, Qin Y, Liu W, Li J. et al. Anti-SARS coronavirus 3C-like protease effects of Rheum palmatum L. extracts. BioScience Trends. 2009:3
  763. Luo, H., Tang, Q., Shang, Y. et al. Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs. Chin. J. Integr. Med. (2020). https://doi.org/10.1007/s11655-020-3192-6
  764. Lv RB, Wang WJ, Li X. Treatment of suspected new coronavirus pneumonia with Chinese medicine Lianhua Qingwen Clinical observation of 63 suspected cases. J Tradit Chin Med. 2020:1-5
  765. Mahy BWJ and Van Regenmortel, eds. (2009). Desk encyclopedia of human and medical virology.
  766. Matyushov D. Protein electron transfer: is biology (thermo)dynamic? J Phys Condens Matter 2015; 27:473001.
  767. Mausch K. Psychoimmunology and disease based on certain research results. Psychiatr Pol 1999; 33:231–239.
  768. Medstrand P, van de Lagemaat L, Dunn C, Landry J, Svenback D, Mager D. "Impact of transposable elements on the evolution of mammalian gene regulation". Cytogenet Genome Res. 110 (1–4): 342–52. 2005
  769. Messenger AM, Barnes AN, Gray GC. "Reverse zoonotic disease transmission (zooanthroponosis): a systematic review of seldom-documented human biological threats to animals". PLoS ONE. 9 (2) 2014
  770. Miller GE, Cohen S, Ritchey AK. Chronic psychological stress and the regulation of pro-inflammatory cytokines: A glucocorticoid-resistance model. Health Psychology. 2002;21:531–541.
  771. Muslin C, Mac Kain A, Bessaud M, Blondel B, Delpeyroux F. "Recombination in Enteroviruses, a Multi-Step Modular Evolutionary Process". Viruses. 11 (9): 859. September 2019
  772. Nasir, Anshan; Caetano-Anollés, Gustavo. "A phylogenomic data-driven exploration of viral origins and evolution". Science Advances. 1 (8): 2015
  773. Natea M, Joosten LAB, Latz E, et al. Trained immunity: a program of innate immunity memory in health and disease. Science 2016; 352:3–19.
  774. National Health Commission of the People's Republic of China. Notice on the issunance of guidelines of diagnosis and treatment for 2019-nCoV infected pneumonia (version 6). 6 ed; http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2.shtml?from=timeline. 2020
  775. Nguyen M, Haenni AL. "Expression strategies of ambisense viruses". Virus Research. 93 (2): 141–50 June 2003
  776. Nguyen TTH, Woo HJ, Kang HK, Nguyen VD, Kim YM, Kim DW. et al. Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris. Biotechnol Lett. 2012;34:831-8
  777. Nordenstrom B. Electric Potentials. Biologically Closed Electric Circuits. Norway, Sweden: Nordic Medical Publications; 1983: 58–65
  778. November 2018
  779. Oschman J. Energy Medicine: The Scientific Basis. Edinburgh, England: Churchill Livingstone; 2000.
  780. Oxford English Dictionary. "retrovirus". 25 September 2018.
  781. Patton JT (editor). (2008). Segmented Double-stranded RNA Viruses: Structure and Molecular Biology. Caister Academic Press. ISBN 978-1-904455-21-9.
  782. Pert C. The Molecules of Emotion: The Science Behind Mind–Body Medicine. New York, NY: Simon & Schuster, Inc; 1997.
  783. Philosophical Transactions of the Royal Society "Environmental and social influences on emerging infectious diseases: past, present and future". B. 359 (1447): 1049–1058.
  784. Pilcher H. Liquorice may tackle SARS. Nature. 2003
  785. Poon PM, Wong CK, Fung KP, Fong CY, Wong EL, Lau JT. et al. Immunomodulatory effects of a traditional Chinese medicine with potential antiviral activity: a self-control study. Am J Chin Med. 2006;34:13-21
  786. Popp F, Zhang J. Mechanism of interaction between electromagnetic fields and living organisms. Sci China (Ser C) 2000; 43:507–518.
  787. Råberg L, Grahn M, Hasselquist D, Svensson E. On the adaptive significance of stress-induced immunosuppression. Proceedings of the Royal Society of London – B. 1998;265:1637–1641.
  788. Rahnama M, Tuszynski JA, Bókkon I, Cifra M, Sardar P, Salari V. Emission of mitochondrial biophotons and their effect on electrical activity of membrane via microtubules. J Integr Neurosci 2011; 10:65–88.
  789. Rawson JM, Nikolaitchik OA, Keele BF, Pathak VK, Hu WS. "Recombination is required for efficient HIV-1 replication and the maintenance of viral genome integrity". Nucleic Acids Research. 46 (20): 10535–10545. November 2018
  790. Ren SY, Gao RD, Chen YL. "Fear can be more harmful than the severe acute respiratory syndrome coronavirus 2 in controlling the corona virus disease 2019 epidemic". World Journal of Clinical Cases. 8 (4): 652–657 February 2020
  791. Rhodes, John (2013). The end of plagues: the global battle against infectious disease. New York City: Palgrave Macmillan.
  792. Robert Belshaw; Pereira V; Katzourakis A; Talbot G; Paces J; Burt A; Tristem M. "Long-term reinfection of the human genome by endogenous retroviruses". Proc Natl Acad Sci USA. 101 (14): 4894–9. April 2004
  793. Rohleder N. Acute and chronic stress induced changes in sensitivity of peripheral inflammatory pathways to the signals of multiple stress systems. Psychoneuroendocrinology 2012; 37:307–316.
  794. Rosen, FS. Isolation of poliovirus – John Enders and the Nobel Prize. New England Journal of Medicine. 2004;351(15):1481–83.
  795. Ross C, Harrison BS. Effect of pulsed electromagnetic field on inflammatory pathway markers in RAW 264.7 murine macrophages. J Inflamm Res 2013; 6:45–51.
  796. Ross C, Harrison BS. The use of magnetic field for the reduction of inflammation: a review of the history and therapeutic results. Altern Ther Health Med 2013; 19:47–54.
  797. Ross C, Pettenati MJ, Procita J, Cathey L, George SK, Almeida-Porada G. Evaluation of cytotoxic and genotoxic effects of extremely low-frequency electromagnetic field on mesenchymal stromal cells. Glob Adv Health Med 2018; 7
  798. Ross C, Siriwardane ML, Almeida-Porada G, et al. The effect of low-frequency electromagnetic field on human bone-Marrow derived mesenchymal stem/progenitor cell differentiation. Stem Cell Research 2015; 15:96–108.
  799. Ross CL. Integral healthcare: the benefits and challenges of integrating complementary and alternative medicine with a conventional healthcare practice. Integr Med Insights 2009; 4:13–20.
  800. Rozanov MN, Koonin EV, Gorbalenya AE (August 1992). "Conservation of the putative methyltransferase domain: a hallmark of the 'Sindbis-like' supergroup of positive-strand RNA viruses". The Journal of General Virology. 73 ( Pt 8) (Pt 8): 2129–34.
  801. Rutherford, G. W.; Sangani, P. R.; Kennedy, G. E. (2003). "Three- or four- versus two-drug antiretroviral maintenance regimens for HIV infection". The Cochrane Database of Systematic Reviews
  802. Rybicki, EP. The classification of organisms at the edge of life, or problems with virus systematics. South African Journal of Science. 1990;86:182–86.
  803. Sanjuán R, Nebot MR, Chirico N, Mansky LM, Belshaw R (October 2010). "Viral mutation rates". Journal of Virology. 84
  804. Schwartz M, Kipnis J, Rivest S, Prat A. How do immune cells support and shape the brain in health, disease, and aging? J Neurosci 2013; 33:17587–17596.
  805. Schwarz S, Sauter D, Wang K, Zhang R, Sun B, Karioti A. et al. Kaempferol Derivatives as Antiviral Drugs against the 3a Channel Protein of Coronavirus. Planta Medica. 2014;80:177-82
  806. Schwarz S, Wang K, Yu WJ, Sun B, Schwarz W. Emodin inhibits current through SARS-associated coronavirus 3a protein. Antiviral res. 2011;90:64-9
  807. Science CAo. Researchers in Shanghai Institute of Drugs and Wuhan Virus Institute discovered that the Chinese patent medicine Shuanghuanglian oral liquid can inhibit the 2019-new coronavirus.; 2020
  808. Segerstrom SC, Miller GE. A meta-analysis of studies linking stress and human immunity, focusing on immune responses to brief versus prolonged stressors 2004
  809. Segerstrom SC, Miller GE. Psychological stress and the human immune system: A meta-analytic study of 30 years of inquiry. Psychological Bulletin. 2004;130:601–630.
  810. Segerstrom SC. How does optimism suppress immunity? Evaluation of three affective pathways. Health Psychology. 2006;25:653–657.
  811. Segerstrom SC. Optimism and immunity: Do positive thoughts always lead to positive effects? Brain Behavior and Immunity. 2005;19:195–200.
  812. Shen YC, Wang LT, Khalil AT, Chiang LC, Cheng PW. Bioactive Pyranoxanthones from the Roots of Calophyllum blancoi. Chem Pharm Bull. 2005;53:244-7
  813. Shors, Teri (2017). Understanding viruses: Third edition. Sudbury, Mass: Jones & Bartlett Publishers.
  814. Silverman M, Sternberg EM. Glucocorticoid regulation of inflammation and its behavioral and metabolic correlates: from HPA axis to glucocorticoid receptor dysfunction. Ann N Y Acad Sci 2012; 1261:55–63.
  815. Small JC, Ertl HC. "Viruses – from pathogens to vaccine carriers". Current Opinion in Virology. 1 (4): 241–45. 2011
  816. Solberg Nes L, Segerstrom SC. Dispositional optimism and coping: A meta-analytic review. Personality and Social Psychology Review. 2006;10:235–251.
  817. Soosaar JL, Burch-Smith TM, Dinesh-Kumar SP. "Mechanisms of plant resistance to viruses". Nature Reviews Microbiology. 3 (10): 789–98. 2005
  818. Steinhardt E, Israeli C, Lambert R.A.. Studies on the cultivation of the virus of vaccinia. The Journal of Infectious Diseases. 1913;13(2):294–300.
  819. Steinhauer DA, Holland JJ (1987). "Rapid evolution of RNA viruses". Annual Review of Microbiology. 41: 409–33.
  820. Su S, Wong G, Shi W, Liu J, Lai AC, Zhou J, et al. "Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses". Trends in Microbiology. 24 (6): 490–502. June 2016
  821. Svarovskaia ES; Cheslock SR; Zhang WH; Hu WS; Pathak VK. "Retroviral mutation rates and reverse transcriptase fidelity". Front. Biosci. 8 (1–3): d117–34. January 2003
  822. Szent-Gyorgyi A. Introduction to a Submolecular Biology. New York, NY: Academic Press; 1960.
  823. Takahashi S, Yoshiya T, Yoshizawa-Kumagaye K, Sugiyama T. Nicotianamine is a novel angiotensin-converting enzyme 2 inhibitor in soybean. Biomed Res. 2015;36:219-24
  824. Takeshita Y, Ransohoff R. Inflammatory cell trafficking across the blood-brain barrier (BBB): chemokine regulation and in vitro models. Immunol Rev 2012; 248:228–239.
  825. Taylor LH, Latham SM, Woolhouse ME. "Risk factors for human disease emergence". Philosophical Transactions of the Royal Society B: Biological Sciences. 356 (1411): 983–989 2001
  826. Tong X, Li A, Zhang Z, Duan J, Chen X, Hua C. et al. TCM treatment of infectious atypical pneumonia-a report of 16 cases. J Tradit Chin Med. 2004;24:266-9
  827. Tsigos C, Kyrou I, Kassi E, Chrousos GP. Stress, Endocrine Physiology and Pathophysiology https://www.ncbi.nlm.nih.gov/books/NBK278945/March. Accessed February 4, 2019. Published 2016.
  828. Turner M, Nedjai B, Hurst T, Pennington DJ. Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease. Biochim Biophys Acta 2014; 1843:2563–2582.
  829. Vargiu, L; Rodriguez-Tomé, P; Sperber, GO; Cadeddu, M; Grandi, N; Blikstad, V; Tramontano, E; Blomberg, J (22 January 2016). "Classification and characterization of human endogenous retroviruses; mosaic forms are common" Retrovirology. 13: 7.
  830. Vazari A, Plenio MB. Quantum coherence in ion channels: resonances, transport and verification. New J Phys 2010; 12:1–17.
  831. Vidal, John. "'Tip of the iceberg': is our destruction of nature responsible for Covid-19?". The Guardian 2020
  832. Villarreal, Luis P (2005). Viruses and the evolution of life. Washington, D.C: ASM Press
  833. Vogelzangs N, Beekman ATF, de Jonge P, Penninx BWJH. Anxiety disorders and inflammation in a large adult cohort. Transl Psychiatry 2013; 3:e249.
  834. Wang J, Qiao LF, Li YS, Yang GT. Shen Fu injection activate the macrophage NF-kB of rats' alveolar induced by LPS. Acta Medicinae Universitatis Scientiae et Technologiae Huazhong. 2009;1:15-8
  835. Wang SQ, Du QS, Zhao K, Li AX, Wei DQ, Chou KC. Virtual screening for finding natural inhibitor against cathepsin-L for SARS therapy. Amino Acids. 2007;33:129-35
  836. Wang W, Ma X, Han J, Zhou M, Ren H, Pan Q. et al. Neuroprotective Effect of Scutellarin on Ischemic Cerebral Injury by Down-Regulating the Expression of Angiotensin-Converting Enzyme and AT1 Receptor. PLoS One. 2016;11:e0146197
  837. Ward CW (1993). "Progress towards a higher taxonomy of viruses". Research in Virology. 144 (6): 419–53.
  838. Weese, J. Scott. Companion animal zoonoses. Wiley-Blackwell. pp. 282–284. 2011
  839. Weiss SR, Leibowitz JL. Coronavirus pathogenesis. Advances in Virus Research. 81. pp. 85–164. 2011
  840. White DW, Suzanne Beard R, Barton ES. "Immune modulation during latent herpesvirus infection". Immunological Reviews. 245 (1): 189–208 2012
  841. Wisneski L, Anderson L. The Scientific Basis of Integrative Medicine. Boca Raton, FL: CRC Press; 2009: 205.
  842. Wolf YI, Kazlauskas D, Iranzo J, Lucía-Sanz A, Kuhn JH, Krupovic M, Dolja VV, Koonin EV. "Origins and Evolution of the Global RNA Virome". mBio. 9 (6)
  843. Wong AT, Chen H, Liu SH, Hsu EK, Luk KS, Lai CK, Chan RF, Tsang OT, Choi KW, Kwan YW, Tong AY, Cheng VC, Tsang DC. "From SARS to Avian Influenza Preparedness in Hong Kong". Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 64 (suppl_2): S98–S104. May 2017
  844. World Health Organization. "Zoonoses and the Human-Animal-Ecosystems Interface". 2014.
  845. World Health Organization. Coronavirus disease (COVID-19) advice for the public: When and how to use masks. 2020
  846. World Health Organization. SARS: clinical trials on treatment using a combination of traditional Chinese medicine and Western medicine. Geneva, Switzerland, 2004. Available at: https://apps.who.int/medicinedocs/pdf/s6170e/s6170e.pdf (Accessed 2020/2/10).
  847. Wu CY, Jan JT, Ma SH, Kuo CJ, Juan HF, Cheng YSE. et al. Small molecules targeting severe acute respiratory syndrome human coronavirus. Proc Natl Acad Sci U S A. 2004;101:10012-7
  848. Wu T, Yang X, Zeng X, Poole P. Traditional Chinese medicine in the treatment of acute respiratory tract infections. Resp Med. 2008;102:1093-8
  849. Xiao GL, Song K, Yuan CJ ea. A literature report on the treatment of SARS by stages with traditional Chinese medicine. J Emerg Chin Med Hunan. 2005:53-5
  850. Xu X, Zhang Y, Li X, Li XX. Analysis on prevention plan of corona virus disease-19 (COVID-19) by traditional Chinese medicine in various regions. Chin Herb Med. 2020:1-7
  851. Xu XT, Chen P, Wang JF, Feng JN, Zhou H, Li X. et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci. 2020
  852. Yao KT, Liu MY, Li X, Huang JH, Cai HB. Retrospective Clinical Analysis on Treatment of Novel Coronavirus-infected Pneumonia with Traditional Chinese Medicine Lianhua Qingwen. Chin J Exp Tradit Med Form. 2020:1-7
  853. Yi L, Li Z, Yuan K, Qu X, Chen J, Wang G. et al. Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells. J Virol. 2004;78:11334-9
  854. Yu MS, Lee J, Lee JM, Kim Y, Chin YW, Jee JG. et al. Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13. Bioorg Med Chem Lett. 2012;22:4049-54
  855. Zhang H, Chen Q, Zhou W, Gao S, Lin H, Ye S. et al. Chinese medicine injection shuanghuanglian for treatment of acute upper respiratory tract infection: a systematic review of randomized controlled trials. Evid Based Complement Alternat Med. 2013;2013:987326
  856. Zhang JW, Hu X, Jin PF. Cytokine storms caused by 2019-nCoV and drug therapy. Chinese Pharmaceutical Journal. 2020:1-9 9
  857. Zhang MM, Liu XM, He L. Effect of integrated traditional Chinese and Western medicine on SARS: a review of clinical evidence. World J Gastroenterol. 2004;10:3500-5
  858. Zhao J, Tian SS, Yang J, Liu J, Zhang WD. Investigating the mechanism of Qing-Fei-Pai-Du-Tang for the treatment of Novel Coronavirus Pneumonia by network pharmacology. Chin Herb Med. 2020:1-7
  859. Zhu YG, Deng ZW, Liu LH, Liu XH, Li XZ, Chen WH. et al. Compilation of drug information for the diagnosis and treatment of COVID-19 (version 1). Central South Pharmacy. 1-14.
  860. Zimmer, Carl (2011). A planet of viruses. Chicago: University of Chicago Press.
  861. Zou HM, He TZ, Chen X. Tetrandrine inhibits differentiation of proinflammatory subsets of T helper cells but spares de novo differentiation of iTreg cells. Int Immunopharmacol. 2019;69:307-12
  862. Zuckerman, Arie J. Principles and practice of clinical virology. New York: Wiley. 1987
  863. Baron S, editor. Medical Microbiology. 4th edition. Galveston (TX): University of Texas Medical Branch at Galveston; 1996.
  864. Epidemiology Working Group for NCIP Epidemic Response. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Chin. J. Epidemiol. 41, 145–151 (2020).
  865. Nie, Y. et al. Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection. J. Infect. Dis. 190, 1119–1126 (2004).
  866. Park, W. B. et al. Virus isolation from the first patient with SARS-CoV-2 in Korea. J. Korean Med. Sci. 35, e84 (2020).
  867. Samuel Scott Perdue, John H. Humphrey Immune system Encyclopedia Britanica 2001
  868. Siu, K. L., Chan, C. P., Kok, K. H., Chiu-Yat Woo, P. & Jin, D. Y. Suppression of innate antiviral response by severe acute respiratory syndrome coronavirus M protein is mediated through the first transmembrane domain. Cell. Mol. Immunol. 11, 141–149 (2014).
  869. Sun, L. et al. Coronavirus papain-like proteases negatively regulate antiviral innate immune response through disruption of STING-mediated signaling. PLoS One 7, e30802 (2012).
  870. Tan, Y. J. et al. Profiles of antibody responses against severe acute respiratory syndrome coronavirus recombinant proteins and their potential use as diagnostic markers. Clin. Diagn. Lab. Immunol. 11, 362–371 (2004).
  871. Taneja, V. Sex hormones determine immune response. Front. Immunol. 9, 1931 (2018).
  872. Tay, M.Z., Poh, C.M., Rénia, L. et al. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol (2020). https://doi.org/10.1038/s41577-020-0311-8
  873. Versteeg, G. A., Bredenbeek, P. J., van den Worm, S. H. & Spaan, W. J. Group 2 coronaviruses prevent immediate early interferon induction by protection of viral RNA from host cell recognition. Virology 361, 18–26 (2007).
  874. Wu, H. S. et al. Early detection of antibodies against various structural proteins of the SARS-associated coronavirus in SARS patients. J. Biomed. Sci. 11, 117–126 (2004).
  1. Can quantum-mechanical description of physical reality be considered complete? Phys. Rev. 47 777 (1935). A. Einstein, B. Podolsky, and N. Rosen.
  2. Towards understanding molecular mechanisms of action of homeopathic drugs: an overview[J]. Mol Cell Biochem, 2003, 253(1-2) : 339-345. Khuda-Bukhsh AR.
  3. Anti-asthmatic and anti-anaphylactic activities of Blatta orientalis mother tincture." Homeopathy : the journal of the Faculty of Homeopathy 100(3): 138-143. Chandrashekara, S., et al. (2002).  Chandrakant Nimgulkar, C., et al. (2011).
  4. Anti-cytolytic homeopathic remedy beneficial in chronic viral hepatitis. Fir J Homeopathic Pharm. 2014:2:1-17. Dodd J. Veterinary Pain Management, 2nd edition Can Vet J. 2010 May; 51(5): 479.  Dobrescu D, Motoc A et al.
  5. A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors. Cancer biology & therapy. Mar 1 2011;11(5):464-473. Lim KJ, Bisht S, Bar EE, Maitra A, Eberhart CG.
  6. Activation of mononuclear bone marrow cells treated in vitro with a complex homeopathic medication. Micron 2008; 39(4): 461–470.  Cesar B, Abud AP, de Oliveira CC, et al.
  7. A double blind randomized placebo controlled study of cholera treatment with highly diluted and succussed solutions." British Homeopathic Journal 83(3): 132-134. Gaucher, C., et al. (1994).
  8. A Double-Blind Randomized Placebo-Controlled Feasibility Study Evaluating Individualized Homeopathy in Managing Pain of Knee Osteoarthritis Journal of Evidence-Based Complementary & Alternative Medicine 2015 Jul;20(3):186-91. Koley, M et al.
  9. Assays of homeopathic remedies in rodent behavioural and psychopathological models. Homeopathy 2009;98:208-27. Bellavite P, Magnani P, Marzotto M, Conforti A.
  10. A Homeopathic Arnica Patch for the Relief of Cellulitis-derived Pain and Numbness in the Hand Glob Adv Health Med. 2012 May; 1(2): 18–20. Barkey E, Kaszkin-Bettag M.
  11. A "Maddox effect"? A reason to adopt time series protocols in tests of homeopathic remedies." Journal of alternative and complementary medicine 11(5): 759-761. Hankey, A. (2005).
  12. A 14-month ranomized clinical trial of treatment strategis for attention- deficit/ hyperactivity disorder." Archives of General Psychiatry 56(12): 1073-1086. Jensen, P., et al. (1999).
  13. Zur Behandlung des Colon irritable: Ein multizentrischer plazebo-kontrollierter Doppelblindversuch in der Allgemeinen Praxis [Treatment of irritable colon: A multicenter placebo-controlled double-blind study in general practice]. Arzneimittel Forschung; 26:2230–2234. Rahlfs VW, Mössinger P (1976).
  14. Zur Wirkung eines homöopathi-schen Fertigarzneimittels auf den Blutdruck von Hypertonikern: Eine randomisierte doppelblinde kontrollierte Parallelgruppen-Vergleichsstudie [The effect of a homeopathic drug on the blood pressure of hypertensive patients: a randomized double-blind, controlled, parallel-group, comparative trial]. Wiener Medizinische Wochenschrift; 155:392–396. Hitzenberger G, Rehak PH (2005).
  15. Phenotypic evidence of ultra-highly diluted homeopathic remedies acting at gene expression level: a novel probe on experimental phage infectivity in bacteria.PHILOSOPHY Research. Santu Kumar Saha (Cytogenetics and Molecular Biology Laboratory, Department of Zoology, University of Kalyani, Kalyani 741235, India ) Sreema
  16. Das (Cytogenetics and Molecular Biology Laboratory, Department of Zoology, University of Kalyani, Kalyani 741235, India ) Anisur Rahman Khuda-Bukhsh (Cytogenetics and Molecular Biology Laboratory, Department of Zoology, University of Kalyani, Kalyani 741235, India E-mail: E-mail: [email protected])
  17. Gender, Depression and Zincum metallicum Silvio Leite Monteiro da Silva, Maria Martha Bernardi, Leoni Villano Bonamin International Journal of High Dilution Research, Vol 15, No 4 (2016)
  18. Evaluation of the quality of life after individualized homeopathic treatment for seasonal allergic rhinitis. A prospective, open, non-comparative study[J]. Homeopathy, 2009, 98(1) : 11-16. Goossens M, Laekeman G, Aertgeerts B, Buntinx F; ARCH study group.
  19. Homeopathy - A Safe, Much Less Expensive, Non-Invasive, Viable Alternative for the Treatment of Patients Suffering from Loss of Lumbar Lordosis. J Pharmacopuncture. 2016 Dec;19(4):358-361. doi: 10.3831/KPI.2016.19.038. Haque S, Das D, Bhattacharya S, Sarkar T, Khuda-Bukhsh AR.
  20. In vivo efficacy of a biotherapic and eugenol formulation against Rhipicephalus microplus.Parasitol Res. 2017 Jan 5. doi: 10.1007/s00436-016-5366-x. Valente PP1, Moreira GH2, Serafini MF2, Facury-Filho EJ2, Carvalho AÚ2, Faraco AA3, Castilho RO3, Ribeiro MF4.
  21. Basic Research on Homeopathy: Analysis of the Top Ten Best Investigated Substances International Journal of High Dilution Research, Vol 15, No 4 (2016) Beate Stock-Schroeer, P. Christian Endler, Petra Koczy, Stephan Baumgartner
  22. Effects of Antimomium crudum 30cH and 200cH on the macrophage – Leishmania (L) amazonensis relation in vitro International Journal of High Dilution Research, Vol 15, No 4 (2016) Leoni Villano Bonamin, Fabiana Rodrigues Santana, Luciane Costa Dalboni, Cideli Paula Coelho, Kátia Fialho Nascimento, Fabiana Toshie Konno, Renato Casarin, Dorly Freitas Buchi, Marcia Dalastra Laurenti, Nilson Roberto Benites
  23. Comparison of effects of homeopathic medicines prepared in glass and plastic vials in macrophage activity in vitro International Journal of High Dilution Research, Vol 15, No 4 (2016)Leoni Villano Bonamin, Luciana Costa Dalboni, Fabiana Rodrigues Santana, Thayná Neves Cardoso, Fabiana Toshie Konno, Silvia Waisse Priven, Amarylis Toledo Cesar
  24. Homeopathic medicine Cantharis modulates uropathogenic E. coli (UPEC)-induced cystitis in susceptible mice. Cytokine. 2017 Jan 28;92:103-109. doi: 10.1016/j.cyto.2017.01.014. [Epub ahead of print] de Paula Coelho, Motta PD, Petrillo M, de Oliveira Iovine R, Dalboni LC, Santana FR, Correia MS, Casarin RC, Carvalho VM, Bonamin LV.
  25. Predominance of Th1 response, increase of megakaryocytes and Kupffer cells are related to survival in Trypanosoma cruzi infected mice treated with Lycopodium clavatum. Cytokine. 2016 Dec;88:57-61. doi: 10.1016/j.cyto.2016.08.015. Epub 2016 Aug 24.
  26. Effect of a biostimulatory homeopathic complex on venom production in captive rattlesnakes (Crotalus durissus). Homeopathy. 2016 Nov;105(4):338-343. doi: 10.1016/j.homp.2016.05.003. Epub 2016 Aug 8. Santa Rita PH1, Cleveland HP2, Pereira PL2, Corrêa W2, Van Onselen VJ3, Corrêa Filho RA3, Teixeira MA4.
  27. Biological homing: hypothesis for a quantum effect that leads to the existence of life. Department of Emergency Medicine, East Carolina University School of Medicine, Greenville, NC 27858, USA Medical Hypotheses Volume 51, Issue 6, December 1998, Pages 503
  28. Depression of transmitter release at the neuromuscular junction of the frog, The journal of physiology DOI: 10.1113/jphysiol.1970.sp009034 Betz W. J.
  29. Quantal components of the excitatory postsynaptic currents at a rat central auditory synapse The journal of physiology DOI: 10.1111/j.1469-7793.2001.00189.x Yoshinori Sahara, Tomoyuki Takahashi
  30. Zinc oxide nanoparticles selectively induce apoptosis in human cancer cells through reactive oxygen species International Journal of Nanomedicine 2012;7:845–57. Akhtar MJ, Ahamed M, Kumar S, Khan MM, Ahmad J, Alrokayan SA.
  31. A complex homeopathic preparation for the treatment of osteoarthritis. Explore 2(3): 234. Anderson, K. (2006).
  32. Growth stimulation of dwarf peas (Pisum sativum L.) through homeopathic potencies of plant growth substances. Forsch Komplementarmed Klass Naturheilkd 2004; 11(5): 281–292. Baumgartner S, Thurneysen A, Heusser P.
  33. Isopathic and pluralist homeopathic treatment of commercial broilers with experimentally induced colibacillosis. Res Vet Science 2005; 78(1): 77–83. Velkers FC, te Loo AJ, Madin F, van Eck JH.
  34. The role of variability in evaluating ultra high dilution effects: considerations based on plant model experiments. Forsch Komplement Med (2006) 2007; 14(5): 301–305. Nani D, Brizzi M, Lazzarato L, Betti L.
  35. Effects of ultrahigh dilutions of 3,5-dichlorophenol on the luminescence of the bacterium Vibrio fischeri. Biochim Biophys Acta 2003; 1621(3): 253–260. Brack A, Strube J, Stolz P, Decker H.
  36. Inhibition of CD203c membrane up-regulation in human basophils by high dilutions of histamine: a controlled replication study. Inflamm Res 2009. Chirumbolo S, Brizzi M, Ortolani R, Vella A, Bellavite P.
  37. The conclusions on the effectiveness of homeopathy highly depend on the set of analyzed trials. J Clin Epidemiol. 2008 Dec;61(12):1197-204. doi: 10.1016/j.jclinepi.2008.06.015. Epub 2008 Oct 1. Lüdtke R1, Rutten AL.
  38. Analysis of the capability of ultra-highly diluted glucose to increase glucose uptake in arsenite-stressed bacteria Escherichia coli. J Chin Integr Med. 2011; 9(8): 901-912. English with abstract in Chinese. Khuda-Bukhsh AR, De A, Das D, Dutta S, Boujedaini N.
  39. A study of the potential of the homeopathic remedy, Arnica Montana 30C, to reduce DNA damage in Escherichia coli exposed to ultraviolet irradiation through up-regulation of nucleotide excision repair genes. J Chin Integr Med. 2012; 10(3): 337-346. English with abstract in Chinese. Das S, Saha SK, De A, Das D, Khuda-Bukhsh AR.
  40. In vitro growth of uropathogenic Escherichia coli isolated from a snow leopard treated with homeopathic and isopathic remedies: a pilot study. Int J High Dilution Res. 2009; 8(27): 41-44. [DOAJ] Kawakami AP, Osugui L, César AT, Priven SW, de Carvalho VM, Bonamin LV.
  41. Potentized homeopathic drugs act through regulation of gene-expression: a hypothesis to explain their mechanism and pathways of action in vivo[J]. Complement Ther Med, 1997, 5(1) : 43-46. [ScienceDirect]Khuda-Bukhsh AR.
  42. Thermoluminescence in UltraHigh Dilution Research. J Altern Complement Med 2006; 12(5): 437–443. Van Wijk R, Bosman S, van Wijk EP.
  43. A biostatistical insight into the As(2)O(3) high dilution effects on the rate and variability of wheat seedling growth. Forsch Komplementarmed Klass Naturheilkd 2005; 12(5): 277–283. Brizzi M, Lazzarato L, Nani D, et al.
  44. Conductometric studies of the serially diluted and agitated solutions on an anomalous effect that depends on the dilution process. J. Molecular Liquids 2007; 135: 158–165. Elia VE, Montanino L, Napoli E, Niccoli M, Nonatelli L.
  45. A Study of the Effect of Decimal and Centesimal Dilutions of Arsenic on the Retention and Mobilization of Arsenic in the Rat. Human Toxicol 1987;6: 315–320.Cazin JC, Cazin M, Gaborit JL, et al.
  46. Does potentized HgCl2 (Mercurius corrosivus) affect the activity of diastase and alpha-amylase? J Altern Complement Med 2006; 12(4): 359–365. Witt CM, Bluth M, Hinderlich S, et al.
  47. Scherr C, Simon M, Spranger J, Baumgartner S. Effects of potentised substances on growth rate of the water plant Lemna gibba L. Complement Ther Med 2009; 17(2): 63–70.
  48. Stimulation of survival capacity in heat shocked cells by subsequent exposure to minute amounts of chemical stressors; role of similarity in hsp-inducing effects. Hum Exp Toxicol 1999; 18(7): 460–470 Wiegant FA, Souren JE, van Wijk R.
  49. Ultra-highly diluted plant extracts of Hydrastis canadensis and Marsdenia condurango induce epigenetic modifications and alter gene expression profiles in HeLa cells in vitro. 2015, 13(6) ( Within JCIM & JIM )
  50. Laboratory research in homeopathy: pro[J]. Integr Cancer Ther, 2006, 5(4) : 320-332.Khuda-Bukhsh AR.
  51. Mice as a model for homeopathy research[J]. Homeopathy, 2009, 98(4) : 267-279.Khuda-Bukhsh AR.
  52. Homeopathic drug discovery: theory update and methodological aspect[J]. Expert Opin Drug Discov, 2008, 3(8): 979-990 [informahealthcare] .Khuda-Bukhsh AR, Pathak S.
  53. Ameliorating effect of microdoses of a potentized homeopathic drug, Arsenicum Album, on arsenic-induced toxicity in mice[J]. BMC Complement Altern Med, 2003, 3: 7.Mallick P, Mallick JC, Guha B, Khuda-Bukhsh AR.
  54. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. J Clin Epidemiol 2009. Moher D, Liberati A, Tetzlaff J, Altman DG.
  55. Modulation of signal proteins: a plausible mechanism to explain how a potentized drug Secale Cor 30C diluted beyond Avogadro’s limit combats skin papilloma in mice. Evid Based Complement Alternat Med. 2011: 286320.Khuda-Bukhsh AR, Bhattacharyya SS, Paul S, Dutta S, Boujedaini N, Belon P.
  56. Potentized homeopathic drug Arsenicum Album 30C positively modulates protein biomarkers and gene expressions in Saccharomyces cerevisae exposed to arsenate[J] J Chin Integr Med, 2011, 9(7) : 752-760. Chinese.Das D, De A, Dutta S, Biswas R, Boujedaini N, Khuda-Bukhsh AR.
  57. The family guide to homeopathy: the safe form of medicine for the future. London: Elm Tree Books. 1989.Lockie A.
  58. An initial report on the efficacy of a millesimal potency Arsenicum Album LM 0/3 in ameliorating arsenic toxicity in humans living in a high-risk arsenic village. 2011, 9(6)
  59. 10 facts on the global burden of disease. 2008. http://www.who.int/features/factfiles/global_burden/facts/en/index6.html. World Health Organization (WHO)
  60. 100 years of Homeopathy Homeopathy, Volume 100, Issues 1–2, January–April 2011, Pages 1-4. Fisher P.  103, Issue 1, January 2014, Pages 4-21. Bellavite P, Marzotto M et al.
  61. 10th Annual Symposium on Complementary Health Care: Royal College of Physicians, London, UK, November 21–22, 2003 Evid Based Complement Alternat Med. 2004 June; 1(1): 107–108. Cooper EL. 11(40): 204-205. Alecu, A. (2012).
  62. Potentized homeopathic drug Arsenicum Album 30C inhibits intracellular reactive oxygen species generation and up-regulates expression of arsenic resistance gene in arsenic-exposed bacteria Escherichia coli. J Chin Integr Med. 2012; 10(2): 210-227. English with abstract in Chinese.De A, Das D, Dutta S, Chakraborty D, Boujedaini N, Khuda-Bukhsh AR.
  63. A Systematic Overview of Reviews for Complementary and Alternative Therapies in the Treatment of the Fibromyalgia Syndrome, Romy Lauche, Holger Cramer, Winfried Häuser, Gustav Dobos, and Jost Langhorst  Volume 2015 (2015), Article ID 610615, 13 pages Evidence-Based Complementary and Alternative Medicine
  64. Transcriptome Profiling of Wheat Seedlings following Treatment with Ultrahigh Diluted Arsenic Trioxide, Ilaria Marotti, Lucietta Betti, Valeria Bregola, Sara Bosi, Grazia Trebbi, Giovanni Borghini, Daniele Nani, and Giovanni Dinelli Volume 2014 (2014), Article ID 851263, 15 pages Evidence-Based Complementary and Alternative Medicine
  65. Complementary and Alternative Medicine for Cancer Pain: An Overview of Systematic Reviews, Yanju Bao, Xiangying Kong, Liping Yang, Rui Liu, Zhan Shi, Weidong Li, Baojin Hua, and Wei Hou Evidence-Based Complementary and Alternative Medicine Volume 2014 (2014), Article ID 170396, 9 pages
  66. The activity of enzymes can be modified by homeopathic dilutions of their effectors. International Journal of High Dilution Research. 2012;11(40):185-186 Elzbieta Malarczyk
  67. Potentized estrogen in homeopathic treatment of endometriosis-associated pelvic pain. A 24-week, randomized, double-blind, placebo-controlled study.Teixeira MZ, Podgaec S, Baracat EC.Eur J Obstet Gynecol Reprod Biol. 2017 Jan 25;211:48-55. doi: 10.1016/j.ejogrb.2017.01.052. [Epub ahead of print]
  68. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001; 357(9263): 1191–1194. Moher D, Schulz KF, Altman DG.
  69. Is there a role for homeopathy in breast cancer surgery? A first randomized clinical trial on treatment with Arnica montana to reduce post-operative seroma and bleeding in patients undergoing total mastectomy.J Intercult Ethnopharmacol. 2017 Jan 3;6(1):1-8. doi: 10.5455/jice.20161229055245. Sorrentino L, Piraneo S, Riggio E, Basilicò S, Sartani A, Bossi D, Corsi F.
  70. Use of non-conventional medicine two years after cancer diagnosis in France: evidence from the VICAN survey.J Cancer Surviv. 2017 Feb 1. doi: 10.1007/s11764-017-0599-y. Sarradon-Eck A, Bouhnik AD, Rey D, Bendiane MK, Huiart L, Peretti-Watel P.
  71. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. Jama 1996; 276(8): 637–639. Begg C, Cho M, Eastwood S, et al.
  72. Complementary and alternative medicine in radiation oncology : Survey of patients' attitudes.Strahlenther Onkol. 2017 Jan 27. doi: 10.1007/s00066-017-1101-5. Lettner S, Kessel KA, Combs SE.
  73. Double-blinded randomised placebo-controlled clinical trial of individualised homeopathic treatment of hyperthyroid cats. Vet Rec. 2017 Jan 11. pii: vetrec-2016-104007. doi: 10.1136/vr.104007. Bodey AL, Almond CJ, Holmes MA.
  74. Microbiological stability of homeopathic medicines using purified water as vehicle International Journal of High Dilution Research. 2011;10(36):222-223 Virginia Teresa Cegalla, Amarilys de Toledo Cesar.
  75. Are the Effects of Homeopathy Attributable to a Statistical Artefact? A Reanalysis of an Observational Study, Rainer Lüdtke, Stefan N. Willich, and Thomas Ostermann Evidence-Based Complementary and Alternative Medicine Volume 2013 (2013), Article ID 612890, 7 pages
  76. Complementary and Alternative Medicines Use during Pregnancy: A Systematic Review of Pregnant Women and Healthcare Professional Views and Experiences, Abdul Rouf Pallivalappila, Derek Stewart, Ashalatha Shetty, Binita Pande, and James S. McLay Evidence-Based Complementary and Alternative Medicine Volume 2013 (2013), Article ID 205639, 10 pages
  77. Testing Homeopathy in Mouse Emotional Response Models: Pooled Data Analysis of Two Series of Studies, Paolo Bellavite, Anita Conforti, Marta Marzotto, Paolo Magnani, Mirko Cristofoletti, Debora Olioso, and Maria Elisabetta Zanolin Evidence-Based Complementary and Alternative Medicine Volume 2012 (2012), Article ID 954374, 9 pages
  78. Identification of Medicinally Active Ingredient in Ultradiluted Digitalis purpurea: Fluorescence Spectroscopic and Cyclic-Voltammetric Study, Anup Sharma and Bulbul Purkait
  79. A Review of Use of Enantiomers in Homeopathy, R. M. Kuzeff ISRN Toxicology Volume 2012 (2012), Article ID 575292, 22 page.
  80. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. Bmj 2008; 337: a2390. Zwarenstein M, Treweek S, Gagnier JJ, et al.
  81. Modulation of Signal Proteins: A Plausible Mechanism to Explain How a Potentized Drug Secale Cor 30C Diluted beyond Avogadro's Limit Combats Skin Papilloma in Mice, Anisur RahmanKhuda-Bukhsh, Soumya Sundar Bhattacharyya, Saili Paul, Suman Dutta, Naoual Boujedaini, and Philippe Belon Evidence-Based Complementary and Alternative Medicine Volume 2011 (2011), Article ID 286320, 12 pages
  82. Homeopathic Individualized Q-Potencies versus Fluoxetine for Moderate to Severe Depression: Double-Blind, Randomized Non-Inferiority Trial, U. C. Adler, N. M. P. Paiva, A. T. Cesar, M. S. Adler, A. Molina, A. E. Padula, and H. M. Calil Evidence-Based Complementary and Alternative Medicine Volume 2011 (2011), Article ID 520182, 7 pages Evidence-Based Complementary and Alternative Medicine
  83. The Homeopathic Revolution: Why Famous People and Cultural Heroes Choose Homeopathy, Ellen Feingold Evidence-Based Complementary and Alternative Medicine Volume 2011 (2011), Article ID 804181
  84. Homeopathic Preparations of Quartz, Sulfur and Copper Sulfate Assessed by UV-Spectroscopy, Ursula Wolf, Martin Wolf, Peter Heusser, André Thurneysen, and Stephan Baumgartner Evidence-Based Complementary and Alternative Medicine Volume 2011 (2011), Article ID 692798, 11 pages
  85. Reporting Experiments in Homeopathic Basic Research—Description of the Checklist Development, B. Stock-Schröer, H. Albrecht, L. Betti, G. Dobos, C. Endler, K. Linde, R. Lüdtke, F. Musial, R. van Wijk, C. Witt, and S. Baumgartner Evidence-Based Complementary and Alternative Medicine Volume 2011 (2011), Article ID 639260, 7 pages Evidence-Based
  86. Homeopathic Doses of Gelsemium sempervirens Improve the Behavior of Mice in Response to Novel Environments, Paolo Bellavite, Paolo Magnani, Elisabetta Zanolin, and Anita Conforti Evidence-Based Complementary and Alternative Medicine Volume 2011 (2011), Article ID 362517, 10 pages
  87. The Use of Intuition in Homeopathic Clinical Decision Making: An Interpretative Phenomenological Study, Sarah Brien, Bridget Dibb, and Alex Burch Evidence-Based Complementary and Alternative Medicine Volume 2011 (2011), Article ID 935307, 8 pages
  88. A Grounded Theory Study of Homeopathic Practitioners' Perceptions and Experiences of the Homeopathic Consultation, Caroline Eyles, Geraldine M. Leydon, George T. Lewith, and Sarah Brien Evidence-Based Complementary and Alternative Medicine Volume 2011 (2011), Article ID 957506, 12 pages Evidence-Based Complementary and Alternative Medicine
  89. Use of Homeopathy in Pediatric Oncology in Germany, Alfred Längler, Claudia Spix, Friedrich Edelhäuser, Genn Kameda, Peter Kaatsch, and Georg Seifert Evidence-Based Complementary and Alternative Medicine Volume 2011 (2011), Article ID 867151, 7 pages
  90. A Review of Three Simple Plant Models and Corresponding Statistical Tools for Basic Research in Homeopathy, Lucietta Betti, Grazia Trebbi, Michela Zurla, Daniele Nani, Maurizio Peruzzi, and Maurizio Brizzi The ScientificWold JOURNAL Volume 10 (2010), Pages 2330-2347
  91. Use of Complementary and Alternative Medicine in Children with Asthma, Vanessa Torres-Llenza, Sanjit Bhogal, Michael Davis, and Francine M Ducharme Canadian Respiratory Journal Volume 17 (2010), Issue 4, Pages 183-189
  92. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999; 354(9193): 1896–1900.  Moher D, Cook DJ, Eastwood S, et al.
  93. The World Summit of Harmonization on Traditional, Alternative and Complementary Medicine (TACM) in Lima, Peru, Gustavo F. Gonzales, José Aguilar, and Martha Villar Evidence-Based Complementary and Alternative Medicine Volume 7 (2010), Issue 2, Pages 271-275
  94. Can Homeopathy Bring Additional Benefits to Thalassemic Patients on Hydroxyurea Therapy? Encouraging Results of a Preliminary Study, Antara Banerjee, Sudipa Basu Chakrabarty, Susanta Roy Karmakar, Amit Chakrabarty, Surjyo Jyoti Biswas, Saiful Haque, Debarsi Das, Saili Paul, Biswapati Mandal, Boujedaini Naoual, Philippe Belon, and Anisur Rahman Khuda-Bukhsh Evidence-Based Complementary and Alternative Medicine Volume 7 (2010), Issue 1, Pages 129-136
  95. Brief Homeopathic Pathogenetic Experimentation: A Unique Educational Tool in Brazil, Marcus Zulian Teixeira Evidence-Based Complementary and Alternative Medicine Volume 6 (2009), Issue 3, Pages 407-414 Evidence-Based Complementary and Alternative Medicine
  96. Knowledge and Attitudes about HIV/AIDS among Homoeopathic Practitioners and Educators in India, Adeline Nyamathi, Vijay Pal Singh, Ann Lowe, Anil Khurana, Divya Taneja, Sheba George, and John L. Fahey Evidence-Based Complementary and Alternative Medicine Volume 5 (2008), Issue 2, Pages 221-225
  97. Scientific Research in Homeopathic Medicine: Validation, Methodology and Perspectives, Giuseppina Pitari Evidence-Based Complementary and Alternative Medicine Volume 4 (2007), Issue 2, Pages 271-273
  98. Journeys in the Country of the Blind: Entanglement Theory and the Effects of Blinding on Trials of Homeopathy and Homeopathic Provings, Lionel R. Milgrom Evidence-Based Complementary and Alternative Medicine Volume 4 (2007), Issue 1, Pages 7-16
  99. Immunology and Homeopathy. 4. Clinical Studies—Part 1, Paolo Bellavite, Riccardo Ortolani, Francesco Pontarollo, Valeria Piasere, Giovanni Benato, and Anita Conforti Evidence-Based Complementary and Alternative Medicine Volume 3 (2006), Issue 3, Pages 293-301
  100. Homeopathy and The Lancet, Peter Fisher Evidence-Based Complementary and Alternative Medicine Volume 3 (2006), Issue 1, Pages 145-147
  101. Immunology and Homeopathy. 2. Cells of the Immune System and Inflammation, Paolo Bellavite, Anita Conforti, Francesco Pontarollo, and Riccardo Ortolani Evidence-Based Complementary and Alternative Medicine Volume 3 (2006), Issue 1, Pages 13-24
  102. CAM and Cell Fate Targeting: Molecular and Energetic Insights into Cell Growth and Differentiation, Carlo Ventura Evidence-Based Complementary and Alternative Medicine Volume 2 (2005), Issue 3, Pages 277-283
  103. Thirtieth Annual Congress on Veterinary Acupuncture: IVAS Report, Krishna Kaphle, Ying-Ling Wu, and Jen Hsou Lin Evidence-Based Complementary and Alternative Medicine Volume 2 (2005), Issue 2, Pages 239-242
  104. Thuja occidentalis (Arbor vitae): A Review of its Pharmaceutical, Pharmacological and Clinical Properties, Belal Naser, Cornelia Bodinet, Martin Tegtmeier, and Ulrike Lindequist Evidence-Based Complementary and Alternative Medicine Volume 2 (2005), Issue 1, Pages 69-78
  105. The Life Mission Theory VI. A Theory for the Human Character: Healing with Holistic Medicine Through Recovery of Character and Purpose of Life, Søren Ventegodt, Maximilian Kromann, Niels Jørgen Andersen, and Joav Merrick The Scientific World Journal Volume 4 (2004), Pages 859-880
  106. Rats Born to Mothers Treated with Dexamethasone 15 cH Present Changes in Modulation of Inflammatory Process, Leoni V. Bonamin, Cristiane Landi de Moraes, Fernanda Sanches, Thayná Neves Cardoso, Cesar Sato, Claudemir Duran Filho, and Lucienne C. Martini Evidence-Based Complementary and Alternative Medicine Volume 2012 (2012), Article ID 710923, 10 pages
  107. Immunology and Homeopathy. 5. The Rationale of the ‘Simile’, Paolo Bellavite, Riccardo Ortolani, Francesco Pontarollo, Giuseppina Pitari, and Anita Conforti Evidence-Based Complementary and Alternative Medicine Volume 4 (2007), Issue 2, Pages 149-163
  108. Immunology and Homeopathy. 4. Clinical Studies—Part 2, Paolo Bellavite, Riccardo Ortolani, Francesco Pontarollo, Valeria Piasere, Giovanni Benato, and Anita Conforti Evidence-Based Complementary and Alternative Medicine Volume 3 (2006), Issue 4, Pages 397-409
  109. Immunology and Homeopathy. 3. Experimental Studies on Animal Models, Paolo Bellavite, Riccardo Ortolani, and Anita Conforti Evidence-Based Complementary and Alternative Medicine Volume 3 (2006), Issue 2, Pages 171-186
  110. Immunology and Homeopathy. 2. Cells of the Immune System and Inflammation, Paolo Bellavite, Anita Conforti, Francesco Pontarollo, and Riccardo Ortolani Evidence-Based Complementary and Alternative Medicine Volume 3 (2006), Issue 1, Pages 13-24
  111. Immunology and Homeopathy. 1. Historical Background, Paolo Bellavite, Anita Conforti, Valeria Piasere, and Riccardo Ortolani Evidence-Based Complementary and Alternative Medicine Volume 2 (2005), Issue 4, Pages 441-452
  112. The EQUATOR Network and reporting guidelines: Helping to achieve high standards in reporting health research studies. Maturitas 2009; 63(1): 4–6. Simera I, Moher D, Hoey J, Schulz KF, Altman DG.
  113. A Comprehensive Survey on Particle Swarm Optimization Algorithm and Its Applications, Yudong Zhang, Shuihua Wang, and Genlin Ji Mathematical Problems in Engineering  Volume 2015 (2015), Article ID 931256, 38 pages
  114. Therapeutic Touch Has Significant Effects on Mouse Breast Cancer Metastasis and Immune Responses but Not Primary Tumor Size, Gloria Gronowicz, Eric R. Secor Jr., John R. Flynn, Evan R. Jellison, and Liisa T. Kuhn Evidence-Based Complementary and Alternative Medicine Volume 2015 (2015), Article ID 926565, 10 pages
  115. Complementary and Alternative Medicine and Cardiovascular Disease: An Evidence-Based Review, Matthew J. Rabito and Alan David Kaye Evidence-Based Complementary and Alternative Medicine Volume 2013 (2013), Article ID 672097, 8 pages
  116. Radiation Response of Cultured Human Cells Is Unaffected by Johrei, Zach Hall, Tri Luu, Dan Moore, and Garret Yount Evidence-Based Complementary and Alternative Medicine Volume 4 (2007), Issue 2, Pages 191-194
  117. CAM and Cell Fate Targeting: Molecular and Energetic Insights into Cell Growth and Differentiation, Carlo Ventura Evidence-Based Complementary and Alternative Medicine Volume 2 (2005), Issue 3, Pages 277-283
  118. Homeopathic trial design in influenza treatment[J]. Homeopathy, 2010, 99(1) : 69-75. Kirkby R, Herscu P.
  119. Usage of alternative medical systems, acupuncture, homeopathy and anthroposophic medicine, by older German adults. 2011, 9(8)
  120. Homeopathy, In Essentials of Law, Ethics, and Professional Issues in CAM, edited by Julie Zetler Rodney Patrick Bonello, Churchill Livingstone Australia, Sydney, 2012, Pages 231-239. Zetler I.
  121. 3D Brownian Diffusion of Submicron-Sized Particle Clusters. ACS Nano 2009, 3 (10), 3326−3334. Hoffmann, M.; Wagner, C. S.; Harnau, L.; Wittemann, A.
  122. 5th Annual Symposium on Complementary Health Care; Exeter, UK, December 10-12th, 1998." The British homoeopathic journal 88(3): 151. Barnes, J. (1999).
  123. Asthma management by private general practitioners of Punjab." The Indian journal of chest diseases & allied sciences 36(1): 9-13. Bedi RS. (1994).
  124. Association between complementary and alternative medicine use, preventive care practices, and use of conventional medical services among adults with diabetes." Diabetes care 29(1): 15-19. Garrow, D. and L. E. Egede (2006).
  125. Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel disease. Journal of Crohn's & colitis 4(3): 283-290. Lakatos, P. L., et al. (2010).
  126. Analysis of the capability of ultra-highly diluted glucose to increase glucose uptake in arsenite-stressed bacteria Escherichia coli. 2011, 9(8)
  127. Potentized homeopathic drug Arsenicum Album 30C inhibits intracellular reactive oxygen species generation and up-regulates expression of arsenic resistance gene in arsenite-exposed bacteria Escherichia coli. 2012, 10(2)
  128. Potential of the homeopathic remedy, Arnica Montana 30C, to reduce DNA damage in Escherichia coli exposed to ultraviolet irradiation through up-regulation of nucleotide excision repair genes. 2012, 10(3)
  129. Asthma in children." Hippokrates 27(8): 241-242. Frick, P. (1956).
  130. At Home in the Universe. The Search for the Laws of Self-Organization and Complexity. NY: Oxford University Press; 1995 Book. Kauffman S.
  131. Atropa belladonna L. water extract: modulator of extracellular matrix formation in vitro and in vivo Physiol Res. 2012 Jul 20;61(3):241-50. Gál P, Vasilenko T, et al.
  132. Attitudes of homoeopathic physicians towards vaccination." Vaccine 19(32): 4859-4864. Lehrke, P., et al. (2001).
  133. Attitudes to homoeopathy in a sample of veterinarians Complementary Therapies in Medicine, Volume 1, Issue 4, October 1993, Pages 185-188. Kayne S, McGuire A.
  134. Attitudes toward integrative paediatrics: a national survey among youth health are physicians in the Netherlands BMC Complement Altern Med. 2012; 12: 4. Jong MC, van Vliet M, et al.
  135. Attitudes towards complementary and alternative medicine in chronic pain syndromes: a questionnaire-based comparison between primary headache and low back pain BMC Complement Altern Med. 2011; 11: 89. Gaul C, Schmidt T, et al.
  136. Awareness and practice concerning oral cancer among Ayurveda and Homeopathy practitioners in Davangere District: A speciality-wise analysis." (0976-9668 (Print)). 103. Kulkarni, R. S., et al. (2015).
  137. Absence of evidence is not evidence of absence. Br Med J 1995; 311:485. Am J Pharm Educ. 2007 Feb 15; 71(1): 07. Altman DG, Bland M.
  138. Phenotypic evidence of ultra-highly diluted homeopathic remedies acting at gene expression level: a novel probe on experimental phage infectivity in bacteria. 2012, 10(4)
  139. Advances in Integrative Nanomedicine for Improving Infectious Disease Treatment in Public Health." Eur J Integr Med 1(5(2)): 126-140. Bell, Ir, B., et al. (2013).
  140. Aldis on Homoeopathy, The Lancet, Volume 27, Issue 696, 31 December 1836, Page 506. Aldis C. Sir C.
  141. Allopathic versus Homeopathic Strategies and the Recurrence of Prescriptions: Results from a Pharmacoeconomic Study in Italy Evid Based Complement Alternat Med. 2011; 2011: 969343. Basili A, Lagona F, et al.
  142. Assessment of homeopathic medicine Aconitum napellus in the treatment of anxiety in an animal model. Int J High Dilution Res 11(38): 33-42. Baptista Haine, G. (2012).
  143. A 14-month ranomized clinical trial of treatment strategis for attention- deficit/ hyperactivity disorder." Archives of General Psychiatry 56(12): 1073-1086. Jensen, P., et al. (1999).
  144. A brief history of homeopathy'." Journal of the Royal Society of Medicine 100(2): 65-66. Horobin, D. (2007).
  145. Rapid green synthesis of silver nanoparticles from silver nitrate by a homeopathic mother tincture Phytolacca Decandra. 2012, 10(5)
  146. A brief study course in homeopathy: the value and relation of diet to our homeopathic remedies." Journal of the American Institute of Homeopathy 59(7): 241-243. Hubbard, E. W. (1966).
  147. A brief study course in homoeopathy." Homoeopathic bulletin 18: 198-200. Hubbard, E. W. (1946).
  148. A century of homoeopathic paediatrics, British Homoeopathic journal, Volume 84, Issue 4, October 1995, Pages 238-242. Leary B.
  149. A comparison of health beliefs and behaviours of clients of orthodox and complementary medicine." The British journal of clinical psychology / the British Psychological Society 32 ( Pt 2): 237-246. Furnham, A. and R. Bhagrath (1993).
  150. A complex systems science perspective for whole systems of CAM research. Forsch Komplementarmed Klass Naturheilkd 2012, 19(Supplement 1):7–14. 101. Koithan M, Bell IR, Niemeyer K, Pincus D.
  151. Alteration of nC60 in the Presence of Environmentally Relevant Carboxylates Langmuir 2012, 28, 7622−7630. Chang X, Duncan LK, et al.
  152. Alternativa medicine: Which way forward? J Family Community Med. 2000 MayAug; 7(2): 13–15. Al-Dawood KM.
  153. Alternative and complementary therapies. Adolescent medicine clinics 17(3): 521-546; abstract ix.  Breuner, C. C. (2006).
  154. Alternative, complementary, and conventional medicine: is integration upon us? Journal of alternative and complementary medicine 9(3): 417-427. Barrett, B. (2003).
  155. An imponderable liberator: J. J. Garth Wilkinson." The Society for the Social History of Medicine bulletin 36: 29-31. Barrow, L. (1985).
  156. A 35-year-old woman experiencing difficulty with breastfeeding, 18 months later." JAMA : the journal of the American Medical Association 286(16): 2022. Delbanco, T. and E. E. Hartman (2001).
  157. A homeopathic complex remedy proves efficacious in migraine therapy: a randomized, double blind, parallel group clinical trial. Abstracts of Headache World conference; London.  Beckmann-Reinhold,A.; Schauer,U.; Wellensiek,B.; Werner,B.; Wartenberg,A. (2000).
  158. A Convergent Synthetic Platform for Single-Nanoparticle Combination Cancer Therapy: Ratiometric Loading and Controlled Release of Cisplatin, Doxorubicin, and Camptothecin J. Am. Chem. Soc., 2014, 136 (16), pp 5896–5899. Liao L, Liu J, et al.
  159. A critical overview of homeopathy. Annals of Internal Medicine. 2003; 138 (5):393-9. Jonas WB, Kaptchuk TJ, Linde K.
  160. A critical review of natural therapies in wound management." Ostomy/wound management 50(2): 36-40, 42, 44-36 passim. Leach, M. J. (2004).
  161. A critique and appraisal of homeopathy." The Hahnemannian 88(3): 125-126. Fox, W. B. (1953).
  162. A darker shade of green: medical botany, homeopathy, and cultural politics in interwar Germany." Social history of medicine : the journal of the Society for the Social History of Medicine / SSHM 15(3): 481-504. Kenny, M. G. (2002).
  163. A First Materia Medica for Homoeopathy, Physiotherapy, Volume 82, Issue 1, January 1996, Page 67. Hollenbery S.
  164. A follow-up study on the efficiacy of the homeopathic remedy Arsenicum album in Volunteers living in high risk arsenic contaminated areas. Evidence-Based Complementary and Alternative Medicine 2009; 11; doi: 10.1093/ecam/nep122. Khuda-Bukhsh AR, Roy-Karmakar SR, Banerjee A, Banerjee P, Pathak S, Biswas AJ, Haque S, Das Debarsi, Boujedaini N, Belon P.
  165. A Gentle Ethical Defence of Homeopathy." (1176-7529 (Electronic)). Levy, D., et al.
  166. A Hahnemannian proving of hippuric acid." The Hahnemannian 88(1): 2-6. Homoeopathy Br Med J. 1951 February 24; 1(4703): 413. Griggs, W. B. (1953).
  167. A homeopathic drug is equivalent to diclofenac?." Der Orthopade 29(6): 596. Graf von Ingelheim, F. A. (2000).
  168. A measure of success." The British journal of general practice : the journal of the Royal College of General Practitioners 47(414): 47-49. Lewith, G. T. (1997).
  169. A Minimum Protocol for Randomised Homeopathic Drug Proving as Basis for Further Research Forsch Komplementmed 2014;21:232–238. Jansen JP, Jong M et al.
  170. A more skeptical review of homeopathy Otolaryngology - Head and Neck Surgery, Volume 142, Issue 2, February 2010, Page 300. Hopfenspirger M.
  171. A morphological study of macrophage and synovial cell interactions with hydroxyapatite crystals. Ann. Rheum. Dis. 44(12) 844−851 (1985). Hirsch RS, Smith K, Vernon-Roberts B.
  172. A mother who opposes immunisation." The Practitioner 242(1585): 243-245, 247, 250 passim. Gerada, C., et al. (1998).
  173. A New Method of Treatment with Homeopathic Medicine. Kolkata, India: Prasanta Banerji; 2013. The Banerji Protocols.
  174. A non-scientific treatment for patients with psoriasis - advocated in a scientific journal." Journal of the European Academy of Dermatology and Venereology : JEADV 23(10): 1222-1223; author reply 1223. 78. Happle, R., et al. (2009).
  175. The process of infection with bacteriophage. Evidence for a “replicative form”. J Mol Biol. 1962: 142-160.Sinsheimer RL, Starman B, Nagler C, Guthrie S.A
  176. Pilot Trial to Study the Perceived Effectiveness of Homoeopathic remedies bought Over The Counter (OTC) in British Pharmacies.Journal of the Royal London Homoeopathic Hospital NHS Trust, 1997, January 23-24, 90-94. Kayne S.
  177. A place for natural remedies." Nursing New Zealand 17(3): 4. Gulley, A. (2011).
  178. A Placebo Controlled Clinical Trial investigating the efficacy of a Homoeopathic After-Bite Gel for Reducing Mosquito bite induced Erythema. Eur J Pharmacol, 1995, 49, 103-108. Hill N, Stam C, Tuinder S, van Haselen RA.
  179. Mechanism of dnaB protein action. Ⅴ. Association of dnaB protein, protein n’, and other repriming proteins in the primosome of DNA replication[J]. J Biol Chem, 1981, 256(10) : 5273-5280.Arai K, Low R, Kobori J, Shlomai J, Kornberg A.
  180. A poor test of homeopathy Can Vet J. 2002 December; 43(12): 909. Kujala C.
  181. A Review of Use of Enantiomers in Homeopathy Homeopathy, Volume 103, Issue 1, January 2014, Pages 86-87. Kuzeff RM
  182. Replication of viral RNA, XVI. Enzymatic synthesis of infectious virual RNA with noninfectious Q-beta minus strands as template. Proc Natl Acad Sci U S A. 1968 Jan; 59(1): 145–152. US National Library of Medicine  National Institutes of Health G Feix, R Pollet, and C Weissmann
  183. A short history of the developmentof homeopathy in India Homeopathy, Volume 99, Issue 2, April 2010, Pages 130-136. Ghosh AK.
  184. A sketch on homoeopathic prophylaxis." The Homoeopathic recorder 63(1): 20-23. Garcia-Trevino, E. (1966). "Pathogenesis of some new Mexican drugs." Journal of the American Institute of Homeopathy 59(11): 330-337. Garcia Trevino, E. (1947).
  185. Ten commandments: lessons from the enzymology of DNA replication[J]. J Bacteriol, 2000, 182(13) : 3613-3618. Kornberg A.
  186. A study on drug utilization and prescription habits of physicians in a government homeopathic hospital in West Bengal, India, Journal of Integrative Medicine, Volume 11, Issue 5, September 2013, Pages 305-313. Koley M, Saha S et al.
  187. A randomized comparison of homoeopathic and standard care for the treatment of glue ear in children." Complementary therapies in medicine 7(3): 132-135. Harrison, H., et al. (1999).
  188. A randomized controlled trial of homeopathy in rheumatoid arthritis." Rheumatology 40(9): 1052-1055. Fisher, P. and D. L. Scott (2001).
  189. A randomized controlled trial to compare the use of homeopathy and internal Teat Sealers for the prevention of mastitis in organically farmed dairy cows during the dry period and 100 days post-calving Homeopathy, Volume 99, Issue 2, April 2010, Pages 90-98. Klocke P, Ivemeyer S, et al.
  190. A randomized, controlled, triple-blind trial of the efficacy of homeopathic treatment for chronic fatigue syndrome. Journal of Psychosomatic Research; 56:189–197. Weatherley-Jones E, Nicholl JP, Thomas KJ, Parry GJ, McKendrick MW, Green ST, Stanley PJ, Lynch SP (2004).
  191. A Rattlesnake and Homoeopathy." Journal of the American Institute of Homeopathy 56: 400-401. Green P, Bergman B. “Mucinemia”: Report of a Case of Carcinomatosis with a Unique Serum rotein Can Med Assoc J. 1962 March 3; 86(9): 418–419. Green, J. M. (1963).
  192. A reevaluation of the effectiveness of homeoprophylaxis against leptospirosis in Cuba in 2007 and 2008. J Ev Based Comp Alt Med. Golden I, Bracho G.
  193. A review of the use and role of low potencies in homeopathy. Complement Ther Med 2005; 13 (4):291-6. Jutte R, Riley D.
  194. A Review of Traditional and Novel Treatments for Seizures in Autism Spectrum Disorder: Findings from a Systematic Review and Expert Panel Front Public Health. 2013; 1: 31. Frye RE, Rossignol D, et al.
  195. A new database on basic research in homeopathy. Homeopathy. 2002;91:162–165. Albrecht, H., Van Wijk, R., Dittloff, S.
  196. A new political contribution to medicine: homeopathy in 19th century Spain." Cuad Complut Hist Med Cienc. 1993;1:175-85. Albarracin Teulon, A. (1993).
  197. A randomized controlled trial to evaluate the effectiveness of homoeopathy in rheumatoid arthritis. Scandinavian Journal of Rheumatology; 20:204–208. Andrade L, Ferraz MB, Atra E, Castro A, Silva MSM (1991).
  198. A strict definition of homoeopathy according to Hahnemann British Homoeopathic journal, Volume 85, Issue 2, April 1996, Pages 79-82. Ambrosio E, et al.
  199. A Study of the Effect of Decimal and Centessimal Dilutions of Arsenic on the Retention and Mobilisation of Arsenic in the Rat. Human Toxicol, 1987, 6, 315-320.  Cazin JC, Cazin M, Gaborit JL, et al.
  200. A survey of medicinal plants used by the Deb barma clan of the Tripura tribe of Moulvibazar district, Bangladesh Journal of Ethnobiology and Ethnomedicine 2014, 10:19. Kabir MH, Hasan N et al.
  201. A systematic review of the content of critical appraisal tools BMC Med Res Methodol. 2004; 4: 22. Katrak P, Bialocerkowski AE, et al.
  202. A systematic review of the quality of homeopathic clinical trials." BMC complementary and alternative medicine 1: 12. Jonas, W. B., et al. (2001).
  203. A textbook of dental homoeopathy for dental surgeons, homoeopathists and general medical practitioners, Complementary Therapies in Medicine, Volume 4, Issue 1, January 1996, Pages 78-79. Levenson JG.
  204. A triplet spike-timing-dependent plasticity model generalizes the Bienenstock-Cooper-Munro rule to higher-order spatiotemporal correlations. Proc Natl Acad Sci U S A. Nov 29 2011;108(48):19383-19388. Gjorgjieva J, Clopath C, Audet J, Pfister JP.
  205. A validation study of homeopathic prescribing and patient care indicators. (2225-4110 (Electronic)). Koley, M., et al.
  206. About entry of homoeopathy into India." Bulletin of the Institute of Medicine 3: 76-78. Kishore, J. (1973).
  207. Classification of systems and methods used in biological basic research on homeopathy. Homeopathy 2007; 96(4): 247–251.Van Wijk R, Albrecht H.
  208. Access to and utilization of the health services among the patients in a government homeopathic hospital in West Bengal, India: a cross-sectional study. J Rvid Based Complementary Altern Med. 2014. Ghosh S, Saha S et al.
  209. Acclimation to intermittent hypobaric hypoxia modifies responses to cold at sea level. Aviat Space Environ Med 2006, 77(12):1230–1235. Launay JC, Besnard Y, Guinet-Lebreton A, Savourey G:
  210. Aconite: a case study in doctrinal conflict and the meaning of scientific medicine. Bull N Y Acad Med. 1984 November; 60(9): 888–904. Haller Jr JS.
  211. Acupuncture, self-care homeopathy, and practitioner-based homeopathy: comparing users in the 2007 NHIS BMC Complementary and Alternative Medicine 2012, 12(Suppl 1):P341. Frye J.
  212. Methodological Standards and Problems in Preclinical Homoeopathic Potency Research.Forsch Komplementarmed 1998; 5(1): 27–32. Baumgartner S, Heusser P, Thurneysen A.
  213. Acute otitis media in children. Comparison between conventional and homeopathic therapy]." HNO 44(8): 462-466.http://www.ncbi.nlm.nih.gov/pubmed/8805013. Friese, K. H., et al. (1996).
  214. Ways to enhance the quality and acceptance of clinical and laboratory studies in homeopathy. Brit Hom J 1994; 83(1): 3–7. Linde K, Melchart D, Jonas WB, Hornung J.
  215. About Quality and standards in Ultra High Dilution Research and Research on Homeopathy. In: Endler PCS (ed). Ultra High Dilution - Physiology and Physics. Dordrecht: Kluwer Academic Publishers, 1994, p. 171–176. Schulte J.
  216. Adaptive coevolutionary networks: a review. Journal of the Royal Society, Interface 2008;5:259–71. Gross T, Blasius B.
  217. Adding women to the ranks, 1860-1890: a new view with a homeopathic lens." Bulletin of the history of medicine 73(3): 429-446. Kirschmann, A. T. (1999).
  218. Additive homeopathy in cancer patients: Retrospective survival data from a homeopathic outpatient unit at the Medical University of Vienna. Complement Ther Med. 2014 Apr;22(2):320-32. Gaertner K, Müllner M, et al.
  219. ADHD in children and adolescents." Clinical evidence 2008. Keen, D. and I. Hadijikoumi (2008).
  220. Adjunctive homeopathic therapy in malignant diseases - A retrospective explorative pilot study with 80 patients. Eur J Int Med 2(4) 2010;2: 170. Gaertner K, Frass M.
  221. Adjunctive homeopathic treatment in patients with severe sepsis: a randomized, double-blind, placebo-controlled trial in an intensive care unit  - Homeopathy, 2005 – Elsevier. M Frass, M Linkesch, S Banyai, G Resch, C Dielacher.
  222. Adjunctive homeopathic treatment in patients with severe sepsis: a randomized, doubleblind, placebo-controlled trial in an intensive care unit." Homeopathy : the journal of the Faculty of Homeopathy 94(2): 75-80. Frass, M., et al. (2005).
  223. Adjunctive homeopathic treatment in patients with severe sepsis: a randomized, double-blind, placebo-controlled trial in an intensive care unit. Homeopathy (2011) 100, 95- 100. Frass M, Linkesch M, Banyai S, et al.
  224. Advances in Resistive Pulse Sensors: Devices Bridging the Void between Molecular and Microscopic Detection. Nano Today 2011, 6 (5), 531−545. Kozak D, Anderson W, Vogel R, Trau M.
  225. Advances in the field of nanooncology. BMC Med. 2010;8:83. 81. Jain KK.
  226. Advantages of nanotechnology-based Chinese herb drugs on biological activities. Current Drug Metabolism 2009;10:905–13. Huang S, Chang WH.
  227. Adverse drug reactions of remedies containing Asteraceae extracts." Drug safety : an international journal of medical toxicology and drug experience 33(8): 705-706; author reply 706-707. Jeschke, E. (2010).
  228. A 35-year-old woman experiencing difficulty with breastfeeding, 18 months later." JAMA : the journal of the American Medical Association 286(16): 2022. Delbanco, T. and E. E. Hartman (2001).
  229. Adverse drug reactions to anthroposophic and homeopathic solutions for injection: a systematic evaluation of German pharmacovigilance databases. LID - 10.1002/pds.3298 [doi]." (1099- 1557 (Electronic)). Jong, M. C., et al. (2012).
  230. Reporting data on homeopathic treatments (RedHot): a supplement to CONSORT. J Altern Complement Med 2007; 13(1): 19–23. Dean ME, Coulter MK, Fisher P, Jobst KA, Walach H.
  231. Adverse effect of nanosilicon dioxide on lung function of rats with or without ovalbumin immunization. PLoS One 2011, 6(2):e17236. Han B, Guo J, Abrahaley T, Qin L, Wang L, Zheng Y, Li B, Liu D, Yao H, Yang J, et al:
  232. Ag-Nanoparticle-Loaded Mesoporous Silica: Spontaneous Formation of Ag Nanoparticles and Mesoporous Silica SBA-15 by a One-Pot Strategy and Their Catalytic Applications. Langmuir 2012, 28 4768−4775. Han J, Fang P, et al.
  233. Albumin/calcium association at different pH, as determined by potentiometry. Clin Chem  23: 2122–2126. Fogh-Andersen N (1977).
  234. Algal testing of titanium dioxide nanoparticles—testing considerations, inhibitory effects and modification of cadmium bioavailability. Toxicology 2010;269:190–7. Hartmann NB, Von der Kammer F, et al.
  235. Allergic contact dermatitis from camomile used in phytotherapy." Contact dermatitis 42(4): 247. Giordano-Labadie, F., et al. (2000).
  236. Allergy. Conventional and alternative concepts. A report of the Royal College of Physicians Committee on Clinical Immunology and Allergy." Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 22 Suppl 3: 1-44. Kay, A. B. and M. H. Lessof (1992).
  237. Allied health – 3006. Homeopathy in treating allergic rhinitis - An interventional pilot study World Allergy Organ J. 2013; 6(Suppl 1): P182. Ghosh S, Saha S.
  238. Allopathy--homeopathy]." Der Landarzt 42(10): 406-407. Lembeck, F. (1966).
  239. Allostatic load biomarkers of chronic stress and impact on health and cognition. Neurosci Biobehav Rev. Sep 2010;35(1):2-16. Juster RP, McEwen BS, Lupien SJ.
  240. Alternative and complementary medicine for asthma. Thorax. 1991 November; 46(11): 787– 797. Lane DJ, Lane TV.
  241. Alternative and complementary medicine for asthma. Thorax. 1992 September; 47(9): 762. Kalyoncu AF, Selçuk ZT, et al.
  242. Alternative approaches to conventional antiepileptic drugs in the management of paediatric epilepsy Arch Dis Child. 2006 November; 91(11): 936–941. Kneen R, Appleton RE.
  243. Alternative dental products." Journal of the California Dental Association 26(3): 191-198. Jacobsen, P. L. and R. P. Cohan (1998). Alternative medicine and the family physician." American Family Physician 54(7): 2205- 2212, 2218-2220. Gordon, J. S. (1996).
  244. Alternative medicine. Explaining homeopathy with energy]." Sygeplejersken 86(40): 28- 29. Hagelsten, J. O. (1986).
  245. Alternative medicine: homeopathy." Nursing times 71(43): 1694-1696. Harling, M. (1975).
  246. Guidelines for the Exact Description of the Preparation and Mode of Application of Serial Dilutions and Potencies in Publications on Ultra Low Dose Effects and Homeopathic Research - a proposal-. The Berlin Journal on Research in Homeopathy 1991; 1(2): 121–123.Hornung J, Linde K.
  247. Alternative medicine's roadmap to mainstream." American journal of law & medicine 26(2- 3): 295-310. Josefek, K. J. (2000).
  248. Alternative therapies and empowerment of older women." Journal of women & aging 11(2-3): 29-47. Gaylord SA.  Gaylord, S. (1999).
  249. Alternative therapies for menopause." Clinical obstetrics and gynecology 43(1): 162- 183. Kass-Annese, B. (2000).
  250. Alternative therapy for atopic dermatitis and psoriasis: patient-reported motivation, information source and effect." Acta dermato-venereologica 70(5): 425-428. Jensen, P. (1990).
  251. Critical review and metaanalysis of serial agitated dilutions in experimental toxicology. Hum Exp Toxicol 1994; 13(7): 481–492.Linde K, Jonas WB, Melchart D, et al.
  252. Alternative therapy is common among children with allergic diseases]." Lakartidningen 85(43): 3580-3581, 3583. Hederos, C. A. (1988).
  253. Alternative treatment methods in ENT]." HNO 45(8): 593-607. Friese, K. H. (1997).
  254. Quality assessment of physical research in homeopathy. J Altern Complement Med 2003; 9(1): 113–132.Becker-Witt C, Weisshuhn TE, Ludtke R, Willich SN.
  255. Alternative treatment possibilities of atopic diseases]." Padiatrie und Padologie 25(6): 389- 396. Haidvogl, M. (1990).
  256. Am. Soc.Nephrol. 15(12), 2959–2964 (2004). Giachelli CM. Vascular calcification mechanisms. J.
  257. Amorphous silica nanoparticles size-dependently aggravate atopic dermatitis-like skin lesions following an intradermal injection. Part Fibre Toxicol. Feb 2 2012;9(1):3. Hirai T, Yoshikawa T, Nabeshi H, et al.
  258. Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease: results from a German national survey." Inflammatory bowel diseases 11(3): 287-295. Langhorst, J., et al. (2005).
  259. An alternative mechanism for pathogenic intra- and extracellular calcification and stone formation. Proc. Natl Acad. Sci. USA 95(14), 8274–8279 (1998). Kajander EO, Ciftcioglu N. Nanobacteria.
  260. An alternative perspective: homeopathic drugs, Royal Copeland, and federal drug regulation." Food and drug law journal 55(1): 161-183. Junod, S. W. (2000).
  261. An approach to educating family practice residents and family physicians about complementary and alternative medicine." Complementary therapies in medicine 12(2-3): 118-125. Frenkel, M., et al. (2004).
  262. An evidence based case of uterine fibroids cured by Pulsatilla. J Case Stud Hom. 2013;1(3):1- 8. Gupta S, Singh R.
  263. An Experimental Double-blind Clinical Trial method in Homoeopathy- Use of a Limited Range of Remedies to Treat Fibrositis. British Homoeopathic Journal, 1986, July, 75, 3, 142-7. Fisher P.
  264. An exploration of the relationship between placebo and homeopathy and the implications for clinical trial design JRSM Short Rep. 2013 September; 4(9): Haresnape C.
  265. An exploratory retrospective study of people suffering from hypersensitivity illnesses who attend medical or classical homeopathic treatment. Homeopathy.2006 Apr;95 (2):73-80. Launso L, Kimby CK, Henningsen I, Fonnebo V.
  266. An initial report on the efficacy of a millesimal potency Arsenicum Album LM 0/3 in ameliorating arsenic toxicity in humans living in a high-risk arsenic village. Zhong Xi Yi Jie He Xue Bao. 2011 Jun;9(6):596-604. Khuda-Bukhsh,A.R.; Banerjee,A.; Biswas,S.J.; Karmakar,S.R.; Banerjee,P.; Pathak,S.; Guha,B.; Haque,S.; Das,D.; De,A.; Das,D.; Boujedaini,N.
  267. An integrative approach to asthma." Australian family physician 34(7): 573-576. Hassed, C. (2005).
  268. The Applications and Features of Liquid Chromatography-Mass Spectrometry in the Analysis of Traditional Chinese Medicine, Bingyao Pang, Ying Zhu, Longqing Lu, Fangbing Gu, and Hailong Chen Volume 2016 (2016), Article ID 3837270, 7 pages Evidence-Based Complementary and Alternative Medicine
  269. Expression Profiling of Transcriptome and Its Associated Disease Risk in Yang Deficiency Constitution of Healthy Subjects, Ruoxi Yu, Yin Yang, Yuanyuan Han, Pengwei Hou, Yingshuai Li, Siqi Li, and Qi Wang Volume 2016 (2016), Article ID 1493098, 9 pages Evidence-Based Complementary and Alternative Medicine
  270. An intricate question in a current debate: how can homeostatic effects be evident in clinical studies?]." Lakartidningen 94(3): 156-157. Lenger K, Bajpai RP, et al.
  271. An Oral Antigen Preparation In the Prevention of Poison Ivy Dermatitis Industrial Medicine and Surgery, 1958: 27 (March) pp 142-144. Gross, E. R.
  272. An overview of CAM: components and clinical uses." Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition 24(5): 549-559. Kiefer, D., et al. (2009).
  273. An unusual case of baboon syndrome due to mercury present in a homeopathic medicine." Contact dermatitis 45(3): 185. Audicana, M., et al. (2001).
  274. Analysis of a general principle of crystal nucleation, formation in the different hard tissues. Adv. Dent. Res. 11, 462–466 (1997). Höhling HJ, Arnold S, et al.
  275. Animal therapy over the ages: 2. chiropractic and 3. homeopathy." Veterinary heritage : bulletin of the American Veterinary History Society 22(2): 38-42. Haas, K. B. (1999).
  276. Anomalies in the anomalous: last gasp or light at last?" The British homoeopathic journal 89(3): 103-104. Jonas, W. B. (2000).
  277. Anthroposophic medical therapy in chronic disease: a four-year prospective cohort study BMC Complement Altern Med. 2007; 7: 10. 77 Hamre H, Witt CM et al.
  278. Anthroposophic therapy for children with chronic disease: a two-year prospective cohort study in routine outpatient settings BMC Pediatr. 2009; 9: 39. Hamre H, Witt CM et al.
  279. Antioxidant components of naturally-occurring oils exhibit marked anti-inflammatory activity in epithelial cells of the human upper respiratory system Respir Res. 2011; 12(1): 92. Gao M, Singh A, et al.
  280. Antioxidant Mexidol premedication of patients with periodontitis during antihomotoxic therapy. Stomatologiia 81(2): 20-22. Larentsova, L. I., et al. (2002).
  281. Antioxidative, antiproliferative and biochemical effects in HepG2 cells of a homeopathic remedy and its constituent plant tinctures tested separately or in combination. Arzneimittelforschung. 2003, 53, 12, 823-30. Gebhardt R.
  282. Analysis of hepatitis B viral load decline under potent therapy: complex decay profiles observed. Hepatology 2001, 34(5):1012–1020. Lewin SR, Ribeiro RM, Walters T, Lau GK, Bowden S, Locarnini S, Perelson AS.
  283. Analysis of the capability of ultra-highly diluted glucose to increase glucose uptake in arsenite-stressed bacteria Escherichia coli. Zhong Xi Yi Jie He Xue Bao 2011, 9(8):901–912. Khuda-Bukhsh AR, De A, Das D, Dutta S, Boujedaini N.
  284. Analysis of the RNA content of the exosomes derived from blood serum and urine and its potential as biomarkers. Philos Trans R Soc Lond B Biol Sci. 2014 Sep 26;369(1652). Li M, Zeringer E et al.
  285. And again: is homeopathy a placebo response? Forschende Komplementarmedizin 6(1): 28; discussion 28-31. Leffers, P., et al. (1999).
  286. Alternative therapies for tension-type headache." Current pain and headache reports 8(6): 484-488. Lenaerts, M. E. (2004).
  287. A Arte de Curar versus A Ciência das Doenças". São Paulo: Dynamis Editorial, 1996. Luz, Madel T.
  288. A background to acupuncture and its use in chronic painful musculoskeletal conditions. The Journal of the Royal Society for the Promotion of Health September 2006 126: 219-227, doi:10.1177/1466424006068238
  289. A biostatistical insight into the As(2)O(3) high dilution effects on the rate and variability of wheat seedling growth. Forsch Komplementarmed Klass Naturheilkd 2005; 12 (5):277-83. Brizzi M, Lazzarato L, Nani D et al.
  290. A Biostatistical Insight into the As2O3 High Dilution Effects on the Rate and Variability of Wheat Seedling Growth. Res Compl Med/ Forsch Komplementärmed 2005; 12: 277-83. Brizzi M, Lazzarato L, Nani D, Borghini F, Peruzzi M, Betti L.
  291.  A brief history of homeopathy'." Journal of the Royal Society of Medicine 100(2): 65-66. Horobin, D. (2007).
  292. A brief study course in homeopathy: the value and relation of diet to our homeopathic remedies." Journal of the American Institute of Homeopathy 59(7): 241-243. Hubbard, E. W. (1966).
  293. A brief study course in homoeopathy." Homoeopathic bulletin 18: 198-200. Hubbard, E. W. (1946).
  294. A case of oesophageal ulcer developed after taking homeopathic pill in a young woman." World journal of gastroenterology : WJG 13(14): 2132-2134. Corleto, V. D., et al. (2007).
  295. A case study of chronic chorea in an old man cured by homeopathy La Revue d'Homéopathie, Volume 5, Issue 2, June 2014, Page 89. Singh SM.
  296. A Case Study on the Substitution Effect between the Length of GP Consultation and Drug Prescribing Practices Healthc Policy. 2010 May; 5(4): 58–68. Ventelou, B, Rolland S, et al.
  297. A century of homoeopathic paediatrics, British Homoeopathic journal, Volume 84, Issue 4, October 1995, Pages 238-242. Leary B.
  298. A cognitive theory of consciousness: Neural networks versus brainwaves", Proc. Int. Symp. Neur. Net. & Neur. Comp., Prague (1990). D. Raković,
  299. Quantum Fields and Strings: A Course for Mathematicians. American Mathematical Society. Deligne, Pierre; Etingof, Pavel; Freed, Daniel; Jeffery, Lisa; Kazhdan, David; Morgan, John; Morrison, David; Witten, Edward, eds. (1999).
  300. M-theory (the theory formerly known as strings). International Journal of Modern Physics A. 11 (32): 6523–41. Duff, Michael (1996).
  301. Arnica for bruising and swelling." American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 64(23): 2434- 2443. Kottke, M. K. (1998).
  302. Arnica montana Gel in Osteoarthritis of the Knee: an open, multicenter clinical trial. Advanced Therapies, 2002, Sep-Oct, 19, 5, 209-18. Kneusel O, Weber M, Suter A.
  303. Arnica--a placebo?" Homeopathy : the journal of the Faculty of Homeopathy 92(3): 174. Ghosh, A. (2003).
  304. Arsenic trioxide induces apoptosis in pancreatic cancer cells via changes in cell cycle, caspase activation, and GADD expression. Pancreas. Aug 2003;27(2):174-179. 111. Li X, Ding X, Adrian TE.
  305. Arthur Lutze's homeopathic treatment of dental and jaw diseases; a contribution to the history of homeopathy in dentistry]." Osterreichische Zeitschrift fur Stomatologie 48(6): 305-307. Hoffmann, K. F. (1951).
  306. Ask the midwife. Prevention and care of hemorrhoids, including homeopathic remedies." The Birth gazette 16(2): 13-16. Goldstein, L. (2000).
  307. Assessment of homeopathic medicine Aconitum napellus in the treatment of anxiety in an animal model." Int J High Dilution Res 11(38): 33-42. Haine, G. (2012).
  308. Association between complementary and alternative medicine use, preventive care practices, and use of conventional medical services among adults with diabetes." Diabetes care 29(1): 15-19. Garrow, D. and L. E. Egede (2006).
  309. A cognitive theory of consciousness: Possible educational framework", Proc. 12th Ann. Int. Conf. IEEE/EMBS, Part 5/5, Philadelphia (1990). D. Raković,
  310. A Comfort Quantum physics and the philosophy of medicine. 77(8): 631–633. PMCID: PMC1440111. J R Soc Med. 1984 Aug;
  311. A comparative consecutive case series of 20 children with a diagnosis of ADHD receiving homeopathic treatment, compared with 10 children receiving usual care Homeopathy May 2016 Volume 105, Issue 2 Pages 194 -201. Fibert, P et al.
  312. A comparative observational study to assess the effectiveness and costs of individualised homeopathy compared to conventional treatment in children with atopic dermatitis—An example for whole system research, European Journal of Integrative Medicine, Volume 1, Supplement 1, November 2008, Page 22. Witt CM, Brinkhaus B et al.
  313. Antiviral Action of Euphorbium Compositum and its Componants. Forschende Komplementarmedizin Und Klassiche Naturheikunde, 2001, 8, 207-212. Glatthaar-Saalmuller B, Fallier-Becker P.
  314. Anxiolytic effect of homeopathic preparation of Pulsatilla nigricans in Swiss albino mice." (1476-4245 (Electronic)). Lakshmipathy Prabhu R Fau - Ruckmani, A., et al.
  315. Appendix 4 - Energy Healing Modalities*, In Textbook of Family Medicine (Seventh Edition), W.B. Saunders, Philadelphia, 2007, Page 1518 74. Guerrera MP.
  316. APPENDIX A – Homeopathy: General Information on Prescribing and Administering Homeopathic Medicines Integrative Medicine for Children, 2009, Pages 468-471. Levatin J.
  317. Applications of particle-tracking analysis to the determination of size distributions and concentrations of nanoparticles in environmental, biological and food samples. TrAC Trend. Anal. Chem 2011, 30 (3), 473−483. Gallego-Urrea, J. A.; Tuoriniemi, J.; Hassellv, M.
  318. Are complementary therapies and integrative care cost-effective? A systematic review of economic evaluations BMJ Open. 2012; 2(5): e001046. Herman PM, Poindexter BL, et al.
  319. Are media attacks justified? A response to Vithoulkas." Homeopathy : the journal of the Faculty of Homeopathy 98(1): 70. Johnson, G. (2009).
  320. Are the clinical effects of homeopathy placebo effects? A meta-analysis of placebo-controlled trials. Lancet 1997; 350:834-43. Linde K, Clausius N, Ramirez G et al.
  321. Are there none so blind?" The New Zealand medical journal 102(869): 299. Godfrey K. New GP network will integrate conventional and complementary medicine BMJ. 2005 October 22; 331(7522): 924. Godfrey, M. E. (1989).
  322. Are we close to a theory of energy medicine?" Journal of alternative and complementary medicine 10(1): 83-86 Hankey, A. (2004).
  323. A Comparative Study of Complementary and Alternative Medicine Use Among Heterosexually and Lesbian Identified Women: Data from the ESTHER Project (Pittsburgh, PA, 2003– 2006) J Altern Complement Med. 2010 November; 16(11): 1161–1170. Smith HA, Matthews A, et al.
  324. A comparative study on phytochemical investigation and pharmacological screening of Platycladus orientalis and Ocimum canum. International Journal of Phytopharmacy. 2016;5(6):130-138 DOI 10.7439/ijpp.v5i6.3686. Jhansee Mishra, Alok Kumar Dash.
  325. A comparison of health beliefs and behaviours of clients of orthodox and complementary medicine." The British journal of clinical psychology / the British Psychological Society 32 ( Pt 2): 237-246. Furnham, A. and R. Bhagrath (1993).
  326. A comparison of observational studies and randomized, controlled trials. ." NEJM 342(25): 1878-1886. Benson, K. (2000).
  327. A completely new global situation?" Homoeopathic publishing and modern world in the 1950s and 1960s." Medizinhistorisches Journal 45(1): 134-152. Eschenbruch, N. (2010).
  328. A complex homeopathic preparation for the symptomatic treatment of upper respiratory infections associated with the common cold: an observational study. Explore (NY) 2006;2: 109–14. Schmiedel V, Klein P.
  329. A complex homeopathic preparation for the symptomatic treatment of upper respiratory infections associated with the common cold: An observational study. Explore (NY); 2: 109–114. Schmiedel V, Klein P (2006).
  330. A complex homeopathic preparation for the treatment of osteoarthritis." Explore 2(3): 234. Anderson, K. (2006).
  331. A complex systems science perspective for whole systems of CAM research. Forsch Komplementarmed Klass Naturheilkd 2012, 19(Supplement 1):7–14. 101. Koithan M, Bell IR, Niemeyer K, Pincus D:
  332. A concepção antiga de símile (1936) In: Selecta Homeopathica, Rio de Janeiro, 1994; 2(1): 5-77.   W. Stumpf, “Homöopathie” Everest, Gräfe und Unzer GmbH, Munich, Deutchland, 1990. Boyd JL.
  333. A conjugation platform for the targeted delivery of anticancer agents. Innovations in Pharmaceutical Technology 2011:56–9. Deonarain MP, Milgrom LR.
  334. A contemporary view of alternative healing modalities." The Nurse practitioner 18(9): 51-55. Engebretson, J. and D. Wardell (1993).
  335. A Controlled Clinical Trial for Testing the Efficacy of the Homoeopathic Drug Eupatorium perfoliatum D2 in the Treatment of Common Cold Arzneimittel Forschung, 1981, 31, 4, 732-736. Von Gasssinger C. A., Wunstel G., Netter P.
  336. A controlled evaluation of a homeopathic preparation in the treatment of influenza-like syndromes.Br J Clin Pharmacol, 27 (3): 329-35. Ferley JP, Zmirou D, D’Adhemar D, Balducci F. (1989).
  337. A Convergent Synthetic Platform for Single-Nanoparticle Combination Cancer Therapy: Ratiometric Loading and Controlled Release of Cisplatin, Doxorubicin, and Camptothecin J. Am. Chem. Soc., 2014, 136 (16), pp 5896–5899. Liao L, Liu J, et al.
  338. A Critical Analysis of Chromotherapy and Its Scientific Evolution Evid Based Complement
  339. A critical examination of evidence regarding the use of individualised homeopathy in the treatment of bipolar spectrum disorders Homeopathy, Volume 103, Issue 1, January 2014, Page 83. Blyden-Taylor K.
  340. A critical note on the role of the quantum mechanical ‘collapse’ in quantum modeling of consciousness", Informatica, Vol. 26, No. 1, pp. 85-90 (2002). D. Raković, M. Dugić.
  341. A critical overview of homeopathy. Annals of Internal Medicine 2003; 138: 393-99. Jonas WB, Kaptchuk TJ, Linde K.
  342. A critical overview of homeopathy." Annals of internal medicine 139(8): W73; author reply W76.
  343. A critical overview of homeopathy." Annals of internal medicine 139(8): W75; author reply W76. Federspil, G., et al. (2003).
  344. A critical review of natural therapies in wound management." Ostomy/wound management 50(2): 36-40, 42, 44-36 passim. Leach, M. J. (2004).
  345. A prospective multi-centric open clinical trial of homeopathy in diabetic distal symmetric polyneuropathy. Homeopathy 2013; 102(2): 130-138. Nayak C, Oberai P, Varanasi R, Baig H, Ch R, Reddy GR, Devi P, S B, Singh V, Singh VP, Singh H, Shitanshu SS.
  346. A protocol for a trial of homeopathic treatment for irritable bowel syndrome BMC Complement Altern Med. 2012; 12: 212.  Peckham EJ, Relton C, et al.
  347. A quantum-like model of homeopathy clinical trials: importance of in situ randomization and unblinding Homeopathy April 2013;102(2):106-113. Beauvais F.
  348. Is quantum entanglement in homeopathy a reality? Peter Fisher  Homeopathy p209–210 Published in issue: August 2016
  349. Motivations of patients seeking supportive care for cancer from physicians prescribing homeopathic or conventional medicines: results of an observational cross-sectional study.Homeopathy, Vol. 105, Issue 4.2016. Karine Danno, Aurélie Colas, Gilles Freyer, Jean-Paul Guastalla, Gérard Duru, Eric Musial, Vincent Libourel, Jean-Philippe Fendler, Jean-Louis Masson, Marie-France Bordet
  350. Treatment with Ruta graveolens 5CH and Rhus toxicodendron 9CH may reduce joint pain and stiffness linked to aromatase inhibitors in women with early breast cancer: results of a pilot observational study.Homeopathy, Vol. 105, Issue 4. 2016. Jean-Claude Karp, Carole Sanchez, Philippe Guilbert, William Mina, Antoine Demonceaux, Hervé Curé
  351. A patient reported outcome measure in homeopathic clinical practice for long-term conditions Homeopathy, Vol. 105, Issue 4.2016 Elizabeth Thompson, Petter Viksveen, Susan Barron
  352. The characteristics, experiences and perceptions of homeopaths in New Zealand: results from a national survey of practitioners.Homeopathy, Vol. 105, Issue 4. 2016 Phillip Cottingham, Jon Adams, Ram Vempati, Jill Dunn, David Sibbritt
  353. Homeopathy outperforms antibiotics treatment in juvenile scallop Argopecten ventricosus: effects on growth, survival, and immune response. Homeopathy, Vol. 105, Issue 4. 2016 José Manuel Mazón-Suástegui, Milagro García-Bernal, Pedro Enrique Saucedo, Ángel Campa-Córdova, Fernando Abasolo-Pacheco
  354. Is metabolic dysregulation associated with antidepressant response in depressed women in climacteric treated with individualized homeopathic medicines or fluoxetine? The HOMDEP-MENOP Study. Homeopathy, Vol. 105, Issue 4. 2016 Emma del Carmen Macías-Cortés, Lidia Llanes-González, Leopoldo Aguilar-Faisal, Juan Asbun-Bojalil.
  355. Number of succussion strokes affects effectiveness of ultra-high-diluted arsenic on in vitro wheat germination and polycrystalline structures obtained by droplet evaporation method. Homeopathy, Vol. 105, Issue 4. 2016. Lucietta Betti, Grazia Trebbi, Maria Olga Kokornaczyk, Daniele Nani, Maurizio Peruzzi, Giovanni Dinelli, Paolo Bellavite, Maurizio Brizzi
  356. Action of antibiotic oxacillin on in vitro growth of methicillin-resistant Staphylococcus aureus (MRSA) previously treated with homeopathic medicines. Homeopathy, Vol. 105, Issue 4. 2016 Tânia Aguiar Passeti, Leandro Ribeiro Bissoli, Ana Paula Macedo, Registila Beltrame Libame, Susana Diniz, Silvia Waisse. Publication stage: In Press Corrected Proof
  357. A Randomised Equivalence Trial Comparing the Efficacy and Safety of Luffa comp.-Heel Nasal Spray with Cromolyn Sodium Spray in the Treatment of Seasonal Allergic Rhinitis Forschende Komplementarmedizin, 1999, 6, 142-148. Weiser M, Gegenheimer LH, Klein P.
  358. A randomised, controlled, triple-blind trial of the efficacy of homeopathic treatment for chronic fatigue syndrome.J Psychosom Res. 56(2): 189-97. Weatherley-Jones E, et al. (2004).
  359. A randomized comparison of homoeopathic and standard care for the treatment of glue ear in children. Complement Ther Med. 7 (3): 132-5. Harrison H, Fixsen A, Vickers A. (1999).
  360. A randomized controlled trial comparing topical piroxicam gel with a homeopathic gel in osteoarthritis of the knee. Rheumatology, 2000, Jul, 39, 7, 714-9. 129. Van Haselen RA, Fisher PA.
  361. Mirror Symmetry (PDF). American Mathematical Society. Hori, Kentaro; Katz, Sheldon; Klemm, Albrecht; Pandharipande, Rahul; Thomas, Richard; Vafa, Cumrun; Vakil, Ravi; Zaslow, Eric, eds. (2003).
  362. Unity of superstring dualities. Nuclear Physics B. 4381 (1): 109–137.Hull, Chris; Townsend, Paul (1995).
  363. A randomized controlled trial of a homeopathic syrup in the treatment of cold symptoms in young children. Complement Ther Med 2016;29:229-234. Jacobs J, Taylor JA.
  364. A randomized controlled trial of homeopathic treatment of weaned piglets in a commercial swine herd, Homeopathy, Volume 97, Issue 4, October 2008, Pages 202-205. Soto FRM, Vuaden ER et al.
  365. A randomized controlled trial of homeopathy in rheumatoid arthritis." Rheumatology 40(9): 1052-1055. Fisher, P. (2001). "Research for whom?" The British homoeopathic journal 90(4): 178-179.  Fisher, P. and D. L. Scott (2001).
  366. A randomized controlled trial to compare the use of homeopathy and internal Teat Sealers for the prevention of mastitis in organically farmed dairy cows during the dry period and 100 days post-calving. Homeopathy. 99: 90-98. Klocke P, Ivemeyer S, Butler G, Maeschli A, Heil F. (2010).
  367. A randomized controlled trial to evaluate the effectiveness of homeopathy in rheumatoid arthritis." Scandinavian journal of rheumatology 20(3): 204-208.6. Andrade, L. E., et al. (1991).
  368. A randomized double-blind placebo-controlled evaluation of the safety and efficacy of a natural over-the-counter (OTC) medication in the management of snoring. Sleep and Breathing; 3: 53-56. Lipman D, Sexton G, Schlesser J (1999).
  369. A randomized equivalence trial comparing the efficacy and safety of Luffa comp.-Heel nasal spray with cromolyn sodium spray in the treatment of seasonal allergic rhinitis. Forsch Komplementarmed. 1999;6:142–8. [PubMed]. Weiser M, Gegenheimer LH, Klein P.
  370. A randomized placebo-controlled pilot study of Cat saliva 9cH and Histaminum 9cH in cat allergic adults. Homeopathy; 102: 123-129. Naidoo P, Pellow J (2013).
  371. A randomized trial in the prevention of influenza-like syndromes by homeopathic management." Revue d'epidemiologie et de sante publique 43(4): 380-382. Attena, F., et al. (1995).
  372. A randomized, controlled clinical trial of the homeopathic medication Traumeel S in the treatment of chemotherapy-induced stomatitis in children undergoing stem cell transplantation. Cancer; 92:684–690. Oberbaum M, Yaniv I, Ben-Gal Y, Stein J, Ben-Zvi N, Freedman LS, Branski D (2001).
  373. A randomized, double-blind, parallel trial comparing capsaicin nasal spray with placebo in subjects with a significant component of nonallergic rhinitis. Ann Allergy Asthma Immunol 2011;107: 171-179. Bernstein JA, Davis BP, Picard JK, Cooper JP, Zheng S, Levin LS.
  374. A randomized, double-blind, placebo-controlled study of classical homeopathy in generalized anxiety disorder. Journal of Clinical Psychiatry; 64:282–287. Bonne O, Shemer Y, Gorali Y, Katz M, Shalev AY (2003).
  375. A rational model for assessing and evaluating complex interventions in health care BMC Health Serv Res. 2006; 6: 86. May C.
  376. A Rattlesnake and Homoeopathy." Journal of the American Institute of Homeopathy 56: 400-401. Green, J. M. (1963).
  377. A reevaluation of the effectiveness of homeoprophylaxis against leptospirosis in Cuba in 2007 and 2008. J Ev Based Comp Alt Med. Golden I, Bracho G.
  378. A relação médico-paciente indireta e o tratamento homeopático na asma infantile [The indirect patient-doctor relationship and the homeopathic treatment of childhood asthma]. Revista de Homeopatia; 60:26–31. De Freitas, Goldenstein E, Sanna OM (1995).
  379. Biomineralization and matrix vescles in biology and pathology. Semin. Immunopathol. 33(5), 409–417 (2011). Golub EE.
  380. The publication in Homeopathy of studies involving animal experimentation. Kate Chatfield (Preston, UK), Robert T. Mathie (London, UK), Leoni V. Bonamin (São Paulo, Brazil), Menachem Oberbaum (Jerusalem, Israel), Peter Fisher (London, UK).August 2016 Volume 105, Issue 3, Homeopathy. p211–216. August 2016 . Published in issue: August 2016
  381. Homeopathic therapy in pediatric atopic diseases: short- and long-term results. Elio Rossi, Marco Picchi, Paola Bartoli, Marialessandra Panozzo, Chiara Cervino, Linda Nurra. August 2016 Volume 105, Issue 3, Homeopathy. p217–224 Published online: April 13, 2016 Full-Text HTMLPDF
  382. Preparation, standardization and in vitro safety testing of Mycobacterium nosodes (Emtact- polyvalent nosode). Suvarna Joshi, Sandeepan Mukerjee, Shashikant Vaidya, Gitanjali Talele, Abhay Chowdhary, Rajesh Shah p225–232 Published online: April 12, 2016. August 2016 Volume 105, Issue 3, Homeopathy. Full-Text HTMLPDF
  383. Survey on hand gestures relevance in patient practitioner communication: a homeopathic example. Max Escher, Arndt Büssing, Thomas Ostermann. p233–239 Published online: August 2016 Volume 105, Issue 3, Homeopathy. May 13, 2016 Full-Text HTML PDF Supplemental Materials
  384. Protocol of randomized controlled trial of potentized estrogen in homeopathic treatment of chronic pelvic pain associated with endometriosis. Marcus Zulian Teixeira, Sérgio Podgaec, Edmund Chada Baracat. August 2016 Volume 105, Issue 3, Homeopathy.n p240–249 Published online: May 13, 2016 Full-Text HTMLPDF
  385. A morphometric and molecular study of the apoptosis observed on tadpoles' tail explants under the exposition of triiodothyronine in different homeopathic dilutions. José Roberto Pereira Guedes, Solange Carrasco, Cláudia M Ferreira, Leoni V Bonamin, Cláudia Goldenstein-Schainberg, Vanessa Martins, Vera L Capelozzi. p250–256 Published online: May 17, 2016 Full-Text HTMLPDF. August 2016 Volume 105, Issue 3, Homeopathy.
  386. Homeopathic treatments modify inflammation but not behavioral response to influenza antigen challenge in BALB/c mice. Camila Monteiro Siqueira, Priscila Dias Motta, Thayná Neves Cardoso, Cideli de Paula Coelho, Ana Flavia Popi, José Nelson Couceiro, Leoni Villano Bonamin, Carla Holandino. August 2016 Volume 105, Issue 3, Homeopathy. p257–264 Published online: May 3, 2016 Full-Text HTMLPDF
  387. In vitro assessment of anticytotoxic and antigenotoxic effects of CANOVA®Henrique Fonseca Sousa do Nascimento, Plínio Cerqueira dos Santos Cardoso, Helem Ferreira Ribeiro, Tatiane Cristina Mota, Lorena Monteiro Gomes, André Salim Khayat, Adriana Costa Guimarães, Marucia Irena Medeiros Amorim, Rommel Rodriguéz Burbano, Marcelo de Oliveira Bahia. August 2016 Volume 105, Issue 3, Homeopathy. p265–269 Published online: May 4, 2016 Full-Text HTMLPDF
  388. First evidence of Beauvais' hypothesis in a plant model. Karin Thieves, Andreas Gleiss, Karl Wilhelm Kratky, Michael Frass. August 2016 Volume 105, Issue 3, Homeopathy. p270–279 Published online: June 29, 2016. Full-Text HTMLPDFSupplemental Materials
  389. Explanatory models for homeopathy: from the vital force to the current paradigm. Silvia Waisse, Leoni Villano Bonamin. August 2016 Volume 105, Issue 3, Homeopathy. p280–285. Published online: April 6, 2016
  390. HRI Rome 2015 – Homeopathy research gathers momentum Alexander L. Tournier, E. Rachel Roberts p2 Homeopathy February 2016 Volume 105, Issue 1, p1-128
  391. Cutting Edge Research in Homeopathy: HRI's second international research conference in Rome. Alexander L. Tournier, E. Rachel Roberts p3–7 Homeopathy February 2016 Volume 105, Issue 1, p1-128 Full-Text HTMLPDF Conference Abstracts
  392. Contribution of clinical observations to the discovery of mode of action of homeopathic medicines Klaus von Ammon p8 Homeopathy February 2016 Volume 105, Issue 1, p1-128
  393. Evaluation of cytotoxic and apoptotic effects of several homeopathic dilutions of Echinacea angustifolia on human breast, cervical and prostate cancer cells and genotoxic study of E. angustifolia MT Lucero Delgado Pastelín, Cynthia Ordaz Pichardo, Gustavo Aguilar Velázquez p8  Homeopathy February 2016 Volume 105, Issue 1, p1 128
  394. Furanodiene, a natural product, inhibits breast cancer growth both in vitro and in vivo,” Cellular Physiology and Biochemistry, vol. 30, no. 3, pp. 778–790, 2012. Z. Zhong, Y. Dang, X. Yuan, et al.
  395. Maslinic acid, a natural triterpenoid compound from Olea europaea, protects cortical neurons against oxygen-glucose deprivation-induced injury,” European Journal of Pharmacology, vol. 670, no. 1, pp. 148–153, 2011. Y. Qian, T. Guan, X. Tang et al.
  396. Tumor suppressor WWOX regulates glucose metabolism via HIF1α modulation,” Cell Death and Differentiation, vol. 21, no. 11, pp. 1805–1814, 2014. View at Google Scholar M. Abu-Remaileh and R. I. Aqeilan.
  397. Basic research on homeopathic principles Paolo Bellavite p9 Homeopathy February 2016 Volume 105, Issue 1, p1-128
  398. Three Malaria studies in Kenya: a retrospective and prospective open label study and a comparison between homeopathy and coartem Martien Brands, Suzanne van Berkel p9 Homeopathy February 2016 Volume 105, Issue 1, p1-128
  399. Feasibility and clinical results of a pilot trial of individualized homeopathic treatment of fatigue in children receiving chemotherapy David Brulé, Biljana Gillmeister, Michelle Lee, Amanda Alli, Lillian Sung p9–10 Homeopathy February 2016 Volume 105, Issue 1, p1-128
  400. Microimmunotherapeutic administration of cytokines improve the clinical symptoms in EAE an animal model of multiple sclerosis Anna Camps, Beatriz Almolda, Berta Gonzalez, Bernardo Castellano p10 Homeopathy February 2016 Volume 105, Issue 1, p1-128 February 2016
  401. Carbo animalis and immune response to Ehrlich ascites tumor in mice: an experimental model Thayná Neves Cardoso, Juliana Amaral, Aloisio Cunha de Carvalho, Luciane Costa Dalboni, Luana Ramos, Silvio Leite Monteiro da Silva, Fabiana Rodrigues Santana, Cideli de Paula Coelho, Elizabeth Cristina Perez Hurtado, Leoni Villano Bonamin p10–11 Homeopathy February 2016 Volume 105, Issue 1, p1-128 February 2016 Full-Text HTMLPDF
  402. Solvatochromic dyes detect the presence of homeopathic potencies Steven Cartwright p11 Homeopathy February 2016 Volume 105, Issue 1, p1-128 Full-Text HTMLPDF
  403. A retrospective cohort study on the efficacy of homeopathy compared to homeopathy plus conventional medicine in the treatment of hypertension Teh Chye Phing p11–12 Homeopathy February 2016 Volume 105, Issue 1, p1-128 Full-Text HTMLPDF
  404. Different approaches in homeopathic basic research: plant-based bioassays and evaporation-induced crystallization Giovanni Dinelli, Grazia Trebbi, Maria Olga Kokornaczyk, Ilaria Marotti, Valeria Bregola, Sara Bosi, Lucietta Betti p12 Homeopathy February 2016 Volume 105, Issue 1, p1-128Full-Text HTMLPDF
  405. Replication of specific effects of a Stannum metallicum 30x preparation in a cress seedling/biocrystallization test system P. Doesburg, J.-O. Andersen, C. Scherr, S. Baumgartner p12–13 Homeopathy February 2016 Volume 105, Issue 1, p1-128 Full-Text HTMLPDF
  406. The role of the research ethics committee in providing ethical approval for provings. The findings from a pilot study Jean Duckworth p13  Homeopathy February 2016 Volume 105, Issue 1, p1-128 Full-Text HTMLPDF
  407. Corrigendum to “Use of Ethnomedicinal Plants by the People Living around Indus River”, Sakina Mussarat, Naser M. AbdEl-Salam, Akash Tariq, Sultan Mehmood Wazir, Riaz Ullah, and Muhammad Adnan Volume 2016 (2016), Article ID 3401263, 8 pages Evidence-Based Complementary and Alternative Medicine
  408. Phytochemical and Pharmacological Studies on the Genus Psoralea: A Mini Review, Cong-Cong Li, Teng-Long Wang, Zhong-Qun Zhang, Wen-Qiang Yang, Yue-Fei Wang, Xin Chai, Chun-Hua Wang, and Zheng Li Volume 2016 (2016), Article ID 8108643, 17 pages Evidence-Based Complementary and Alternative Medicine
  409. Repetitions of fundamental research models for homeopathically prepared dilutions beyond 10−23: a bibliometric study P. Christian Endler p13–14 Homeopathy February 2016 Volume 105, Issue 1, p1-128
  410. The clinical experience in the centre of integrated medicine, Pitigliano hospital using magistral homeopathic formulations: results in outpatients affected by chronic diseases and considerations on the chronic care model integrated with homeopathic approach. Rosaria Ferreri, Simonetta Bernardini, Roberto Pulcri, Franco Cracolici, Massimo Rinaldi p14 Homeopathy February 2016 Volume 105, Issue 1, p1-128
  411. Homeopathy and public health: multimorbidity, polypharmacy, antimicrobial resistance, adverse drug reactions and homeopathy Peter Fisher p14 Homeopathy February 2016 Volume 105, Issue 1, p1-128
  412. Proving ethics: at the coalface Alastair Gray p14–15 Homeopathy February 2016 Volume 105, Issue 1, p1-128Full-Text
  413. Homeopathic treatment of respiratory illnesses in children: results from two randomized trials James A. Taylor, Jennifer Jacobs p15 Homeopathy February 2016 Volume 105, Issue 1, p1-128
  414. Homeopathic Pathogenetic Trials (provings) do not always match homeopathic clinical practice. Possible answers from the qualitative research tradition Jean Pierre Jansen p15–16  Homeopathy February 2016
  415. A randomized open comparative clinical trial on the effectiveness, safety and tolerability of a homeopathic medicinal product for frequent acute upper respiratory tract infections in children M. Jong, M. van Vliet, J. Burkart, P. Klement, E. Baarsp16 Homeopathy February 2016 Full-Text HTMLPDF
  416. Results of an international, randomised, controlled clinical trial with a complex homeopathic medication in feverish upper respiratory tract infections M. Thinesse-Mallwitz, V. Maydannik, T. Keller, S. De Jaegere, P. Klement p16–17 Homeopathy February 2016 Full-Text HTMLPDF
  417. Effect of ultra-high dilutions of Lycopodium clavatum on reproductive and sexual functions in aged male Wistar albino rats Ganesh Lakshmanan, Seppan Prakash p17 Homeopathy February 2016
  418. Exploring the model of murine infection by Trypanosoma cruzi to investigate treatment with highly diluted drugs: the influence of Lycopodium clavatum or Phosphorus in Wistar rats
  419. Silvana Marques de Araújo, Camila Fernanda Brustolin, Paula Fernanda Massini, Neide Martins Moreira, Carlos Edmundo Rodrigues Fontes, Denise Lessa Aleixo p17–18 Published in issue: Homeopathy February 2016 Full-Text HTMLPDF
  420. Systematic review and meta-analysis of randomised, placebo-controlled, trials of individualised homeopathic treatment Robert T. Mathie, Michel Van Wassenhoven, Jennifer Jacobs, Menachem Oberbaum, Joyce Frye, Raj K. Manchanda, Helmut Roniger, Flávio Dantas, Lynn A. Legg, Jürgen Clausen, Sian Moss, Jonathan R.T. Davidson, Suzanne M. Lloyd, Ian Ford, Peter Fisher p18–19 Published in issue:Homeopathy February 2016 Full-Text HTMLPDF
  421. Quantal Nature of Synaptic Transmission Department of Physiology, University of Utah Colkge of Medicine, Salt Lake City, Utah A. R. Martinhttp://www.octopus.huji.ac.il/course/OldWebSite/Labs/QuantalNature.pdf
  422. The Biofield Hypothesis: Its Biophysical Basis and Role in Medicine Beverly Rubik. The Journal of Alternative and Complementary Medicine. July 2004, 8(6): 703-717. doi:10.1089/10755530260511711.The Journal of Alternative and Complementary Medicine
  423. Quantum Hypothesis Testing for Gaussian States: Quantum Analogues of χ2, t-, and F-Tests Communications in Mathematical PhysicsMarch 2013, Volume 318, Issue 2, pp 535–574 Wataru Kumagai, Masahito Hayashi
  424. The Order of Coincidence Required for Visual Threshold Proceedings of the Physical Society. Section B, Volume 67, Number 9 G S Brindley
  425. Quantum Events of Biophoton Emission Associated with Complementary and Alternative Medicine Therapies: A Descriptive Pilot Study Marius Hossu and Ronald Rupert. The Journal of Alternative and Complementary Medicine. March 2006, 12(2): 119-124. doi:10.1089/acm.2006.12.119. The Journal of Alternative and Complementary Medicine
  426. Homeopathy outperforms antibiotics treatment in juvenile scallop Argopecten ventricosus: effects on growth, survival, and immune response DOI: http://dx.doi.org/10.1016/j.homp.2016.12.002 homeopathy José Manuel Mazón-Suástegui, Milagro García-Bernal, Pedro Enrique Saucedo, Ángel Campa-Córdova, Fernando Abasolo-Pacheco
  427. Developmental regulation of transmitter release at the calyx of Held in rat auditory brainstem Shinichi Iwasaki, The journal of physiology August 2001 DOI: 10.1111/j.1469-7793.2001.00861.x Tomoyuki Takahashi
  428. Effects of homeopathic Arnica montana on gene expression of human macrophages-results of quantitative real-time PCR D. Olioso, M. Marzotto, C. Bonafini, P. Bellavite p19 Published in issue: Homeopathy February 2016 Full-Text HTMLPDF
  429. Investigation of effects of highly diluted substances in periodontal inflammation using flow cytometry analysis – a pilot study C. Raak, F. Schaupp, F. Entschladen, T. Ostermann, G. Gassmann, K. Büchel, A. Friedmann p19 Published in issue: Homeopathy February 2016 Full-Text HTMLPDF
  430. Homoeopathy in iatrogenic disorders Pawan Pareek p20 Published in issue: Homeopathy February 2016 Full-Text HTMLPDF
  431. How safe is homeopathy? An analysis of the Posadzki et al. 2012 safety paper and fresh review of the same literature E. Rachel Roberts, Alexander L. Tournier, Kate Chatfield, Petter Viksveen, Robert T. Mathie p20 Published in issue: Homeopathy February 2016 Full-Text HTMLPDF
  432. The translation of prover journals to standard homoeopathic formats: accountability and traceability of proving data Ashley H.A. Ross p21 Homeopathy February 2016 Full-Text HTMLPDF
  433. Homeopathy and complementary medicine for cancer patients: results of a survey on integrative oncology centres in Europe Elio Rossi, Alessandra Vita, Sonia Baccetti, Mariella Di Stefano, Fabio Voller, Alberto Zanobini p21 Homeopathy February 2016
  434. Improving cough treatment with a mixed methods approach Lex Rutten, Christien Klein-Laansma p21–22  Homeopathy February 2016
  435. Clinical trial for evaluation of a HIV nosode in the treatment of HIV infected participants Rajesh Shahp22 Published in issue: February 2016 Full-Text HTMLPDF
  436. A group of recent provings in which the new HPCUS Provings. Guidelines were applied: some comments on the methodology Peter Smith, Ashley Ross, Todd Rowe, Ulrike Striebich p22–23  Homeopathy February 2016
  437. Single-blind study assessing the individualized homeopathic treatment of cancer patients versus placebo Francesca Talarico, Costanza Maria Pullano, Sebastiano Di Salvo, Vincenzo Falabella p23 Homeopathy February 2016 Full-Text HTMLPDF
  438. Physicochemical investigations of homeopathic potencies: a systematic review of the literature Alexander L. Tournier, Sabine D. Klein, Sandra Würtenberger, Ursula Wolf, Stephan Baumgartner p23–24  Homeopathy February 2016
  439. Homeopathy in self-reported depression: a pragmatic randomised controlled trial Petter Viksveen p24 Published in issue: Homeopathy February 2016 Full-Text HTMLPDF
  440. In Vitro Antiproliferative and Antioxidant Effects of Extracts from Rubus caesius Leaves and Their Quality Evaluation, Daniel Mirosław Grochowski, Roman Paduch, Adrian Wiater, Adrianna Dudek, Małgorzata Pleszczyńska, Monika Tomczykowa, Sebastian Granica, Paulina Polak, and Michał Tomczyk Volume 2016 (2016), Article ID 5698685, 8 pages Evidence-Based Complementary and Alternative Medicine
  441. Neuroprotective Effect of Paeonol Mediates Anti-Inflammation via Suppressing Toll-Like Receptor 2 and Toll-Like Receptor 4 Signaling Pathways in Cerebral Ischemia-Reperfusion Injured Rats, Wen-Yen Liao, Tung-Hu Tsai, Tin-Yun Ho, Yi-Wen Lin, Chin-Yi Cheng, and Ching-Liang Hsieh Volume 2016 (2016), Article ID 3704647, 12 pages Evidence-Based Complementary and Alternative Medicine
  442. Spatholobus suberectus Column Extract Inhibits Estrogen Receptor Positive Breast Cancer via Suppressing ER MAPK PI3K/AKT Pathway, Jia-Qi Sun, Gan-Lin Zhang, Yi Zhang, Nan Nan, Xu Sun, Ming-Wei Yu, Hong Wang, Jin-Ping Li, and Xiao-Min Wang Volume 2016 (2016), Article ID 2934340, 13 pages Evidence-Based Complementary and Alternative Medicine
  443. Immunomodulatory Efficacy of Standardized Annona muricata (Graviola) Leaf Extract via Activation of Mitogen-Activated Protein Kinase Pathways in RAW 264.7 Macrophages, Goon-Tae Kim, Nguyen Khoi Song Tran, Eun-Hye Choi, Yoo-Jeong Song, Jae-Hwi Song, Soon-Mi Shim, and Tae-Sik Park Volume 2016 (2016), Article ID 2905127, 10 pages Evidence-Based Complementary and Alternative Medicine
  444. Use of homeopathy in patients with organ transplant in Switzerland: first results and further steps Martin Frei-Erb, Klaus von Ammon, Loredana Torchetti p25 Published in issue:Homeopathy February 2016
  445. The effect of disclosing information about prescribed homeopathic medicine to patients on their clinical outcomes: a comparative study Mahsa Asasi, Nazila Assasi p25 Homeopathy February 2016
  446. Homeopathy in a clinical setting of Integrated Medicine for inpatients in an Italian public hospital. Report of four years of activity Simonetta Bernardini, Rosaria Ferreri, Roberto Pulcri, Franco Cracolici, Massimo Rinaldi p26 Homeopathy  February 2016
  447. Effectiveness of the concomitant use of psychotropic pharmaceuticals and individualized homeopathic treatment: a Delphi study Kimberlee Blyden-Taylor p26 Published in issue: Homeopathy February 2016
  448. Retrospective observational study of people with HIV and AIDS receiving homeopathic treatment in Swaziland Barbara J. Braun, Kathryn P. Braun, Thandeka Mabuza p26–27 Published in issue: Homeopathy February 2016
  449. Consciousness and Quantum Information Processing: Uncovering the Foundation for a Medicine of Light, The Journal of Alternative and Complementary Medicine - The Journal of Alternative and Complementary Medicine. June 2004, 10(1): 27-39. doi:10.1089/107555304322848931. Published in Volume: 10 Issue 1: June 30, 2004  Bruce D. Curtis and J.J. Hurtak.
  450. Study design of a Randomized, Placebo Controlled Trial of the Homeopathic Treatment of Attention Deficit Hyperactivity Disorder (ADHD) David Brulé p27 Homeopathy February 2016 Full-Text HTMLPDF
  451. Effectiveness of homeopathic remedies in severe laminitic horses P. Cayado p27–28 Homeopathy February 2016
  452. Literature review of the in vitro and in vivo evidence for homeopathic medicines in the treatment or prevention of malaria Elena Cecchetto p28 Homeopathy February 2016
  453. Rationale for a pragmatic randomised controlled trial of the effectiveness of treatment by homeopaths for ADHD Philippa Fibert p28–29 Homeopathy February 2016 Full-Text HTMLPDF
  454. Homeopathic treatment for otitis media in children: the case for pragmatic trials Alison Fixsen p29 Homeopathy February 2016 Full-Text HTMLPDF
  455. A case for creating homeopathy-based first aid kit for Traumatic Brain Injury and implementing that in 108 emergency services in India Srinivasulu Gadugu p29–30 Published in issue: Homeopathy February 2016
  456. Ultra High Dilution – Physiology and Physics comes of age Peter Fisher p221–222 Homeopathy November 19, 2015 Full-Text HTMLPDF
  457. Ultra High Dilution 1994 revisited 2015 – the state of follow-up research P. Christian Endler, Jurgen Schulte, Beate Stock-Schroeer, Saundra Stephen Homeopathy p223–226 Homeopathy August 29, 2015 Full-Text HTMLPDF
  458. Update on hormesis and its relation to homeopathy Menachem Oberbaum, Cornelius Gropp p227–233 Homeopathy August 31, 2015
  459. Replications of fundamental research models in ultra high dilutions 1994 and 2015 – update on a bibliometric study Peter Christian Endler, Paolo Bellavite, Leoni Bonamin, Tim Jäger, Sintia Mazon p234–245 Homeopathy November 25, 2015
  460. Wheat and ultra high diluted silver nitrate – further experiments and re-analysis of data Waltraud Scherer-Pongratz, Peter Christian Endler, Harald Lothaller, Saundra Stephen p246–249 Homeopathy November 21, 2015
  461. Amphibians and ultra high diluted thyroxine – further experiments and re-analysis of data Peter Christian Endler, Waltraud Scherer-Pongratz, Bernhard Harrer, Gerhard Lingg, Harald Lothaller p250–256 Homeopathy November 20, 2015
  462. Wheat and ultra high diluted gibberellic acid – further experiments and re-analysis of data Peter Christian Endler, Waltraud Scherer-Pongratz, Harald Lothaller, Saundra Stephen p257–262 Homeopathy November 6, 2015
  463. Immunological models in high dilution research following M Bastide Leoni Villano Bonamin, Paolo Bellavite p263–268 Homeopathy September 14, 2015
  464. Survey of immuno-allergological ultra high dilution research Bernard Poitevin p269–276 Homeopathy Published online: July 13, 2015
  465. The use of plant-based bioassays in homeopathic basic research Tim Jäger, Claudia Scherr, Devika Shah, Vera Majewsky, Ursula Wolf, Lucietta Betti, Stephan Baumgartner p277–282 Homeopathy July 14, 2015
  466. The use of animal models in homeopathic research – a review of 2010–2014 PubMed indexed papers Leoni Villano Bonamin, Thayná Neves Cardoso, Aloísio Cunha de Carvalho, Juliana Gimenez Amaral p283–291 Homeopathy July 11, 2015
  467. Physiological effects of homeopathic medicines in closed phials – a critical evaluation Roeland van Wijk, Frederik Anton Clemens Wiegant p292–294 Homeopathy July 15, 2015
  468. From high dilutions to digital biology: the physical nature of the biological signal Yolène Thomas p295–300 August 23, 2015
  469. Electromagnetic and magnetic vector potential bio-information and water Cyril William Smith p301–304 Homeopathy October 14, 2015
  470. Experimental physical methods and theories – then and now Jurgen Schulte p305–310 Homeopathy October 14, 2015
  471. Publications on experimental physical methods to investigate ultra high dilutions – an assessment on quality Jurgen Schulte p311–315 Homeopathy July 20, 2015
  472. Observations on entanglement, non-locality and ultra-high dilutions Jurgen Schulte p316–321 Homeopathy August 6, 2015
  473. Scientific proving of ultra high dilutions on humans Harald Walach, Michael Teut p322–327 Homeopathy October 9, 2015
  474. Controll